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Chapter 1: Blood-Brain Barrier and neurovascular unit 
1.1 History of the Blood-Brain Barrier 
The direct evidence for the existence of the blood-brain barrier (BBB) came dawn in 
the twentieth century, when a German scientist Paul Ehrlich observed that most acidic 
dyes, including trypan blue, injected into blood stream readily stain most regions of the 
body but not the brain and spinal cord (Ehrlich, 1885). But he wrongly concluded that 
these findings were due to the low affinity of central nervous system (CNS) for these 
dyes. Few years after, his student Edwin Goldman completed Erlich’s experiments, 
and showed that injection of the same dyes into the subarachnoid space of rats readily 
stained nervous tissue, but not the rest of body’s organs. This finding falsified the 
hypothesis that the differential staining was due to lower affinity for the dyes in the CNS 
tissue, suggesting that once within the CNS, the dyes did not cross the wall of brain 
capillaries to the blood circulation (Goldmann, 1913). This study provided an evidence 
for the existence of the BBB and confirmed the observations of another german 
scientist, Lewandowsky. Lewandowsky found that intravenous injection of bile acids or 
potassium ferrocyanide were of no central pharmacological effect, while direct injection 
into subarachnoid space of a dog’s spinal cord induced strong pharmacological effect 
(Lewandowsky, 1900). Further supports for the existence of the BBB came from the 
work of the Russian neurophysiologist Lina Stern in 1921, when she explained why 
certain medications and serum injected to blood stream did not enter the CNS. For 
example, intravenous injection of anti-tetanus serum failed to induce pharmacological 
effect in the CNS. Stern concluded that it must be a barrier protecting the CNS from 
toxins and germs. She called this barrier the "hematoencephalic barrier" {for review, 
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see (Palmer, 2010; Vein, 2008)}. Stern’s work was extended and confirmed by other 
german scientists, Friedman and Elkeles in 1934 (Friedemann, 1934; Palmer, 2010). 
The properties of the cerebral vasculature remained unclear until the discovery of 
electron microscopy allowing Reese and Karnovsky to observe the ultrastructural 
localization of BBB within capillary endothelial cells: they demonstrated that the 
morphological correlate of these cells is constituted by continuous belts of tight 
junctions, using injection of the electron dense tracer horseradish peroxidase, a protein 
of 40 kDa, into the vasculature or into CNS (Reese and Karnovsky, 1967). 
1.2 Concept of the Blood-Brain Barrier and neurovascular unit 
All organisms with a well-developed central nervous system (CNS) consist of the brain 
and spinal cord complex. The CNS requires a tightly regulated environment in order to 
efficiently encode and process the huge amounts of received information. The brain 
constitutes only 2% of the total body mass while it consumes 20% of the body’s energy. 
The brain needs a constant blood flow, and is very sensitive to a decrease in blood 
flow. The endothelial cells (ECs) which constitute the walls of the brain capillaries, form 
the largest interface for blood-brain exchange. This area depending on the anatomical 
area is between 150 and 200 cm²/g tissue giving a total area for exchange in the brain 
between 12 and 18 m² for the average human adult (Abbott et al., 2010). 
1.2.1 The blood-brain barrier 
The concept of the blood-brain barrier (BBB) was anticipated by the french physiologist 
Claude Bernard by the nineteenth century in his sentence “La fixité du milieu intérieur 
est la condition d’une vie libre et indépendante” (“The constancy of the internal 
environment is the condition for a free and independent life”) (Palmer, 2010) This 
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barrier is supported by a multicellular vascular structure that separates the CNS from 
the peripheral circulation. The BBB is a dynamically regulated - physical and metabolic 
barrier which is necessary for proper physiological function of the CNS. This barrier is 
important to regulate the influx and efflux of molecules and ions, and therefore is 
important for protecting the brain from fluctuations in plasma composition. BBB has 
also an important role in the hemostatic regulation of the brain microenvironment, 
which is necessary for the healthy function of the CNS (Abbott, 2002; Obermeier et al., 
2013). Blood vessels consist of two main cell types: endothelial cells that form strictly 
the vessel walls, and mural cells that sit on the abluminal surface of the endothelial cell 
layer (Daneman and Prat, 2015). These cerebral endothelial cells are differ from 
endothelial cells present in the rest of the body (discussed below, paragraph 1.4.1).  
The development and maintenance of the BBB are achieved by cellular and non-
cellular elements that directly interact with endothelial cells: basement membrane (BM) 
also known as basal lamina (BL), astrocyte end-feet ensheathing the vessels, and 
pericytes embedded within the BM. The term neurovascular unit (NVU) additionally 
refers to neurons, and microglial cells (Iadecola, 2004) (Fig.1). It is believed that all 
these components are essential for the normal function and stability of the BBB. Blood-
brain barrier disruption is associated with many neurodegenerative diseases as 
(Alzheimer’s disease, and Parkinson’s disease) stroke, multiple sclerosis, traumatic 
brain injury, diabetes, gliomas, and viral and parasitic infections (Zhao et al., 2015; 
Zlokovic, 2008, 2008). BBB may also contribute or cause diseases affecting the CNS 
when its function is disrupted. (Discussed below, paragraph 1.6) 
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Figure 1: The cell association at the blood-brain barrier. Cellular interactions at the 
neurovascular unit, which show vascular endothelial cells sealed by tight junctions. The 
endothelial abluminal surface is covered by a basement membrane in which pericytes 
are embedded. Astrocytes extend foot processes that encircle the abluminal side of the 
vessel. (Obermeier et al., 2013). 
In certain areas of the brain, endothelial cells do not form tight junctions (TJs) and allow 
free exchange of molecules between blood or cerebrospinal fluid and the parenchyma. 
Most of these areas are close to the third and fourth ventricles, these areas called 
circumventricular organs, including the median eminence, pituitary, choroid plexus, 
pineal gland, subfornical organ, organum vasculosum lamina terminalis and area 
postrema. The capillaries of these circumventricular organs are continuous fenestrated 
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vessels, with a high permeability which is important to maintain direct exposure of 
certain neurons to the blood (Fig. 2). 
Figure 2: Anatomical distribution of brain circumventricular organs. A key to the 
organs is provided in the box on the right. Anatomical abbreviation, ac: anterior 
commissure, oc: optic chiasma, pc: posterior commissure, V3 third ventricle, IV: 
forth ventricle, cc corpus callosum (Joly et al., 2007). 
In these regions, the direct exposure of certain neurons to the blood is of functional 
importance. For example, neuroendocrine hormones released from specialized nerve 
terminals can freely enter the blood and influence the activity of distance target organs. 
Additionally, these neurons ‘sense’ the level of circulating hormones resulting in an 
adjustment of their activity by feedback control (Risau and Wolburg, 1990).  
1.2.2 Concept of the Neurovascular Unit 
The BBB is an essential component of the neurovascular unit (NVU). The concept of 
NVU defined as "a complex multicellular functional unit of the CNS comprising vascular 
cells, glial cells and neurons that, together, ultimately determine CNS activities and 
responses in health and disease" (Muoio et al., 2014). Each component is intimately 
and reciprocally linked to each other, establishing an anatomical and functional unit, 
which results in a highly efficient system of regulation of the BBB to serve the needs 
of the brain and facilitates brain-body communication. The astrocytes and pericytes in 
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particular are responsible for enabling the capillary bed to adopt and maintain barrier 
characteristics (Abbott and Friedman, 2012; Banks, 2016). 
The architecture of the NVU is the result of a cascade of events, genetically 
programmed, resulting in anatomical and functional coupling of neuronal components 
with vascular components, during early embryogenesis. During this period, neuronal 
progenitor cells (derived from the neural tube) and vascular progenitor cells (derived 
from the neural crest) become juxtaposed. The components of the NVU share a similar 
embryonic origin and are susceptible to the same growth factors, such as vascular 
endothelial growth factor (VEGF) and nerve growth factor (NGF). The NVU 
components remain after development in deep anatomical and chemical coupling, 
sharing several structural and functional similarities (Muoio et al., 2014). 
Neuroimmune modulators are clearly involved in NVU-BBB crosstalk. Cytokines and 
other immunoactive substances release from astrocytes, microglia, leukocytes and the 
brain endothelial cells themselves modify a host of BBB function and alerting BBB 
integrity, and the permeability of the BBB to pathogens and circulating immune cells. 
(Banks, 2012, 2016). 
It seems that each component of the NVU has its specific role in maintaining the 
dynamic interaction under the normal physiological condition. Furthermore, the 
concept of the NVU establishes a framework for an integrative approach to understand 
how the brain responds to cerebrovascular pathology. Also, it provides a basis for 
understanding the multiple pathways by which cerebral microvascular permeability 
could be regulated (Lo et al., 2004) 
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The development of the BBB varies with species and this has been best studied in 
rodents. The first blood vessels invade the outer surface of the developing neural tube 
at embryonic day 10 (E10) in the mouse (Bauer et al., 1993) and E11 in the rat (Stewart 
and Hayakawa, 1994) Neurogenesis occurs between E11 and E17 in the developing 
mouse neocortex and up to E21 in rats. Gliogenesis starts from E17 in rodents and 
continues in subventricular zone even in the adult period (Jacobson, 1991). The 
invasion of blood vessels into the developing nervous tissue is therefore associated 
with neurogenesis rather than with gliogenesis. The formation of the BBB starts shortly 
after intraneural neovascularization, and the neural microenvironment seems to play a 
key role in inducing BBB function in capillary endothelial cells. Fenestrations in the 
intraparenchymal cerebral vessels are frequent at E11, decline rapidly, and are not 
seen after E13 and at E17 in pial vessels (Stewart and Hayakawa, 1994). Thus, the 
BBB seems to develop between E11 and E17. This also suggests that development of 
endothelial tight junction may precede the development of astrocyte end-feet. Occludin 
expression has been reported to be low in rat brain endothelial cells at postnatal day 8 
but clearly detectable on postnatal day 70 (Hirase et al., 1997). Development of other 
TJ molecules has not been investigated. At present, there is no systemic study of the 
development of TJ, astrocyte end-feet, and pericytes in the developing human brain 
(Ballabh et al., 2004). 
1.3 Morphological basis of the neurovascular unit 
The importance of the NVU in the maintenance of cerebral homeostasis is being 
gradually established. The knowledge of each of the components and their respective 
pathways are critical to understand various neurovascular diseases, such as stroke 
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and Alzheimer’s disease. Thus, NVU could be considered as a potential therapeutic 
target for such pathological conditions. 
1.3.1 Endothelial cells 
Endothelial cells are mesodermal derived modified simple squamous epithelial cells 
that form the wall of blood vessels. The endothelial cells of CNS microvasculature are 
extremely thin cells that are 39% less thick than endothelial cells of muscles with very 
narrow separating distance between luminal surface and parenchymal surface 
(Coomber and Stewart, 1985). 
The endothelial cells of CNS have unique properties compared with endothelial cells 
of the rest of the body that allow them to tightly regulate the movement of ions, 
molecules, and cells between the blood and the brain. The endothelial cells of CNS 
have continuous intercellular tight junctions (TJs), which greatly limit the paracellular 
flux of solutes, also these cells are characterized by absence of fenestrations, so 
undergo extremely low rates of transocytosis, that cause sever restriction of both the 
transcellular and paracellular movement of molecules through endothelial cell layer 
(Brightman and Reese, 1969; Coomber and Stewart, 1985; Reese and Karnovsky, 
1967). Endothelial cell tight junctions limit the paracellular flux of hydrophilic molecules 
across BBB, so that penetration across the brain endothelium is effectively confined to 
transcellular mechanisms. Small lipophilic substances as oxygen, carbon dioxide, and 
ethanol diffuse freely across plasma membrane along their concentration gradient. 
Small polar solutes as glucose and amino acids needed for brain function enter the 
brain via transporters, whereas receptor mediated endocytosis mediate the uptake of 
larger molecules as insulin, leptin...etc. (Abbott, 2002; Ballabh et al., 2004). CNS 
endothelial cells contain higher amounts of mitochondria compared to other endothelial 
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cells, which are important to generate ATP to derive ion gradients critical for transport 
function. Also, these endothelial cells have lower expression of leukocyte adhesion 
molecules as compared to other endothelial cells which greatly limited the amount of 
immune cells entering the CNS (Daneman and Prat, 2015; Daneman et al., 2010). 
Metabolism or modification of substances is another mechanism by which brain 
endothelial cells generate a barrier by altering the physical properties of molecules, 
which can change their reactivity, solubility, and transport properties For example, 
blood derived L-DOPA is metabolized by L-DOPA decarboxylase and monoamine 
oxidase enzymes within the capillary endothelial cells. This "enzymatic blood-brain 
barrier" limits passage of L-DOPA into the brain (Risau and Wolburg, 1990). The 
combination of physical barrier properties (TJs, low transcytosis), molecular barrier 
properties (efflux transport, specific metabolism, and low leukocyte adhesion 
molecules) as well as specific transporters to deliver required nutrients, allow the 
endothelial cells to maintain homeostasis of the neuronal microenvironment. 
1.3.2 Basement membrane 
A cellular interplay within the NVU is essential for proper BBB function, and lack or 
dysfunction of one cell type impairs BBB development or promotes its breakdown. This 
concept of interplay also applies to the extracellular matrix (ECM) which consists of the 
interstitial matrix and basement membrane (BM) and is strongly associated with 
increased BBB permeability in pathological states (Rascher et al., 2002; Rosenberg et 
al., 1993). Vascular tube is surrounded by two BMs, the inner vascular BM and the 
outer parenchymal BM, which also called the vascular glia limitans (Sorokin, 2010; Wu 
et al., 2009). The extracellular matrix of the inner vascular BM is secreted by 
endothelial cells and pericytes, whereas parenchymal BM is primarily secreted by 
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astrocytic process that extend towards the vasculature. BM are made up mostly of 
structural proteins including collagen type IV, laminin, nidogen, heparin sulfate 
proteoglycans, and other glycoproteins. The vascular and parenchymal BMs have a 
different composition, for instance, the former is made up of laminins α4 and α5, 
whereas the latter contains laminins α1 and α2. These BMs provide an anchor for many 
signaling processes at the vasculature, and also provide an additional barrier for 
molecules and cells to cross before accessing the neural tissue. Disruption of these 
BMs by matrix metalloproteinase is an important element of BBB dysfunction, being to 
allow leukocyte infiltration as it is observed in many different neurological disorders {for 
review, see (Daneman and Prat, 2015; Obermeier et al., 2013)}. 
1.3.3 Pericytes 
Pericytes are smooth muscle-derived cells that play a crucial role in keeping brain 
homeostasis given their presence at the BBB and particularly their active role in the 
NVU. These cells were firstly described by Roget in 1874 as a population of branched 
cells with contractile properties that surrounded endothelial cells. Fifty years later, 
Zimmerman gave the name pericytes for these cells according to their anatomical 
location, abluminal to endothelial cells and luminal to parenchymal cells {for review, 
see (Hurtado-Alvarado et al., 2014; Zlokovic, 2008)}. 
Pericytes warp around microvessels and capillaries in the brain and communicate with 
endothelial cells, astrocytes and neurons in the NVU. Morphologically pericytes tend 
to be aligned with the vessel axis and extend protrusions that twist around the 
capillaries. A thin layer of BM separates pericytes from endothelial cells and from 
surrounding astrocyte end-feet. The ratio of pericytes to endothelial cells is typically 
1:3 (Wong et al., 2013). 
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Anatomically, pericytes are located directly on the capillary wall and share a common 
basement membrane with endothelial cells. Both pericytes and endothelial cells are 
attached to extracellular matrix of the basement membrane (BM) by different intregins 
(Fig.3). Pericytes project elongated, stellate-shape finger-like processes, that 
ensheath the capillary wall. In areas where the BM is absent between the endothelial 
cells and pericytes, different types of endothelial/pericytes cell contacts have been 
described. An intercellular space between the two cell types is maintained and contains 
fibronectin deposits. Areas called peg-socket contacts represent membrane 
invaginations extended from either the two cell type, which contain, gap-, or adherence 
junctions (Fig.3) (Armulik et al., 2005; Hurtado-Alvarado et al., 2014; Winkler et al., 
2011; Wong et al., 2013). 
Figure 3: Structural and molecular pericytes connections within the NVU (Winkler et al., 
2011). 
Pericytes are contractile cells, with actin stress fibers throughout the cell body that 
contribute in regulation of capillary structure and diameter and so regulate the blood 
flow. However, less is known about the involvement of pericytes at the BBB. It has 
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been reported that pericytes coverage and their number are related to the permeability 
of the biological barriers, higher coverage correlates with lower permeability (Hurtado-
Alvarado et al., 2014; Wong et al., 2013). The association of pericytes to brain blood 
vessels has been suggested to regulate endothelial proliferation (Lai and Kuo, 2005), 
to induce TJ proteins (occludin) expression (Hori et al., 2004), and to maintain the low 
permeability of the brain endothelial cells by reducing endothelial transcytosis (Armulik 
et al., 2011). 
1.3.4 Astrocytes end-feet 
Astrocytes are the most common cell type in the mammalian brain, conforming the glia 
with oligodendrocytes and microglia (Cabezas et al., 2014). Anatomical examination 
of the brain microvasculature shows that the end-feet of astrocytic glia form a lacework 
of fine lamellae closely opposed to the outer surface of the endothelium (Fig.4A). This 
closed anatomical apposition leads to the suggestion of the active influence of 
astrocytes on the development of the specialized BBB phenotype as the interactions 
between the astrocytic sheath and the vascular endothelial cells are thought to be 
responsible for the formation of the endothelial tight junctions (Abbott, 2002; Kimelberg 
and Nedergaard, 2010). The astrocytes end-feet of the basal processes completely 
ensheath the vascular tube and contain discrete arrays of proteins including 
dystroglycan, dystrophin, and aquaporin 4 (AQP-4). The dystroglycan-dystrophin 
complex is important to astrocytes end-feet-basement membrane linkage through 
agrin binding (Noell et al., 2011). This linkage is important to AQP-4 function in 
regulating water homeostasis in the CNS (Fig. 4B). 
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Figure 4: (A) Astrocytes surround endothelial cells to create the BBB (Abbott, 
2002). (B) Schema represented the dystrophin complex is anchored to the basal 
lamina through laminin and agrin and binds AQP4 (Amiry-Moghaddam et al., 2004) 
Astrocytes provide a cellular link between the neuronal circuitry and blood vessels, this 
communication establishing versatile connexions. Such connexions enable the 
interplay between neurons and also between blood capillaries and pericytes through 
the release of gliotransmitters (Daneman and Prat, 2015; Muoio et al., 2014). 
Additionally, astrocytes communicate between each other through gap junctions 
forming a functional syncytium with well-coordinated responses, as regulating 
vasodilation and vasoconstriction. Furthermore, astrocytes release several growth 
factors as vascular endothelial growth factor (VEGF), glial cell line-derived 
neurotrophic factor (GDNF), basic fibroblast growth factor (bFGF), and angiopoetin-1 
(ANG-1). These growth factors are important in the development and maintenance of 
endothelial cells of BBB characteristics by enhancing the formation of TJs, the 
promotion of enzymatic systems and the polarization of transporters in endothelial cells 
(Abbott, 2002; Abbott et al., 2006; Cabezas et al., 2014; Wong et al., 2013).  
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Among of these many functions, astrocytes have many metabolic functions as the 
promotion of neurovascular coupling, the attraction of cells through the release of 
chemokines, K+ buffering, release of glutamate by calcium signaling, control of brain 
pH, metabolism of dopamine and other substrates by monoamine oxidases, uptake of 
glutamate and γ-aminobutyric acid (GABA), and production of antioxidant compounds 
as glutathione and superoxide dismutases (SODs) enzymes (Kimelberg and 
Nedergaard, 2010; Volterra and Meldolesi, 2005). Astrocytes are characterized by the 
expression of the intermediate filaments proteins vimentin (Vim) and glial fibrillary 
acidic protein (GFAP), which are upregulated under CNS insults in a process known 
as astrogliosis. Morphologically, astrocytes are characterized by a stellate shape with 
multiple processes of ramifications, and become activated following brain injuries and 
neurodegenerative diseases (Adelson et al., 2012; Cabezas et al., 2014; Hamby and 
Sofroniew, 2010).  
Reactive astrogliosis is not merely a marker of neuropathology, but plays essential 
roles in orchestrating the injury response, as well as in regulating inflammation and 
repair in a manner that markedly affects functional and clinical outcomes. Reactive 
astrogliosis is a response of astrocytes to a variety of brain insults that is characterized 
by hypertrophy of the cell bodies and processes, altered gene expression, an increase 
in the expression of GFAP and Vim, and proliferation bordering the wound that occurs 
in a gradated fashion in relation to the severity of the injury (Barreto et al., 2011; Ridet 
et al., 1997). In the initial stages of brain injury, reactive astrocytes have a 
neuroprotective effect to enhance neuronal survival, while, in advanced stages, these 
cells have also been shown to inhibit CNS regeneration (Barreto et al., 2011). 
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1.3.5 Neurons 
Due to the highly complexity of the homeostatic mechanism, the neurons can be called 
the pacemaker of the NVU. Neurons detect very small variations in their supply of 
nutrients and oxygen, and transform these signals into electrical and chemical 
messages to adjacent interneurons and astrocytes. In response to these signals, the 
necessary adjustment mechanisms are activated. When necessary, neurons 
communicate with the vessels through astrocytes, thus influencing the vascular tone 
and consequently the blood supply to the area surrounding them. It is known that NVU 
astrocytes are able to detect glutamate and GABAergic neuronal levels, and convert 
those signals into vasomotor commands (Muoio et al., 2014). However, the pathways 
involved in this communication are still largely being explored. 
Interestingly, disruption of BBB integrity often associates pathological changes in 
cerebral blood flow and perfusion pressure (i.e., ischemia, hemorrhage, or traumatic 
injury), and there is evidence that such BBB opening may be a selective, compensatory 
event rather than a simple anatomical disruption, suggesting that neuronal-
microvascular communications can modulate BBB permeability. This implies that 
communication between neurons and the vasculature may not simply regulate blood 
flow, but BBB permeability as well. Anatomical evidences found that microvascular 
endothelium and/or associated astrocytic processes are innervated by noradrenergic, 
serotonergic, cholinergic, and GABAergic neurons. Several significant evidences 
provide that neurons can regulate BBB function {for review, see (Hawkins and Davis, 
2005; Persidsky et al., 2006a) 
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1.3.6 Microglia 
Microglia has been first described in 1932 by del Rio-Hortega as a distinct class of glial 
cells. Microglia are the resident immune cells in the CNS and perform an essential role 
in the immune response, while they are also an important component of the NVU. 
Microglia derived from myeloid/monocytic cells and their hematopoietic precursors or 
from neuroectodermal matrix cells and represent the resident macrophage of the CNS 
(Johann and Beyer, 2013). 
In the absence of pathology, the "resting state" microglia are cells with small cell bodies 
and long, thin processes and lacking endocytotic and phagocytotic activity. Microglia 
is very susceptible to changes of the brain environment and become rapidly activated 
in response to CNS insults and immunological stimuli and undergo several alterations. 
Attracted by endogenous and other chemotactic factors, microglia cells show the 
capacity to migrate toward the site of brain injury. This orchestrated process of 
migration followed by local proliferation allows this cell type to achieve sufficient cell 
numbers at the site of inflammation. Upon activation, microglia undergo morphological 
and functional changes such as hypertrophy, loss the long extensions typical of the 
resting microglia, and show stubby processes. During activation, microglia transform 
from a "ramified" form to an "ameboid" form, and finally to a phagocytic form (da 
Fonseca et al., 2014; Johann and Beyer, 2013; Zlokovic, 2008). This evolution is 
associated with changes in surface antigen, production of neurotoxic mediators such 
as nitric oxide, hydrogen peroxide, and inflammatory cytokines. This activation and 
consequent neuroinflammation have been implicated in development of neuronal 
death in various CNS pathological states including ischemic stroke and cerebral 
hypoxia. Furthermore, activation of microglia is directly associated with dysfunction of 
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the BBB characterized by changes in tight junction proteins expression and enhanced 
paracellular permeability {see for review (Ronaldson and Davis, 2012; Sumi et al., 
2010)}. 
Biochemically, activated microglia are identified by up-regulation of cell surface 
receptors as CD14 and toll-like receptors (TLRs) (Bsibsi et al., 2002; Rivest, 2003). 
Microglia express specifically Ionized calcium binding adaptor molecule 1 (Iba-1) that 
is upregulated during the activation of these cells (Ito et al., 1998; Sasaki et al., 2001). 
The degree of microglia activation appears to be correlated to the type and severity of 
brain injury (Raivich et al., 1999). 
1.4 The molecular composition of the tight junction 
The BBB is responsible for the sever restriction of paracellular diffusional pathway, 
only small lipophilic molecules less than 400 Da and dissolved gases can penetrate 
from the blood to the brain. The high electrical resistant of the BBB (about 1800 Ω cm²) 
results in extremely low paracellular permeability and is chiefly due to TJ protein 
complex (Abbott et al., 2010; Butt et al., 1990). 
Junction complex in the BBB comprises adherens junctions (AJ) and tight junctions 
(TJ). Adherens junctions are composed of a cadherin-catenin complex and its 
associated proteins. Tight junctions ultrastructurally appear as a site of apparent fusion 
involving the outer leaflets of plasma membrane of adjacent endothelial cells (Fig 5A). 
The number of TJs stands, as well as the frequency of their ramification, is variable. 
The TJ consists of three integral membrane proteins (occludin, claudins, and junction 
adhesion molecules) and a number of cytoplasmic accessory proteins including zonula 
occludens (ZOs) such as ZO-1, ZO-2, and ZO-3, themselves indirectly associated with 
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integral protein cingulin. Cytoplasmic proteins link trans-membrane proteins to actin, 
which is the primary cytoskeleton protein involved in the maintenance of structural and 
functional integrity of endothelial cells (Ballabh et al., 2004; Dyrna et al., 2013) (Fig 
5B).  
Figure 5: Blood-brain Barrier tight junction. (A) Electron micrograph of mammalian 
BBB showing endothelial tight junction (arrow). (Ballabh et al., 2004). (B) Schematic 
representation of basic molecular organization of the BBB tight junction (Cardoso 
et al., 2010). 
Tight junction proteins are components of BBB and regulate paracellular permeability 
between adjacent endothelial cells (Coisne and Engelhardt, 2011). Reduced TJ protein 
levels result in BBB breakdown and brain edema, and changes in protein levels are 
also associated with the development and progression of brain diseases (Jiao et al., 
2011; Yang et al., 2007). In addition, age-dependent BBB dysfunctions and alteration 
of TJ integrity, in the absence of disease, has been demonstrated (Bake et al., 2009; 
Farrall and Wardlaw, 2009), implying that aged brains are susceptible to develop brain 
diseases. 
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1.4.1 Occludin 
Occludin (from the Latin word occludre, shut in English, fermer in french) has been 
identified on 1993 as the first integral protein localized at the ultrastructural level in the 
TJs of chicken intestinal epithelial and liver cells (Furuse et al., 1993) and then in 
mammals (Ando-Akatsuka et al., 1996). The availability of commercial sensitive and 
specific antibodies, made it possible to identify the expression of occludin in rodents 
(Hirase et al., 1997) and in adult human brain microvessels (Papadopoulos et al., 
2001). Occludin, a 60-65 KDa protein, has four transmembrane domains with a long 
carboxyl (COOH)-terminal and a short amino (NH2)-terminal oriented to the cytoplasm 
and two extracellular loops that span the intercellular cleft (Furuse et al., 1993). The 
cytoplasmic carboxyl-terminal domain of occludin is directly interact with the guanylate 
kinase (GUK) domain of the accessory proteins ZO-1 and ZO-2 which ensure the 
connection to the cytoskeleton (Fig. 6) (Fanning et al., 1998). Expression of C-terminal 
truncated versions of occludin leads to increase paracellular permeability to low 
molecular weight molecules (Balda et al., 1996). The extracellular domain of occludin 
has been shown to function in localization of occludin to TJs and in regulating the 
paracellular permeability barrier between cells (Wong and Gumbiner, 1997). 
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Figure 6: Tight junction integral protein, occludin. COOH-terminal 
occludin interaction with the ZO-1 GUK domain. TM: 
transmembrane, EL extracellular loop, IL: intracellular loop, GUK: 
guanylate kinase (Cummins, 2012). 
Occludin is present at high levels and is distributed continuously at cell-cell contacts in 
brain endothelial cells, and its expression at the TJs of brain endothelial cells increases 
with development. In contrast, occludin expression in the endothelial cells of non-
neural tissue is much lower and is distributed in a discontinuous fashion at cell-cell 
contact, suggesting that occludin, is a regulatory protein that can alter TJ permeability 
(Hirase et al., 1997). 
There are two isoforms of occludin that result from alternative mRNA splicing, but have 
similar tissue distributions (Muresan et al., 2000). It has been shown that an 
overexpression of occludin results in a lower paracellular permeability and a higher 
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transendothelial resistance (TER), suggesting a crucial role in the formation and 
function of TJ complexes (McCarthy et al., 1996). However, experiments using 
occludin-deficient mice indicate that occludin is not essential for the formation of TJ 
strands and regular transendothelial electrical resistance (Saitou et al., 2000), despite 
the fact that the decrease in occludin expression is associated with disrupted BBB 
function in a number of disease states (Brown and Davis, 2005; Huber et al., 2002). 
Localization of occludin to tight junction is regulated by phosphorylation in both 
epithelial and endothelial cells (Sakakibara et al., 1997). Occludin has multiple sites of 
phosphorylation on serine, threonine (Sakakibara et al., 1997), and tyrosine residues 
(Chen et al., 2000), which control its intracellular distribution. Non-phosphorylated 
occludin is localized to both the basolateral membrane and cytoplasmic vesicles, 
whereas, phosphorylated one is localized to TJ (Sakakibara et al., 1997). It have been 
found that hyper phosphorylated occludin at intercellular junctions is necessary for 
maintaining barrier function (Wong, 1997). Moreover, decrease phosphorylation status 
of occludin, by inhibiting protein kinase C (PKC), has been shown to be correlated with 
a rapid fall in transendothelial resistance (TER) (Clarke et al., 2000). 
1.4.2 Claudin 
Claudins belong to a family of 24 integral proteins, with 20 - 27 KDa, have been 
identified in mammals, family members sharing a high sequence homology in the first 
and fourth transmembranous domains and two extracellular loops (Furuse et al., 
2002). Claudins have a similar membrane morphology as occludin but without any 
similarities in sequence and homology (Morita et al., 1999a). Claudins are the major 
components of TJ and are localized exclusively at TJ strands. The hemophilic and 
heterophilic interactions between the four extracellular loops of claudins ensure tight 
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contacts of the cell monolayers. Carboxyl terminal of claudins is capable to bind to a 
specific PDZ-1 domain of zonula occludens (ZOs) (Fig. 7) (Dyrna et al., 2013; Furuse 
et al., 1998, 1999; Huber et al., 2001). Overexpression of claudins can induce cell 
aggregation and formation of TJ-like structures, while occludin expression does not 
result in TJ formation. The two extracellular loops of claudin and occludin originating 
from neighboring cells form the paracellular barrier of TJ. Often cells expressing 
Claudins exhibit of more than two isoforms depending on different TJ sizes and on the 
particular requirements of the tissue. In cerebral endothelial cells, claudin-1, -2, -3, -5, 
-11, and -12 have been detected (Cardoso et al., 2010). 
Figure 7: Claudin structure and interaction. MLCK: myosin light 
chain kinase (Robinson et al., 2015). 
Phosphorylation is a major regulatory mechanism of tight junction proteins (Sakakibara 
et al., 1997) Claudin-5 phosphorylation of its C-terminal domain on Thr207 residue in 
response to protein kinase A (PKA) or Rho kinase activation generally affected TJ 
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integrity in brain endothelial cells and increased paracellular permeability (Persidsky et 
al., 2006b; Soma et al., 2004; Yamamoto et al., 2008).  
In brain, claudin-1, -3, and -5 associated with occludin, have been described to be 
present in endothelial TJs forming the BBB (Hawkins and Davis, 2005; Nitta et al., 
2003). Claudin-5, present in early developing brain blood vessels, is considered as 
endothelial cell-specific component of TJ strands (Morita et al., 1999a), with 100 times 
higher expressed than any other claudin and dominates the TJs of the BBB, (Haseloff 
et al., 2014). Deletion of claudin-5 using siRNA resulted in increased paracellular 
permeability in a cell culture model of the BBB using human brain endothelial cells 
(Luissint et al., 2012). Claudin-5 knock-out mice exhibit normal TJs with an increase of 
paracellular permeability for small molecular weight tracers (< 800 D), but not larger 
molecules. Concluding, claudin-5 has important role in establishing the paracellular 
barrier (Nitta et al., 2003). In another study, claudin-5 down-regulation constitutes a 
significant mechanism in BBB breakdown (Argaw et al., 2009). Other studies reported 
loss of claudin-1, but not claudin-5 from cerebral vessels under pathologic conditions 
such as tumor, stroke, inflammation (Liebner et al., 2000a, 2000b; Lippoldt et al., 
2000). 
Together, claudins and occludin form the extracellular component of TJs and are both 
required for the BBB formation and maintenance (Ballabh et al., 2004) 
1.4.3 Junctional adhesion molecules 
The third type of tight junction integral membrane proteins is junctional adhesion 
molecules (JAM) of approximately 40 KDa (Martìn-Padura et al., 1998). These 
molecules, belong to the immunoglobulin (IgG) superfamily, are expressed in the TJs 
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of epithelial and endothelial cells, and are believed to mediate the early attachment of 
adjacent cell membranes via hemophilic and probably heterophilic interactions in the 
tight junctional region (Dejana et al., 2000). They are implicated in transendothelial 
migration of leukocytes and are also expressed on circulating monocyte, neutrophils, 
lymphocytes subsets, and platelets. The JAM family consists of three members JAM-
1, -2, and -3. They have a single transmembrane domain and their extracellular portion 
has two immunoglobulin-like loops that form disulfide bonds (Aurrand-Lions et al., 
2000; Palmeri et al., 2000). JAM-1 (formerly JAM) is expressed in endothelial and 
epithelial cells (Martìn-Padura et al., 1998), whereas, JAM-2 and JAM-3 (formerly VE-
JAM) are expressed in most vascular endothelial cells (Aurrand-Lions et al., 2001; 
Palmeri et al., 2000). JAM-1, a 32 KDa protein, interacts with actin and ZO-1 through 
its cytoplasmic PDZ-binding domain and is involved in cell-to-cell adhesion through 
hemophilic interactions (Bazzoni et al., 2000; Liu et al., 2000; Martìn-Padura et al., 
1998) (Fig.8). Upon platelet activation, JAM-1 is phosphorylated by PKC causes 
redistribution of JAM-1 in human endothelial cells (Ozaki et al., 1999). JAM-1 
transfection to Chinese hamster ovary (CHO) cells reduces paracellular permeability 
and promotes occludin localization at intracellular junction (Dejana et al., 2000). JAM-
1 can also modulate leukocyte extravasation through interendothelial junctions in vivo 
and in vitro (Del Maschio et al., 1999). JAM-2 protein is highly expressed in embryonic 
tissue, kidney vascular structures, high endothelial venules in lymphoid organs, and 
lymphendotelial cells. Its cytoplasmic tail is necessary for TJ direction. JAM-2 
transfection into CHO cells, decreased paracellular permeability and improved the 
sealing of the cells (Wolburg and Lippoldt, 2002). JAM-3 protein, is expressed in high 
endothelial venules, in lymphoid organs and also in endothelial cells of blood vessels 
of different size in rat, human heart, human placenta, lung and foreskin. JAM-3 is 
Literature review 
 
38 
 
localized at intercellular boundaries like JAM-1 and -2 and can inhibit transmigration of 
monocytes (Palmeri et al., 2000) 
In addition to their developmental roles, JAMs may regulate the trans-endothelial 
migration of leukocytes, but their function in the mature BBB is still incomplete, and 
more investigations are required (Hawkins and Davis, 2005).  
Figure 8: Junctional adhesion molecule 
structure and interaction (Robinson et al., 2015). 
1.4.4 Cytoplasmic accessory protein (membrane-associated guanylate kinase - 
like protein 
Membrane-associated guanylate kinase (MAGUK) proteins are accessory proteins for 
the transmembranous components of the tight and adherens junctions. MAGUK 
proteins possess multiple domains (three PDZ domains, SH3 domain, and guanylate 
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kinase domain) for protein-protein interactions, enabling MAGUK proteins to form a 
clustering of protein complexes to the cell membrane (González-Mariscal et al., 2000; 
Shin et al., 2000). Three MAGUK proteins have been identified to be associated with 
the TJ: ZO-1, ZO-2, and ZO-3. 
ZO-1, a phosphoprotein with a molecular mass of 220 KDa, is the first protein positively 
associated with the TJ (Stevenson et al., 1986), and it remains one of the best studied. 
ZO-1 is mostly expressed in endothelial and epithelial cells as well as in many cell 
types that do not have TJ (Howarth et al., 1992; Mitic and Anderson, 1998). In addition 
to its association to the tight junction, it has been found to be associated with adherens 
junction (Itoh et al., 1993) and gap junction proteins (Toyofuku et al., 1998). ZO-1 links 
the TJ transmembrane proteins to the actin cytoskeleton (Fanning et al., 1998). This 
interaction is likely critical for the stability and the function of TJ, as the loss or 
dissociation of ZO-1 from the junctional complexes is associated with increased barrier 
permeability (Abbruscato et al., 2002; Mark and Davis, 2002). A dissociation of ZO-1 
form the junctional complex often results in an increased permeability thereby 
underlying its critical function in the molecular architecture as in multiple sclerosis (MS) 
(Kirk et al., 2003; Zlokovic, 2008). ZO-1 gene deletion causes embryonic lethal 
phenotype in mice, suggesting that ZO-1 could communicate the state of the TJ to the 
interior of the cell or vice versa (Katsuno et al., 2008). 
ZO-2, a 160 KDa phosphoprotein, has significant homology with ZO-1 (Itoh et al., 
1999), and it has been also found to be expressed in non-TJ- containing tissues and 
localize into the nucleus during stress and proliferation (Betanzos et al., 2004; Islas et 
al., 2002; Traweger et al., 2003). In cultured brain microvessels endothelial cells, ZO-
2 was found to be localized along the membrane at cell-cell contacts (Mark and Davis, 
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2002). Interestingly, ZO-2 may function somewhat redundantly with ZO-1, replacing it 
and facilitating formation of morphologically normal TJ in cultured epithelia lacking ZO-
1 (Umeda et al., 2004). ZO-3, a 130 KDa, is found to be concentrated at tight junctions 
in various types of epithelium, but not in endothelium (Inoko et al., 2003). 
1.4.5 Actin 
At the ultrastructural level, tight junctions and adherens junctions appear as highly 
organized structures that encircle the apical–lateral boundary of cells. These structures 
are composed of transmembrane proteins such as claudins and occludin. These 
proteins are associated with cytoplasmic proteins that are directly or indirectly 
connected to the actin cytoskeleton. A transmembrane protein and its cytoplasmic 
adaptor proteins may thus form a functional module that works both individually and in 
combination in order to establish and maintain apical junctions of epithelial cells 
(Miyoshi and Takai, 2008). Actin remodeling is accomplished by assembling multi-
molecular complexes of structural and regulatory proteins at specific cell contact sites. 
Then, actin filaments undergo elongation, branching, bundling, and depolymerization, 
leading to assemble superstructures. 
Actin, non-muscle myosin 2A, 2B, 2C, and microtubules have critical roles in TJ 
architecture and physiology. Interactions between the peri-junctional cytoskeleton is 
required for the junction maintenance and so, the barrier integrity and function. A 
common feature of physiological and pathological feature alteration of the barrier is 
alteration of the junction associated actin cytoskeleton (Van Itallie and Anderson, 
2014). This becomes evident by the work of Nico (Nico et al., 2003) on the mice lacking 
the actin-binding dystrophin (the mdx mice). These mice exhibit an increase in the 
cerebrovascular permeability due to disorganized cytoskeleton α-actin in endothelial 
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cells and in astrocytes, as well as alteration of subcellular localization of ZO-1, claudin-
1, and AQP4 assembly, suggesting that actin filaments and their binding to tight 
junction and/or adherens junction proteins are important for normal BBB function. 
It had been shown that hypoxia as well as post-hypoxia reoxygenation could induce 
alterations in brain microvessels endothelial cells (Crawford et al., 1996). In vitro 
studies show that after exposure to hypoxic stress, the metabolic and physical barrier 
of brain microvascular endothelial cells was perturbed and resulted in an increase of 
paracellular permeability. This changes in paracellular permeability was in direct 
correlation with alterations in expression of actin filaments (Mark and Davis, 2002). 
Reoxygenation following a period of hypoxia was concurrent with rapid polymerization, 
spatial redistribution of actin filaments. More importantly, the thickness of the cortical 
actin coincided with the reduction of junctional permeability (Crawford et al., 1996; 
Mark and Davis, 2002). Therefore, in addition to the role of structural support, actin 
reorganization appears to contribute a direct role in the formation and maintenance of 
the integrity of TJ complexes. 
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1.5 Transport across the Blood-Brain Barrier 
The BBB forms an interface between the circulating blood and the brain and possesses 
various carrier-mediated transport systems for small molecules to support and protect 
CNS function. The BBB also represents a significant roadblock in delivering drugs to 
the brain (Ohtsuki and Terasaki, 2007; Wong et al., 2013). Only very few CNS 
disorders, such as depression, schizophrenia, chronic pain, and epilepsy, are currently 
treatable with small molecule drug therapy. The BBB can also present a major obstacle 
in the development of drugs that are targeted for the CNS including neurodegenerative 
diseases, cerebrovascular diseases, and brain cancer. Therefore, methods to study 
the transport of drugs and other molecules across the BBB are key to understand how 
the BBB regulates transport and will be invaluable for drug discovery and the treatment 
of CNS diseases (Kuhnline Sloan et al., 2012). 
Endothelial cells of the CNS are highly polarized cells that have distinct luminal and 
abluminal compartments. The low permeability of the paracellular junctions allow to 
control the movement of ions and molecules between the blood and the brain 
(Daneman and Prat, 2015), while transcellular transport can occur through several 
mechanisms (Abbott et al., 2010; Wong et al., 2013) (Fig 9A). They are two main types 
of transporters expressed by CNS endothelial cells: influx transporters and efflux 
transporters. 
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Figure 9: (A) Transcellular and paracellular pathways in endothelial 
cells (Azzi et al., 2013). (B) Transcellular transport mechanisms 
(Wong et al., 2013). 
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1.5.1 Passive diffusion 
Passive diffusion is a spontaneous process depending on random movement of 
solutes. The free-energy change of a solute diffusion across a membrane is directly 
dependent on the magnitude of the concentration gradient. 
Passive transcellular transport is limited to small molecules that have a combination of 
sufficient hydrophilicity to be soluble in water and sufficient lipophilicity to be soluble in 
the hydrophobic core of the lipid bilayer (Abbott et al., 2010). There is a general 
correlation between the rate at which a solute enters the CNS and its lipid solubility, so 
a wide range of lipid-soluble molecules can diffuse through the BBB and enter the brain 
passively (Liu et al., 2004). Small gaseous molecules such as O2 and CO2 can diffuse 
through the cell membrane, as well as small molecules such as barbiturates, ethanol, 
and caffeine (Fig.9B). Almost large molecules and 98% of all small molecules do not 
cross the BBB. In general, molecules that passively diffuse across the BBB have a 
molecular weight less than 500 Da, and the number of hydrogen bond donors is less 
than 5 (Lipinski et al., 2001; Pardridge, 1998). Many of molecules that cross the 
membrane by passive transport are subsequently transported back to the vascular 
system by efflux pump, many of the unwanted molecules return back to the circulatory 
system. 
1.5.2 Facilitated diffusion (carrier-mediated transport) 
Specific carrier-mediated transport systems facilitate transport of small polar 
molecules, organic anions and cations, nucleosides, and nutrients, such as glucose 
and amino acids necessary for metabolism down their concentration gradient 
(Zlokovic, 2008) Endothelial cells of the CNS express a wide variety of these 
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transporters to deliver very specific nutrients across BBB brain into the CNS 
parenchyma. Many of these transporters are belong to the solute carrier class (Slc) of 
facilitated transporters {for review, see (Daneman, 2012; Zlokovic, 2008). Expression 
of these transporters are highly enriched in CNS endothelial cells compared with 
endothelial cells of nonneural tissues (Cornford et al., 1994). GLUT1 glucose 
transporter, LAT1 large neutral amino acid transporter, and MCT1 monocarboxylates, 
lactate, pyruvate transporter have been cloned from BBB-specific cDNA (Pardridge, 
2005) These solute carriers may be specific to one molecule or multi-specific to several 
molecules (Wong et al., 2013). 
Large solutes, such as proteins and peptides, are transported across the BBB by 
receptor-mediated (for insulin, transferrin, leptin, IgG, TNFα) or adsorption-mediated 
(for histone, albumin) endocytotic transport. As a result of this regulation, there is large 
differences in the concentration of amino acids and proteins between blood and brain 
parenchyma, while differences in the concentration of ions in the blood and cerebral 
spinal fluid are relatively small (Abbott et al., 2006; Wong et al., 2013). 
1.5.3 Active transport  
Active transport through a protein carrier with a specific binding site requires ATP 
hydrolysis and conducts movement against the concentration gradient. 
When comparing brain penetrance with lipid solubility, the CNS concentration of a 
large number of solutes and dugs is much lower than expected. These substances and 
many of their metabolites are actively effluxed from the brain and the capillary 
endothelium forming the BBB by members of the ABC transporter (ATP-binding 
cassette) family (Abbott et al., 2010). 
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Efflux transporters, including multi drug resistant-1 (MDR1) (also called P-glycoprotein, 
P-gp), breast cancer resistance protein (BCRP), and multidrug resistance-associated 
proteins (MRPs), use the hydrolysis of ATP to transport their substrates against their 
concentration gradient. Many of these transporters are localized to the luminal surface 
and transport a wide array of substrates into the blood compartment. This wide 
substrate diversity allows these transporters to provide a barrier to many small 
lipophilic molecules, which would otherwise passively diffuse through the endothelial 
membrane (Daneman and Prat, 2015). In this role they are removing from the brain 
potentially neurotoxic endogenous or xenobiotic molecules and carrying out a vital 
neuroprotective and detoxifying function (Dallas et al., 2006). Studies using P-gp 
knock-out mice show elevated drug levels in many tissues (especially in brain) and a 
decrease in drug elimination, which suggests the possible role of P-gp transporter in 
the clinical use of many drugs, especially those with potential targets in the CNS 
(Schinkel et al., 1994, 1995, 1996). Also P-gp contribute to drug resistance for some 
diseases as epilepsy and tumor (Abbott et al., 2002; Potschka et al., 2001) 
1.5.4 Blood-brain barrier transport of macromolecules 
Transcytosis of macromolecules across the BBB via endocytotic mechanisms provides 
the main route by which large molecular weight solutes such as proteins and peptides 
can enter the CNS. Although the majority of large blood-borne molecules are physically 
prevented from entering the brain by the presence of the BBB tight junction, specific 
and some nonspecific transcytotic mechanisms exist to transport a variety of large 
molecules across the BBB (Abbott et al., 2010) (Fig.9A). 
One of the important feature of the BBB endothelial cells that the rate of transcytosis 
is dramatically lower than in endothelial cells in non-neural tissues, and is up-regulated 
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as a major component of BBB dysfunction during injury and disease (Gu et al., 2012; 
Zhao et al., 2014). Transcytosis describes the vectorial movement of cargo-back 
endocytosed vesicles across the cell cytoplasm, toward a target membrane. 
Transcytosis through endothelial cells is mediated through caveolin-based vesicle 
trafficking (De Bock et al., 2016). Caveolae are the most commonly reported plasma 
clathrin independent membrane buds. These specialized lipid draft domains, rich in 
cholesterol and sphingolipids are defined as smooth, flask-shaped investigations of the 
cell surface (Hayer et al., 2010) The structural coat of caveolae is formed by caveolin 
(Cav) proteins (Fig.10). Three Caveolin proteins have been identified, Cav-1 and Cav-
2 have been identified in murine, bovine and human BBB endothelial cells, whereas, 
Cav-3 appears to be limited to astrocytes (Badaut et al., 2015; Tome et al., 2015). 
 
 
 
 
 
Figure 10: Composition of caveolae (Razani et al., 2002). 
Caveolae have been recognized in both luminal and abluminal membranes, indicating 
that they mediate transcytosis in both directions. Physiologically, the loss of caveolae 
results in impairment of cholesterol homeostasis (Frank et al., 2004), insulin sensitivity 
(Cohen et al., 2003a), nitric oxide, and calcium signaling (Drab et al., 2001; Razani et 
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al., 2001), and cardiac function (Cohen et al., 2003b). The roles of Cav-1 in regulating 
BBB permeability are yet unclear. It has been reported that nitric oxide induced the 
loss of Cav-1 in focal cerebral ischemia and reperfusion injury (Gu et al., 2011), Cav-
1 down-regulation is associated with an increase of matrix metalloproteinases (MMP-
2 and -9) activity (Zhao et al., 2014), a decrease of TJ protein ZO-1 expression, and 
an enhance of the BBB permeability (Gu et al., 2012). 
1.6 The Blood-Brain Barrier in pathological conditions 
There is a growing list of CNS pathologies involving an element of BBB dysfunction, 
such as multiple sclerosis (MS), hypoxia and ischemia, Parkinson disease (PD), 
Alzheimer disease (AD), epilepsy, tumors, glaucoma and lysosomal storage diseases 
(Abbott et al., 2010; Daneman, 2012). In all these pathological processes, it is possible 
to recognize a BBB dysfunction from transient and mild TJ opening to chronic barrier 
break down, changes in transport systems and enzymes, and an inflammatory 
response can also occur. These are common features, but each one of these diseases 
has its unique fingerprint from the others. 
1.6.1 Hypoxia and ischemia 
Cerebral ischemia leads to disruption of blood flow, as well as depletion of oxygen and 
essential nutrients associated with an increase of the in the BBB permeability (Petty 
and Wettstein, 2001; del Zoppo and Hallenbeck, 2000). The early reestablishment of 
blood circulation is essential to limit cerebral injury. However, during reperfusion, the 
return of oxygenated blood to the ischemic area challenges the BBB with oxidative 
stress. Different studies using in vitro BBB models have indicated that hypoxia and 
hypoxia/reoxygenation lead to an increase permeability and neutrophil infiltration 
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through disruption of BBB tight junction (Mark and Davis, 2002). In rat, BBB 
permeability and TJ alteration induced by hypoxia/reoxygenation mediated by vascular 
endothelial growth factor (VEGF) and nitric oxide (NO) (van Bruggen et al., 1999; Mark 
et al., 2004), and involve activation of the transcription factors, as nuclear factor KB 
(nFkB) and hypoxia-inducible-1. A more recent study performed with a young and aged 
mice reports that BBB disruption in the peri-infarct cortex is associated with an increase 
of endothelial caveolae, increase of basement membrane thickness, and pericyte and 
astrocyte swelling with mitochondrial disorganization, without affecting endothelial tight 
junctions (Nahirney et al., 2015). 
1.6.2 Inflammation- associated neurological diseases 
A number of neuroinflammatory conditions as allergic reaction, meningitis, HIV-1 
encephalitis, sepsis, endotoxins, multiple sclerosis, and Alzheimer’s disease are 
associated with altered permeability of the BBB to many substances and immune cells 
(Banks et al., 2015; Persidsky et al., 2006a). The pathogenesis of HIV-1 dementia, 
multiple sclerosis, and Alzheimer disease involves activation of inflammatory 
mechanisms, production of toxins and neurotropins and the breakdown of the BBB. 
Inflammation can induce BBB disruption by altering TJ function, thus promoting 
paracellular leakage, and re-inducing vascular process, thus promoting transocytotic 
leakage (Mayhan and Heistad, 1985; Ziylan et al., 1984). An inflammatory process 
may be induced experimentally by lipopolysaccharide (LPS) injection to animals. LPS-
induced inflammation produces a significant increase of brain cytokines level and is 
associated with a BBB disruption. LPS-mediated BBB breakdown leads to microglia 
and astrocytes activation, this latter can be prevented by a COX-inhibitor, 
indomethacin. In addition LPS induces a dose-dependent cytoarchitectural 
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disorganization for TJ proteins ZO-1 and occludin, but not claudin-5 (Banks et al., 
2015). 
HIV-induced neurological diseases 
Individuals infected with human immunodeficiency virus (HIV-1) often develop HIV-
related encephalitis (HIVE) or HIV-associated dementia (HAD), and BBB dysfunction 
is observed in HIV patients (Petito and Cash, 1992). HIV-1 infected macrophages and 
microglia which produce cytokines, chemokines, reactive oxygen species (ROS), 
glutamate, and activate matrix metalloproteinases (MMPs) that may alter expression 
and function of tight junction (Persidsky and Gendelman, 2003). In addition, viral 
proteins secreted by infected cells also directly affect TJ protein expression and 
function (András et al., 2005). Immunohistochemical analysis for both occludin and 
ZO-1 tight junction proteins in HIVE patients show significant TJ disruption with 
fragmentation or absence of immunoreactivity for occludin and ZO-1(Dallasta et al., 
1999), while a loss of ZO-1 immunoreactivity is highly correlated with monocyte 
infiltration and the degree of dementia in HAD patients (Boven et al., 2000). Interaction 
between activated brain macrophages and astrocytes further amplify inflammatory 
responses leading to BBB alterations through effects on endothelial cells or 
enhancement of monocyte migration from blood to parenchyma (Persidsky et al., 
2006a). 
Alzheimer’s disease 
Alzheimer’s disease (AD) is a leading cause of dementia and is commonly 
accompanied by BBB dysfunction (Erickson and Banks, 2013; Lyros et al., 2014). 
Cerebral tissue exhibits insoluble senile plaques and neurofibrillary tangles. The senile 
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plaques are comprised primarily by aggregation of the amyloid β (Aβ) protein and 
accumulate in neurophils around and inside cerebral capillaries which causes toxicity 
to endothelial cells and a neuronal loss (Zlokovic, 2002). In the initial stage of AD, there 
is loss of BBB homeostasis, leading to the production of proinflammatory cytokines 
and suppressors of the cerebral blood flow by endothelial cells, which exacerbate 
synapse destruction, and activation of microglia (Zlokovic, 2004, 2011). Microglial cell 
and astrocyte activation are also observed around Aβ plaques present in AD brain, 
releasing of inflammatory cytokines, such as IL-1, IL-6, and TNFα (Wyss-Coray, 2006; 
Zhou et al., 2012). 
Animal studies suggest that the presence of amyloid is a factor in the opening of the 
BBB. In vivo and in vitro studies, amyloid proteins induce MMP-9. Genetically 
transgenic mice with human amyloid proteins show disruption of the BBB with 
decrease expression of the TJ proteins claudin-1 and claudin-5 and increase 
expression MMP-2 and MMP-9 (Hartz et al., 2012). Furthermore, transgenic mice with 
apoE4 (human apolipoprotein E) which is considered as major genetic risk factor for 
Alzheimer’s disease) demonstrate BBB breakdown by activating a proinflammatory 
CypA-nuclear factor-ΚB-matrix-metalloproteinase-9 pathway in pericytes (Bell et al., 
2012). This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic 
proteins, and microvascular and cerebral blood flow reductions which causes 
degradation of the TJ and basal lamina proteins (Bell et al., 2012; Deb and Gottschall, 
1996; Hartz et al., 2012). Mice over expressing Aβ-precursor protein, have pericytes 
loss, elevating brain Aβ40 and Aβ42 levels and accelerating amyloid angiopathy and 
cerebral amyloidosis (Sagare et al., 2013). Data from animal models supports a role 
for BBB disruption in AD, but the human data is less convincing. 
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Multiple sclerosis 
Multiple sclerosis (MS) is caused by a combination of autoimmune, genetic, and 
environmental factors, is a chronic, progressive, and neuroinflammatory demyelinating 
disease which affects the brain or spinal cord. MS is characterized by demyelination 
and intense CNS invasion of immune cells, especially lymphocytes and macrophages. 
The precipitating event or predisposing conditions of MS is unknown, but immune cells 
entry into the parenchyma is both a consequence enhanced by and a cause of 
neuroinflammation, thus suggesting a mechanism of self-maintenance of the disease 
(Banks, 2016). 
Multiple sclerosis is often associated with an increase of BBB permeability, and 
consequently inflammatory response causing by the formation of lesions and 
demyelination, inflammation leads to microglial cells activation and release cytotoxic 
factors, such as NO and reactive oxygen species (ROS), provoking myelin damage, 
release of proinflammatory cytokines as interferon-ˠ (IFN-ˠ), TNF-α, and IL-3. 
Damaged oligodendrocytes lead interference between the presence of myelination and 
expression of the gene encoding myelin (Mahad and Ransohoff, 2003; Minagar and 
Alexander, 2003; Raivich and Banati, 2004) Abnormal distribution of ZO-1 and occludin 
in blood vessels in active MS lesions (Kirk et al., 2003; Plumb et al., 2002). The 
expression of chemokines on endothelial cells of the BBB as well as an increase of 
MMP activity that allows the leukocytes to enter the CNS and release of 
proinflammatory mediators which contribute to the autoimmune response associated 
with MS (Holman et al., 2011). BBB disruption is one of the initial key steps of MS 
which precedes massive infiltration of T-lymphocytes that attack myelin sheath-forming 
demyelinating foci. 
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1.6.3 Parkinson disease 
Parkinson disease (PD) is a progressive neurodegenerative disorder caused by 
neuronal death in substantia nigra (SN), degeneration of dopaminergic 
neurotransmission, and the presence of α-synuclein and protein inclusions in neuronal 
cells (Lewy bodies) and axons (Lewy neurites) throughout the central and peripheral 
nervous system (Cabezas et al., 2014; Halliday and Stevens, 2011). Main symptoms 
of PD include asymmetrical bradykinesia, rigidity, resting tremor and post instability 
(Fernandez, 2012; Singer, 2012). Initiation and progression of PD is dependent upon 
cellular events, such as failures in the protein degradation machinery, oxidative stress, 
mitochondrial dysfunction, defects in mitochondrial autophagy and the continuous 
accumulation of α-synuclein driven through cell-to-cell interactions between glial cells 
and neurons that ultimately lead to apoptosis (Halliday and Stevens, 2011; Vives-
Bauza and Przedborski, 2011). Although the cause of PD is unknown, genetic factors 
and various environmental factors as pesticide exposure have been found to induce 
PD-like symptoms (Betarbet et al., 2000; Tanner et al., 2011; Wang et al., 2011). 
Disruption of BBB in PD has been quite controversial. It was initially assumed that BBB 
remained unaltered during the development of the pathology (Haussermann et al., 
2001; Kurkowska-Jastrzebska et al., 1999). More recently, clinical studies have 
presented evidences of BBB disruption during PD development, these studies have 
shown that α-synuclein deposition increases BBB permeability, suggesting the 
importance of α-synuclein in the BBB disruption during PD development (Cabezas et 
al., 2014; Halliday and Stevens, 2011; Jangula and Murphy, 2013; Ohlin et al., 2011). 
A decrease in cerebral blood flow have been associated with an increase of BBB 
permeability (Kortekaas et al., 2005; Ohlin et al., 2011). Polymorphisms in P-
Literature review 
 
54 
 
glycoprotein (P-gp) are also believed to be associated with increased risk of PD in 
pesticide-exposed subjects, suggesting that PD may result from a loss of CNS 
detoxification by the BBB (Droździk et al., 2003; Rappold and Tieu, 2010). Reduction 
in P-gp activity may lead to accumulation of α-cynuclein which is associated with PD 
pathogenesis (Bartels, 2011). The release of proinflammatory cytokines by microglia 
and astrocytes during PD is associated with both an increase of neuronal death and 
protein rearrangements in the endothelial cells tight junctions (Desai Bradaric et al., 
2012). 
1.6.4 Epilepsy 
Epilepsy encompasses a diverse group of conditions that are characterized by 
recurrent seizures. BBB dysfunction is critical not only in the causation but also in the 
development of treatments for this disease (Obermeier et al., 2013; Oby and Janigro, 
2006). BBB breakdown, identified by albumin extravasation into the CNS parenchyma, 
has been observed in both acute seizures and in recurrent syndromes (Mihály and 
Bozóky, 1984; van Vliet et al., 2007). Although it is unclear whether BBB dysfunction 
is cause or result of the seizures, it has been suggested that BBB dysfunction may in 
fact cause the seizures by altering either CNS ion balance or energy metabolism. This 
hypothesis is strengthened by the finding that seizures often accompany conditions in 
which the BBB is disrupted, including stroke, trauma, and CNS infections, as well as 
the finding that osmotic opening of the BBB can lead to seizure (Mihály and Bozóky, 
1984; Roman-Goldstein et al., 1994; van Vliet et al., 2007). The BBB is also critical in 
the treatment of epilepsy, as an increase of P-gp expression is associated with drug-
refractory cases (Aronica et al., 2003; Daneman, 2012; Marchi et al., 2004). 
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1.6.5 Brain tumors 
The BBB is compromised in brain tumors leading to increase vascular permeability. 
Investigations have shown abnormal permeability to protein-bound tracers which has 
been found to be related to defective capillary endothelium. Abnormalities in capillary 
endothelium include gap junctions, fenestrations of membranes, and opening of tight 
junctions in human gliomas and metastatic adenocarcinoma (Long, 1970, 1979). The 
expression of the tight junction protein claudin-1 is lost in the majority of tumor 
microvessels. Claudin-5 and occludin are significantly down-regulated only in 
hyperplastic vessels, whereas ZO-1 expression is unaffected (Liebner et al., 2000a). 
In astrocytoma and adenocarcinoma, occludin is lost from microvessels, which may 
contribute to endothelial cell TJ opening (Papadopoulos et al., 2001). The explanation 
for TJ protein loss in brain tumor is not clear: VEGF, cytokines, and scatter factor or 
hepatocyte growth factor secreted by brain tumors may be involved in TJ protein down-
regulation and increased BBB permeability associated with cerebral edema (Ballabh 
et al., 2004). Cerebral edema is considered as the most important brain tumor 
consequence. Water channel molecules, AQP4, are found to be massively upregulated 
in reactive astrocytes in metastatic adenocarcinomas. There is a significant correlation 
between BBB opening and upregulated AQP-4 expression. That may facilitate the flow 
of fluid causing edema (Saadoun et al., 2002). 
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1.6.6 Diabetes 
The CNS is increasingly recognized as a root cause of diabetes, especially diabetes 
type two. Indeed, CNS (hypothalamus area) is involved in controlling serum glucose 
level, feeding behavior and body weight. Altered transport of hormones from blood 
circulation to parenchyma can misinform the brain about nutrient status, thus fostering 
the development of hyperglycemia and obesity (Banks, 2016). 
Diabetes is a metabolic disease with well-established microvasculature effects and a 
known risk factor for ischemic stroke (Goldstein et al., 2001). This disease is also 
associated with vascular permeability such as a blood-retinal barrier permeability and 
reduced retinal occludin protein expression (Antonetti et al., 1998). Like the blood-
retinal barrier, the diabetic BBB becomes disrupted in humans and animal models 
(Huber et al., 2006; Starr et al., 2003). In both cases, glycotoxicity primarily at the level 
of pericytes underlies the BBB disruption (Hammes et al., 2002; Price et al., 2012). 
Cerebral occludin expression in diabetic rats is significantly reduced, while ZO-1 
expression in cerebral tissue from diabetic rats is not significantly altered (Chehade et 
al., 2002). 
1.6.7 Other insults 
In addition to the above pathological conditions, BBB can also be compromised by 
drugs of abuse. For example, nicotine, a potent vasoactive drug, alters the transport 
of glucose and ions at the BBB. Nicotine also decreases the expression and normal 
localization of ZO-1 and alters the BBB permeability in both in vitro and in vivo studies 
(Abbruscato et al., 2002; Hawkins et al., 2004). It is proposed that nicotine leads to 
changes in BBB permeability via reduced the expression of ZO-1 protein. Cocaine can 
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accelerate the progression on HIV-associated dementia (HAD) in a process which 
involve both direct effect of cocaine on the endothelium and proinflammatory effects 
(Nath et al., 2001). 
Obesity is currently thought to occur when the brain underestimates the energy reserve 
of the body. Leptin, a hormone secreted from fat and crosses the BBB, is one of the 
chief hormones that informs the brain about their reserves. Obesity occurs when leptin 
is not secreted, when leptin resistance is developed, or when there is a signaling defect 
downstream of the leptin receptor. There is two types of leptin resistance, central 
resistance (occurs at the level of CNS receptors) and peripheral resistance (occurs at 
the level of BBB transporters) (Banks, 2016). 
In summary, the BBB and the neurovascular unit perform numerous functions ranging 
from structural integrity to transport of different substances from and to CNS and 
leukocyte migration. Impairment of BBB functions is clearly linked to many pathological 
conditions in the human CNS. The numerous pathways by which specific TJ proteins 
are regulated and the specific effects of certain pathologies on TJ proteins suggest that 
therapies targeted to individual components of the TJ and NVU complex hold a 
significant promise for the prevention and treatment of neurological diseases. 
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Chapter 2: Sex steroid hormones and the central nervous system 
Steroid hormones are vital substances that have a wide spectrum of impact, serving 
as fundamental regulators of widely physiological functions within human body, 
including water regulation, metabolism, general immune functions, sexual 
differentiation, events during pregnancy, and brain function. Steroid hormones are 
formally defined by their chemical structure, having three cyclohexane rings and one 
cyclopentane ring that vary by the functional groups attached to the ring structures and 
by the oxidation state. There are five classes of steroid hormones: androgens, 
estrogens, progestogens, glucocorticoids, and mineralocorticoids, each with distinctive 
receptors. Endogenous steroid hormones are primarily synthesized from cholesterol 
primarily by the adrenal glands or gonads, and secreted into the blood stream in a 
highly regulated manner. Synthetically derived steroids encompass a wide spectrum 
of therapeutics capable of interacting with endogenous receptors, although there are 
many nonsteroids also capable of interaction with steroid receptors. All steroids are 
relatively small and lipophilic, allowing entry into cells via passive diffusion. Thus, 
unconjugated steroids within the systemic circulation can readily cross the BBB and 
impact CNS function. (Witt and Sandoval, 2014a). 
In this work we will focus on two of sex steroid hormones, androgen hormones and 
estrogen hormones and their effects on the BBB function and integrity. 
The major sex hormones, estrogen and testosterone, can have both organizational 
and activational effects (Arnold, 2009). Organizational effects of hormones are 
permanent and independent of acute circulating hormone levels and, therefore, cannot 
be reversed by gonadectomy. For example, the formation of the sex-specific genitalia 
occurs early in life and remains stable despite changing hormonal concentrations 
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during life span. In males, organizational effects occur prenatally or in early postnatal 
life when peaks of testosterone occur (Cohen-Bendahan et al., 2005). Testosterone 
metabolized by aromatase to 17β-estradiol and organizes the brain to become male 
as reflected by the development of cerebral sexually dimorphic nuclei and male specific 
behavior. Males exposed prenatally to aromatase inhibitors have been shown to exhibit 
female specific sexual behavioral patterns (lordosis) (Clemens and Gladue, 1978). In 
females, the organization of the brain occurs owing to the lack of local estrogen 
produced by the ovaries, binding to α-fetoprotein and does not reaching the brain 
(Bakker et al., 2006). 
Activational effects of hormones are dependent on the continuous production of 
gonadal hormones and are therefore reversible by gonadectomy (Arnold, 2009). The 
interaction between organizational and later activational effects may also occur. The 
brain is programmed by organizational effects of hormones very early in life, but the 
activational effects of hormones can subsequent activate these traits. However, 
activational effects are often, but not always, constrained by earlier organizational 
effects. For example, the male brain becomes organized by estrogen, but the spine 
density in the CA1 regions of the hippocampus does not respond to the estrogen 
administration in adulthood (Woolley and McEwen, 1993). Otherwise, hippocampal 
spine synapses growth in castrated adult male rats and can be induced by androgens 
(Leranth et al., 2003). In contrast, the female brain, which gets organized in the 
absence of estrogen, has increased apical spine density in the CA1 region of 
hippocampus with the administration of estrogen (Woolley and McEwen, 1993). 
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2.1 Androgens and androgen receptor 
2.1.1 Androgens 
Classically, androgens have been described as endogenous “male” hormones known 
for their steroidal actions in reproductive tissues and skeletal muscles. However, 
androgens also mediate physiological responses in a variety of tissues including brain, 
bone, cardiac and skeletal muscles, and the blood vessel wall in both male and females 
(Gonzales, 2013). Once Leydig cells are developed in the fetal testis, they start 
synthesizing testosterone as early as embryonic day-13 (E13) in mice. Testosterone 
is a steroid hormone and its biosynthesis takes place in the mitochondria of the Leydig 
cells through enzymatic conversion of cholesterol in a series of steps (Fig. 11). 
Cholesterol is transported through the inner mitochondrial membrane by the 
steroidogenic acute regulatory protein StAR, where it is cleaved by the cytochrome 
P450 side chain cleavage enzyme (P450scc) and further processed by 3β-
hydroxysteroid dehydrogenase (3β-HSD), 17α-hydroxylase/c17, 20-lyase (P450c17), 
and 17β- hydroxysteroid dehydrogenase (17β-HSD). In certain tissues, testosterone 
can be further reduced into the more potent 5α dihydrotestosterone (DHT) by 5α-
reductase type 1 and type 2 enzymes (Shimazaki et al., 1965), or aromatized into 
estradiol by P450 aromatase (Arzu, 2003; Ryan et al., 1972; Simpson et al., 1994) 
(Fig. 12). 
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Figure 11: Schema represented testosterone synthesis in Leydig cells (Hall, 
2011). 
 
 
 
 
 
 
 
 
Figure 12: Androgen synthesis from cholesterol to dihydrotestosterone (Tsai 
and Chen, 2006). 
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Testosterone production and secretion in newborn mice and adult animals is regulated 
by pituitary gonadotropins and luteinizing hormone (LH), unlike initial fetal testosterone 
synthesis, which appears to be independent of LH since it already occurs before LH 
transcripts are detected in the pituitary. Thus, testosterone dependent male fetal 
sexual differentiation does not require pituitary hormones (Arzu, 2003; El-Gehani et al., 
1998).  
The gonadal hormones evolve differently throughout life. In male, in the perinatal 
period there are two peaks of testosterone which play a key role in sexual 
differentiation of the nervous system. The end of differentiation testicular marks 
beginning of release of testosterone. The testosterone concentration increases from 
14th embryonic (E14) day, and are responsible for sexual differentiation of genital tract. 
The first peak of testosterone is reached in E18-19 (Salgueiro and Reyss, 2002), 
followed by a second peak a few hours after birth (Corbier et al., 1992; Pang and Tang, 
1984). After that, testosterone levels is decreased and remained low until puberty. 
Then gradually increase from the postnatal day 35-40eme in mice (Clarkson et al., 
2012). This new increase is responsible for the physical characters and the outbreak 
of spermatogenesis. Finally, between the 50th and 60th postnatal day, testosterone 
concentration is stabilized and will reach at age adult about 1 ng / ml in rodents (Fig.13) 
(Jean-Faucher et al., 1978; O’Shaughnessy et al., 2009). 
 
 
 
Figure 13: Testosterone concentration along the life span in male. 
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Testosterone deprivation in men contributes to the development of metabolic 
syndrome. Male AR knockout mice developed insulin resistance, leptin resistance, and 
late onset obesity primarily caused by decreased energy expenditure due to deceased 
locomotor activity (Fan et al., 2005; Lin et al., 2005). 
2.1.2 Androgen receptor 
Testosterone and DHT may act in different target tissues. They bind to and exert their 
action through the same intracellular receptor, the androgen receptor (AR) , a protein 
of 110KDa (Chang et al., 1988; Lubahn et al., 1988). Testosterone can act also 
indirectly via stimulation of estrogen receptors, estrogen receptor α (ERα) and 
estrogen receptor β (ERβ), proteins of 66 and 54 KDa respectively, following its 
conversion into estradiol (Fig.14) (Raskin et al., 2009; Revankar et al., 2005). 
Figure 14: Testosterone interaction with the receptors. 
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These receptors belong to the super-family of nuclear receptors (NRs), which regulate 
gene expression through their function as transcription factors. The classical nuclear 
receptors for sex steroid hormones, including estrogens, progestogens, and 
androgens, are activated by their respective steroid hormones and undergo 
conformational changes, dimerize with other hormone receptors, and recruit 
coactivator/corepressor molecules. The dimers then bind to their respective hormone 
response elements in the promoter of target genes and function as nuclear 
transcription factors, to modulate transcription and expression of specific target 
hormone responsive genes and to relaying biological actions of their respective 
hormones. Such genomic activity between steroid hormones and their respective 
receptors typically occurs over a course of several hours to a day for the effects to be 
manifested, due to the time needed for transcription and translation of hormone 
responsive genes (Liu and Shi, 2015). While these hormones can induce non-genomic 
action (rapid action) which takes place by inducing several intracellular signaling 
kinase cascade pathways, including stimulation of adenylyl cyclase activity and cAMP-
dependent protein kinase (PKA) pathway and cAMP-response element binding protein 
signaling cascade, mobilization of intracellular Ca2+-dependent protein kinase C (PKC) 
pathway, activation of extracellular signal-regulated kinase (ERK)/mitogen-activated 
protein kinase (MAPK) pathway, and activation of receptor tyrosine kinase and 
phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway (Liu and Shi, 2015; Sutter-
Dub, 2002). 
Androgen receptor is widely expressed in interconnected limbic regions such as the 
medial amygdala (MeA), the posteromedial component of the medial subdivision of the 
bed nucleus of the stria terminalis (BNST), and the preoptic hypothalamus (POA) 
(Fig.18).(Juntti et al., 2010). These regions are known to be important in regulating 
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male behavior and hypothalamus pituitary gland (HPG) axis (Shah et al., 2004). 
Testosterone metabolizing enzymes are also expressed in these regions (POA, MeA, 
and BNST) (Lauber and Lichtensteiger, 1994; Melcangi et al., 1998; Wagner and 
Morrell, 1996). 
The function and integrity of the AR generally depend on the adequate circulating level 
of androgen hormones (Kemppainen et al., 1992; Syms et al., 1985). However, several 
studies examining gonadectomy/androgen replacement, reveal different effects 
according to different sex and animal species. In adult male rat and mouse brain, AR 
levels are either low or undetectable 1 to 4 days after castration in the evaluated 
regions, and testosterone treatment restores AR in these regions (Freeman et al., 
1995; Lu et al., 1998; Simon et al., 1996; Zhou et al., 1994). Castration of male 
mandarin vole (Microtus mandarinus) significantly reduced levels of serum 
testosterone and the number of AR immunoreactivity in the anterior hypothalamus, 
BNST, MeA and lateral septal nucleus (He et al., 2012). In male guinea pig, 4 days of 
castration is of no effect on neural AR immunoreactivity in both POA and medial basal 
hypothalamus (Choate and Resko, 1992). Two weeks of castration in male Syrian 
hamsters causes reduction in nuclear AR expression and gradual increase in 
cytoplasmic AR expression in throughout the brain, while long-term exposure to 
testosterone and DHT maintains nuclear AR immunoreactivity (Wood and Newman, 
1999). Castration of male hamsters is of no effect on the immunoreactivity of AR in 
whole brain regions, except in lateral septum, where AR immunoreactivity is enhanced 
after castration (Clancy et al., 1994). 
Concerning sex differences, studies shown that the expression of AR is sexually 
dimorphic, AR immunostaining is greater in male versus female in rat hypothalamic 
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periventricular nucleus and BNST (Herbison, 1995), in all hypothalamic region in adult 
mice (Brock et al., 2015), and also in lateral septum, posteromedial bed nucleus of the 
stria terminalis, and medial preoptic nucleus in Syrian hamster (Wood and Newman, 
1999). In mouse brain, immunostaining and Western blot analyses for four brain areas 
(BNST, posterior aspect of MPOA, and dorsal and ventral aspects of the lateral 
septum) that have been linked to the regulation of male-typical behavior, have been 
evaluated, findings how regional differences in the expression of AR, sexual 
dimorphism differences in the intensity of AR immunostaining in these regions is 
reported, that the intensity of AR immunostaining is greater in intact male vs. female 
rat. The loss of AR is noticed in both sexes after gonadectomy to a higher extent in 
males. Testosterone treatment significantly up-regulates AR expression in both male 
and female without sexual differences in response to testosterone (Lu et al., 1998). 
The same results have been obtained from two studies using BALB/c or C57BL6 mice, 
exhibiting strong sex differences in AR expression between male and female, whereas 
castration decreases AR expression in both sex and which was restored by DHT 
treatment (Arteaga-Silva et al., 2007; Brock et al., 2015). There is no significant 
difference in AR expression between male and female cynomolgus monkeys (Michael 
et al., 1995). 
These results suggest that there is regional, sex and/or species differences in neural 
AR regulation. 
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2.2  Estrogens and estrogen receptors 
2.2.1 Estrogens 
The synthesis of steroids in the ovaries occurs in two type of cells, theca cells and 
granulosa cells. The synthesis of steroid hormones in the theca cells occurs under the 
control of the pituitary hormone, luteinizing hormone (LH), which stimulate cholesterol 
conversion to pregenolone, which then convert to androgens. Androgens synthesized 
in theca cells are transported to the granulosa cells where P450 aromatase converts 
these androgens to estrone and 17β-estradiol (Fig. 15) (Young and McNeilly, 2010). 
There is no androgen synthesis in granulosa cells, while these cells express follicle 
stimulating hormone (FSH) receptors which has an essential role in activating 
aromatase enzyme which is responsible to convert androgen to estrone and then to 
estradiol (Thibault and Levasseur, 2001). (Fig 15) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Ovarian sex steroids synthesis (Doshi and Agarwal, 2013) 
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Level of circulating sex hormone and reproductive status may have a regulatory effect 
on ERs expression. In men, androgen levels rise during puberty and decline gradually 
with age (Davidson et al., 1983). In contrast, from puberty through menopause, female 
continuously experience cycles of fluctuations of estrogens and progestogens in their 
lives. All these sex hormones decrease suddenly following menopause (Lovejoy, 1998; 
Zacur, 2006). In rodents’ female, the ovaries are silent and no synthesis of steroid 
hormones is observed during fetal life. Estradiol levels increase gradually from the 7th 
day postnatal (Greco and Payne, 1994; Lamprecht et al., 1976) until puberty where the 
synthesis of estradiol becomes cyclic between the 40th and 50th day postnatal 
(Kauffman, 2009) (Fig.16). However, in some species, including human, transient 
synthesis of estrogen is observed during fetal life (George and Wilson, 1978). 
Estrogens are present in both men and women, they are usually present at significantly 
higher levels in women in reproductive age. They promote the development of female 
secondary sexual characteristics, such as breasts, and are also involved in the 
thickening of the endometrium and other aspects of regulating the menstrual cycle. In 
males, estrogen regulates certain functions of the reproductive system important to the 
maturation of sperm and may be necessary for a healthy libido. 
Figure 16: Estrogen concentration during the life span. 
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2.2.2 Estrogen receptors 
Estrogenic activity is mediated through genomic along with nongenomic mechanisms. 
Like other sex steroids, estrogens exert their biological functions through binding to 
ERs, including classic nuclear ERα and ERβ, membrane-localized nuclear ERs, and 
membrane-bound G protein-coupled estrogen receptor (GPER) (Fig.17). Estradiol 
(E2) has both genomic and non-genomic effects. Genomic effects include the classical 
intracellular estrogen receptors (ER), which after binding of E2 interact with estrogen-
response element (ERE) in DNA, resulting in gene expression and eNOS production. 
While, E2 binding to GPER leads to activation of different transcriptional factors such 
as cAMP response element (CRE) which also induces endothelial nitric oxide synthase 
(eNOS) expression. Among non-genomic effects, ER and GPER regulate the E2-
induced eNOS activity (Novella et al., 2012)  
 
 
 
 
 
 
Figure 17: Estrogen interaction with its receptors (Novella et al., 2012) 
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Estradiol is the most abundant and potent female sex hormone target for nuclear ERα. 
ERα also binds to other natural forms of estrogens such as estrone and estriol but with 
lower affinity than estradiol. Additionally, many pharmacological, environmental, and 
food compounds are capable of binding ERα, either promoting or disturbing ERα 
genomic activity. Estrogen receptors are also involved in the hypothalamic control of 
energy homeostasis (Liu and Shi, 2015). 
2.2.2.1 Estrogen receptor alpha 
ERα distribution in the hypothalamus is highly conserved in different species, including 
rat, mouse, hamster, guinea pig, nonhuman primates at pubertal stage and adulthood, 
and adult human (Donahue et al., 2000; Goldsmith et al., 1997; Herbison, 1995; Li et 
al., 1993; Lisciotto and Morrell, 1993; Merchenthaler et al., 2004; Meredith et al., 1994; 
Shughrue et al., 1997). Comparison of ER mRNA in these species indicates that data 
cannot be extrapolated from one specie to another. ERα is abundantly distributed in 
several key brain regions implicated in regulating energy homeostasis in both males 
and females rats, including the ventral lateral portion of the ventromedial nucleus of 
the hypothalamus (VMH) and the arcuate nucleus (ARC) related to the control of food 
intake, the paraventricular nucleus of the hypothalamus (PVH) related to energy 
expenditure and hypothalamus-pituitary-adrenal (HPA) axis regulation, the medial 
preoptic area (MPOA) that influences thermogenesis, and the anteroventral 
periventricular nucleus (AVPV) regulating sexual behavior and HPG axis (Handa et al., 
2008; Osterlund et al., 1998; Parsons et al., 1982; Shughrue et al., 1997; Simerly et 
al., 1990) (Fig.18). A comprehensive study comparing ERα and ERβ mRNA 
expression patterns in rat CNS has indicated some overlap, but also some striking 
differences in the distribution and abundance of expression of these two receptors 
(Shughrue et al., 1997). In the mouse brain, both estrogen receptors were generally 
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expressed in a similar distribution, nuclear ERα-immunoreactivity was the predominant 
subtype in the hippocampus, preoptic area, and most of the hypothalamus, whereas it 
is sparse or absent from the cerebral cortex and cerebellum (Mitra et al., 2003). In 
general, males express less amount of ERα than females in these key hypothalamic 
nuclei involved in metabolic regulation (Brock et al., 2015; Liu and Shi, 2015). 
The gene expression, protein levels, and distribution pattern of ERα in the 
hypothalamus can be modified by alterations in circulating steroid hormone levels. In 
female animals, hormone levels can be experimentally manipulated using methods of 
surgical removal of gonads and hormone replacement, or fluctuate due to natural 
variation across estrous cycles and during certain physiological stages such as 
puberty, menopause and pregnancy (Liu and Shi, 2015). But this hormonal regulation 
for ERs is not in the same manner for both ERα and β; For example, there is differential 
regulation by estradiol of the ERs mRNAs. Two weeks of estradiol treatment decreases 
ERα mRNA expression levels in the ARC, VMH, and posterolateral cortical amygdala 
nucleus, but increases ERβ mRNA in the ARC. In the medial amygdala nuclei, only 
ERβ mRNA levels are decreased by estradiol treatment (Osterlund et al., 1998). 
ERα expression can be regulated due to the dynamic endocrine status and changes 
in circulating steroid levels could be region-specific and different among species, sex 
and life span. For example, Lauber et al. have reported sex differences in the ERα 
expression after gonadectomy of both male and female rats. They found that castrated 
males have significantly lower basal ERα mRNA levels than ovariectomized females 
in the VMH and in the ARC, suggesting a sex difference in their constitutive expression 
levels (Lauber et al., 1991). 
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Regulation of ERα under the estradiol control is species and brain region dependent. 
Several studies have demonstrated that ERα expression can be down- or upregulated 
by circulating levels of estrogens in a brain region-dependent cross species. For 
example, Estrogen treatment of ovariectomized whiptail lizard result in a significant up-
regulation of ERα mRNA expression in the VMH and torus semicircular is, down-
regulation of ERα mRNA expression in the lateral septum, and no change in the PVH, 
the periventricular nucleus of the preoptic area, and the dorsal hypothalamus (Young 
et al., 1995). In another study using male ferrets, ERα positive cells are decreased in 
POA, increased the in the medial VMH (MVMH), and not affected in the lateral VMH 
(LVMH) or ARC by estradiol treatment after castration (Sisk and DonCarlos, 1995). 
Therefore, regulation of ERα by estradiol either at expression level or protein level is 
regulated in a brain area-specific manner. 
It is generally assumed that estradiol would down-regulate its own receptor ERα. In 
agreement with this, several groups have shown that the removal of majority of 
endogenous estradiol due to ovariectomy increases the number of ERα mRNA-
positive neurons in the VMH (Lauber et al., 1990; Simerly and Young, 1991). 
Accordingly, ovariectomized female or castrated male rats receiving treatment of 
estradiol benzoate have decreased levels of ERα mRNA in the hypothalamus (Yamada 
et al., 2009). It seems that, at least in rats that are treated with pharmacologic level of 
estradiol, hypothalamic ERα mRNA and protein levels are inversely correlated with 
circulating estradiol concentration to maintain responsiveness to hormonal activation 
in ERα -containing cells, which would ensure a balanced, homeostatic system to 
prevent excessive estrogenic action {for review, see (Liu and Shi, 2015). In contrast, 
other in vivo and in vitro studies report a positive correlation between estradiol level 
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and ERα expression (Brown et al., 1988; Devidze et al., 2005; Malikov and Madeira, 
2013). 
Estrogen receptor alpha can also be regulated by androgen. It had been found that 
castration, and thus reduce androgen level, increases ERα mRNA in different brain 
regions of different species, suggesting that ERα expression in the CNS is inhibited by 
androgens (He et al., 2012; Lisciotto and Morrell, 1993; Simerly and Young, 1991; Sisk 
and DonCarlos, 1995). It has been also reported that ERα positive-cell density is 
significantly lower in testosterone treated male rats (Wu and Gore, 2010). Furthermore, 
androgens also affect ERα expression in females. Testosterone treatment attenuates 
ERα mRNA expression in different region in female rats (DonCarlos et al., 1995; 
Simerly and Young, 1991). 
Thus, ERα expression in the hypothalamus is greater in females than in males (Lauber 
et al., 1991), increased by castration in males, and inhibited by androgen treatment in 
both male and females. There are two possible mechanisms through which androgen 
treatment may regulate ERα expression, either through its aromatization to estradiol 
or through binding to AR and inducing genomic changes in AR and ERα coexpressing 
neurons. DonCarlos et al., confirm that estrogen derived from aromatization of 
testosterone suppresses ER expression in the hypothalamus (DonCarlos et al., 1995). 
2.2.2.2 Estrogen receptor beta 
Estrogen receptor beta (ERβ) is more narrowly distributed. ERβ has a distinct mRNA 
distribution pattern from that of ERα in the human forebrain. The hippocampal 
formation (primarily the subiculum), entorhinal cortex, thalamus, and claustrum are the 
predominant ERβ mRNA-expressing areas. In contrast, the most abundant expression 
of ERα mRNA is within the hypothalamus and amygdala. The expression of ERβ 
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mRNA in the hippocampal formation, entorhinal cortex, and temporal cortex suggests 
that ERβ might regulate gene transcription in neuronal populations involved in 
cognition and memory (Osterlund et al., 2000). 
In the rat hypothalamus ERβ mRNA is concentrated in the preoptic, supraoptic, and 
paraventricular nuclei of the hypothalamus, bed nucleus of the stria terminalis, and 
medial amygdala, whereas only weak hybridization signal is seen in the arcuate 
nucleus. ERβ mRNA has been also detected in the rat olfactory lobes, cerebellum, 
brain stem, spinal cord (Osterlund et al., 1998; Shughrue et al., 1996, 1997) (Fig. 18). 
In mice brain ERβ is detected in the medial preoptic and arcuate nuclei (Mozhui et al., 
2012). Immunohistochemical analysis were held to detect the expression of ERβ in 
brain region (Mitra et al., 2003), but the absence of specific antibody anti- ERβ failed 
to detect the precise localization of ERβ (Snyder et al., 2010). The use of the transgenic 
ERβ-EGFP mice allow to confirm the localization of ERβ protein as it has been reported 
(Milner et al., 2010).  
It has been found in ovariectomized female treated with estradiol, that, the expression 
of ERβ mRNA levels is increased within the arcuate nucleus after estradiol treatment, 
but decreased in the medial amygdala. These results suggest that estrogen can 
modulate behaviors and functions mediated by the amygdala and hypothalamus via 
differentially regulated ER-subtypes (Osterlund et al., 1998). 
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Figure 18: Regional distribution of androgen (AR, blue) and estrogen 
receptors (ERα, red; ERβ, green) in virtual rostro-caudal sections of the rat 
brain, and their possible involvement in CNS function (Patchev et al., 2004). 
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2.3 Sex steroid hormones and receptors in cerebral blood vessels 
It is now known that the vasculature in general and cerebral blood vessels are targets 
for sex steroids (Orshal and Khalil, 2004). Cerebrovascular tissues express specific 
receptors and metabolic enzymes for gonadal steroids.  
The nuclear sex steroid receptors are the nuclear one which modulate gene expression 
in concert with other transcription factors that are often tissue specific. The 
nongenomic “nonnuclear” effect of these hormones appear to be mediated via ion 
channels, membrane receptors, and cellular signaling pathways (Ho and Liao, 2002a, 
2002b; Orshal and Khalil, 2004). 
For ERs, it has been demonstrated the presence of ERα in rat pial arteries and 
intracerebral blood vessels (Dan et al., 2003; Stirone et al., 2003a, 2005a). Both 
immunoblot of cerebrovascular lysate and confocal immunofluorescent imaging of 
cerebral arteries show ERα in both male and female rats (Dan et al., 2003; Gonzales 
et al., 2007; Stirone et al., 2003a). In these cells, ERα has been detected in the nucleus 
(Stirone et al., 2005b), colocalized to caveolin-1 at the plasma membrane of 
endothelial cells lining cerebral arteries (Stirone et al., 2005a), and in cerebrovascular 
mitochondria (Guo et al., 2010; Stirone et al., 2005b). ER-α in cerebral vessels 
decreased after gonadectomy of both sex but significantly increased after chronic 
estrogen treatment (Gonzales et al., 2007; Stirone et al., 2003a). The detection of ER 
β in the cerebral artery lysate (Dan et al., 2003) and in the brain endothelial cells (Guo 
et al., 2010; Kemper et al., 2013), suggest that this receptor may have a role in 
mediating effects of estrogen on the cerebral circulation. 
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The presence of AR has been reported in cerebral blood vessels. AR protein has been 
detected in both rat pial arteries and intracerebral vessels (Ohtsuki et al., 2005). In 
cerebral endothelium, the level of AR protein increases in the cerebral vasculature after 
long term in vivo treatment with androgen, while treatment with estrogen has no effect 
on AR protein level in castrated male rats (Gonzales et al., 2007). 
Cerebral arteries also express sex steroid hormones metabolizing enzymes. As 
discussed before (chapter 2.1). Testosterone is converted by aromatase P450 to 17β-
estradiol, and metabolized to the potent androgen DHT by 5-α reductase. Confocal 
immunofluorescent imaging for middle cerebral arteries segments of male rats show 
the presence of 5-α reductase type 2 in both the endothelium and smooth muscle 
layers, and aromatase in the endothelial layer but not in smooth muscle (Gonzales et 
al., 2007). These results are confirmed with Western blot analysis performed with 
cerebral blood vessels isolated from whole brain, suggesting local metabolism of sex 
steroids by the cerebral vasculature (Gonzales et al., 2007). There is no effect of long-
term treatment with androgen or estrogen on levels of these enzymes (Gonzales et al., 
2007). 
2.3.1 Functional effects of sex steroids on cerebral arteries: Vascular tone 
One of the major function of the cerebral arteries is to regulate blood flow to the brain. 
As a result of the critical metabolic requirements for this vital organ, vascular reactivity 
and flow are highly regulated in the large cerebral arteries on the surface of the brain. 
Mechanisms intrinsic to the vessel wall, such as smooth muscle autoregulation and 
endothelial production of vasoactive factors, are combined with extensive 
neuroregulation and sensitivity to circulating factors such as hormones (Krause et al., 
2011). 
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Sex steroid hormones have an important impact on the cerebral vasculature by their 
ability to alter vascular reactivity and so modulate blood flow. Estrogen level in females 
is higher than males, and estrogen enhances the production or the sensitivity to 
vasodilators factors leading to vascular tone regulation (Geary et al., 1998, 2000a, 
Ospina et al., 2002, 2003; Pelligrino et al., 2000a; Skarsgard et al., 1997). Sex-related 
differences in cerebral arterial tone have been described by monitoring the pressure 
and the diameter of middle cerebral artery segments. It has been found that male 
rodents arteries tend to be more constricted than the female arteries at any given 
pressure, mainly because the effects of endothelial vasodilators, such as nitric oxide 
(NO) (Geary et al., 1998, 2000a, 2000b). Both in vivo and in vitro exposure of cerebral 
blood vessels of female rats and mice to estrogen increase endothelial NO-synthase 
(eNOS) (McNeill et al., 1999, 2002, Stirone et al., 2003b, 2005a). 
Ovariectomized female rats have more constricted cerebral arteries and exhibit less 
NO-mediated dilation than arteries of intact females, and estrogen treatment restores 
the level of NO, and inhibit the constriction resulted by ovariectomy (Geary et al., 1998; 
Pelligrino et al., 2000a; Skarsgard et al., 1997). The same results are obtained from 
female mice: the cerebral arteries from ovariectomized female are more constricted 
from those from intact females, and treatment with estrogen reversed constriction 
caused by ovariectomy (Geary et al., 2000a, 2001). There is no effect of estrogen 
treatment on eNOS level and vascular tone in ERα-knockout female mice, suggesting 
that the estrogen effect on eNOS is mediated by ERα (Geary et al., 2001) (Fig.19). 
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Figure 19: Estrogen-related cerebral vasodilation (Krause et al., 2006). 
The effect of gonadectomy and hormone replacement were studied in cerebral arteries 
isolated from male rats. It has been found that male castration induces vasodilation 
and increases eNOS level (Fig.20), whereas, in vivo treatment of these animals with 
androgen hormones causes vasoconstriction and increases vascular tone (Geary et 
al., 2000b; Gonzales et al., 2004a). This suggest that testosterone effects are 
independent of the endothelial vasodilator eNOS. In contrast estrogen treatment of 
castrated males increases NO-mediated dilation (Geary et al., 2000b). 
 
 
 
 
 
Figure 20: Opposing effects of estrogen and testosterone 
on cerebrovascular tone (Krause et al., 2006) 
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Both estrogens and androgens can affect endothelial production of vasoactive 
prostaglandins, and so modulate cerebrovascular tone. The prostaglandins (PG) are a 
group of physiologically active lipid compounds having diverse hormone-like effects in 
animals. Prostaglandins have been found in almost every tissue in humans and other 
animals. They are derived enzymatically from fatty acids. Prostaglandins have two 
derivatives: prostacyclins and thromboxanes (Fig.21). Prostacyclins are powerful 
locally acting vasodilators and inhibit the aggregation of blood platelets. Through their 
role in vasodilation, prostacyclins are also involved in inflammation. They are 
synthesized in the walls of blood vessels and serve the physiological function of 
preventing needless clot formation, as well as regulating the contraction of smooth 
muscle tissue. Conversely, thromboxanes (produced by platelet cells) are 
vasoconstrictors and facilitate platelet aggregation. Their name comes from their role 
in clot formation (thrombosis). Prostaglandins are produced following the sequential 
oxidation of arachidonic acid by cyclooxygenases (COX-1 and COX-2) which both are 
located in the blood vessels, stomach and the kidneys. 
 
 
 
 
 
 
Figure 21: Prostaglandins synthesis. Prostaglandins: PGF2, PGE2, 
PGI2, and PGD2. Thromboxanes: TXA2. (Moore et al., 2010). 
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Indomethacin, a cyclooxygenase (COX) inhibitor, dilates cerebral arteries of intact 
males and ovariectomized females rats, while it constricts cerebral arteries of 
ovariectomized females exposed to estrogen (Gonzales et al., 2005; Ospina et al., 
2002, 2003). Estrogens appear to decrease cerebrovascular tone by shifting the 
primary end product of the endothelial cyclooxygenase-1 (COX-1) pathway from the 
constrictor prostaglandin (PGH2) to the vasodilator prostacyclin (PGI2) (Ospina et al., 
2002, 2003). Interestingly, estrogens-enhancement of endothelial-dependent dilation 
is COX and NOS dependent. Estrogen effects on COX-1 pathway are more potent in 
the absence of NOS activity (Li et al., 2004), suggesting that PGI2 may serve as 
vasodilator during NOS function (Fig.22). 
Androgens enhance endothelium thromboxane A2 (TxA2) (a potent vasoconstrictor 
and platelet-aggregating action) production by increasing TxA2 synthase, which 
mediates vasoconstriction (Gonzales et al., 2005). In contrast endothelium-dependent 
TxA2 constriction is seen in ovariectomized female rats, and estrogen treatment 
elevates the levels of COX-1 and PGI2, which indicates that there is no effect of 
estrogen on TxA2.(Ospina et al., 2004) (Fig.22).  
Thus, in cerebral arteries, estrogens shift the balance of endothelium prostaglandins 
production towards PGI2, whereas androgens shift production to TxA2. 
Steroid hormones also regulate cerebral vascular tone through their effects on 
endothelial derived hyperpolarizing factors (EDHF). EDHF appears to have a role in 
regulating vascular tone in small arteries and arterioles, its effect is persisting in the 
presence of NOS and COX inhibitors and is inhibited by specific Ca2+ -dependent K+ 
channel blockers. Testosterone treatment of castrated male rats reduced EDHF-
mediated dilatation in pressurized, small branches of the middle cerebral arteries 
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(Gonzales et al., 2004b). It has also been reported that estrogen treatment decreased 
agonist stimulated EDHF-mediated dilation in female rat middle cerebral artery 
(Golding and Kepler, 2001). However, there was no effect of estrogen treatment in 
small, penetrating brain arterioles on EDHF (Cipolla et al., 2009). These results 
underscore the heterogeneity within a given vascular bed and the complexity of 
vascular regulation that may be impacted by sex steroid hormones (Krause et al., 
2011) (Fig. 22). 
Figure 22: Local action and metabolism of sex steroids in cerebral blood vessels 
(Krause et al., 2011). 
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2.3.2 Functional effects of sex steroids on cerebral arteries: inflammatory 
responses 
Vascular inflammation is an important injury response, and chronic inflammation is a 
major contributor to vascular diseases. Inflammation of the brain following stroke 
worsen the outcome after brain injuries.  
Sex steroid hormones have been shown to have a role in the inflammatory processes 
in cerebral blood vessels (Fig. 22). Experimentally, inflammation was assessed by 
measuring induction of cyclooxygenase 2 (COX-2) and inducible NOS (iNOS) in 
cerebral blood vessels following treatment with IL-1β or lipopolysaccharide (LPS) 
endotoxin (Krause et al., 2011). These effects have important consequences for 
vascular disease and ischemic brain injury. It has been reported that estrogen 
treatment decreases adhesion of leukocytes in pial venules (Santizo and Pelligrino, 
1999). Ovariectomized female rats have shown more leukocytes adhesion under 
resting conditions as well as after transient forebrain ischemia compared with estrogen 
treated ovariectomized or intact females (Santizo and Pelligrino, 1999; Santizo et al., 
2000). The estrogens mediate eNOS increase which appears to be an important 
mechanism underlying suppression of leukocyte adhesion (Santizo et al., 2002). 
Estrogens also inhibit expression of adhesion molecules by cerebral microvascular 
endothelial cells. 
Both in vivo and in vitro studies in both male and female rats have shown that estrogen 
treatment suppress induction of COX-2 and PGE2 in cerebral blood vessels which is 
exposed to either IL-1β, LPS or transient ischemia by cerebral artery occlusion (Ospina 
et al., 2004; Razmara et al., 2005; Sunday et al., 2006, 2007). Estrogen treatment 
suppress iNOS expression in vessels after ischemia in female mice (Park et al., 2006), 
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or LPS endotoxins in both male and female rats (Pelligrino and Galea, 2001; Razmara 
et al., 2005). Estrogens attenuate endothelial NFKB activation pathway induced by IL-
1β and TNF-α in cerebral vessels (Galea et al., 2002), and decrease the expression of 
protein inflammatory enzymes such as COX-2 and iNOS, so the levels of inflammatory 
mediators produced by these enzymes, PGE2 and NO will also be reduced (Ospina et 
al., 2004). All these data suggest the anti-inflammatory effect of estrogen. 
Androgens, meanwhile, are generally known to have proinflammatory effects on 
cerebral blood vessels. COX-2 and iNOS proteins are induced in the endothelium 
cerebral vessels and smooth muscles after LPS injection in male rats. This induction 
is higher in castrated rats treated with testosterone compared to castrated rats 
(Razmara et al., 2005). DHT treatment of male human endothelial cells or cerebral 
arteries isolated from castrated male rat increases activation of NFKB in cerebral 
vessels, and increases the expression of COX-2 and iNOS proteins (Death et al., 2004; 
Gonzales et al., 2009). In another study using castration of male mice as a model for 
Parkinson disease, castration is associated with an increase of the expression of iNOS, 
IL-1β, and TNF-α in substantia nigra (Khasnavis et al., 2013). 
2.4 Sex steroid hormones and the blood-brain barrier 
In addition to functional effect, sex steroid hormones are well recognized by their 
impact on the vascular endothelium. They have been identified to impact several 
critical properties of the BBB, including cellular efflux mechanisms, nutrient uptake, 
and TJ integrity. Such actions influence both brain homeostasis and the delivery of 
CNS-targeted therapy. Steroids have been identified to impact BBB transport 
processes and barrier integrity through various interdependent mechanisms. 
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Alteration of the BBB interendothelial integrity may be due to mechanical (as shear 
stress), biochemical (as enzymes, inflammatory mediators), and/or molecular (as 
transactivation/transrepression) pathways. Such mechanisms directly or indirectly 
have an impact on TJ proteins, with corresponding changes in paracellular 
permeability. Steroid hormones contribution to the BBB TJ response is complex and 
often condition specific (Witt and Sandoval, 2014b). 
Evidences indicate that sex steroid hormones influence BBB permeability (Krause et 
al., 2006). Ovariectomized female rats have higher permeability to tracers than intact 
female in different brain regions (Cipolla et al., 2009; Saija et al., 1990; Uzum et al., 
2015), Estrogen treatment reduces dye extravasation into olfactory bulb and 
hippocampus in young ovariectomized female rats compared to ovariectomized 
without estrogen treatment (Bake and Sohrabji, 2004; Cipolla et al., 2009). Estrogens 
have an effect on glucose transporter, GLUT-1. It has been found that estrogen 
treatment causes increases of glucose uptake into the BBB endothelial cells and 
GLUT-1 protein expression by microvessels (Bishop and Simpkins, 1995; Shi and 
Simpkins, 1997; Shi et al., 1997). Thus, the increase in glucose transport into the brain 
after estrogen exposure indicates the potential role of the estrogen hormone in the 
cerebral glucose homeostasis. 
For the impact of estrogen on the TJ proteins expression, Sandoval and Witt have 
found that, in young female rats ovariectomized, estrogen treatment significantly 
increases the expression of tight junction proteins claudin-5 and occludin (55 KDa) 
(Sandoval and Witt, 2011). In contrast, another study has reported that there is no 
significant changes of both claudin-5 and occludin expression in ovariectomized 
female rats received estrogen (Bake et al., 2009). 
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Both in vitro and in vivo study have reported that estrogen treatment leads to an 
increase in claudin-5 promoter activity, mRNA, and protein levels corresponding to 
enhancement of electric resistance in murine endothelial cells and female C57BL/6 
mice (Burek et al., 2010, 2014), suggesting that claudin-5 is a target gene of estrogen 
in vascular endothelium. Another study using ovariectomized female mice as a 
postmenopausal model, has shown that both claudin-5 and occludin expression are 
affected by ICI, a non-specific estrogen receptor antagonist (Shin et al., 2015). On 
other hand, occludin mRNA levels are significantly lower in the ovariectomized female 
mice compared to sham operated, and one single dose of estrogen causes a significant 
increase of occludin mRNA levels compared with vehicle control (Kang et al., 2006). 
Estrogens also affect caveolin-1 (Cav-1), the scaffolding protein characteristic of 
caveolae, anchors eNOS and inhibits eNOS activity (Duckles and Krause, 2007). 
Expression of Cav-1 is higher in pial arteries of ovariectomized female rats compared 
to intact or estrogen treated (Pelligrino et al., 2000b; Santizo et al., 2002). Cav-1 
expression decrease caused by estrogen, is correlated with the increase of eNOS 
activity (Santizo et al., 2002; Sobey et al., 2004; Xu et al., 2001). Estrogens also cause 
an increase of cerebral artery expression of calmodulin, a protein necessary for 
calcium activation of eNOS (Sobey et al., 2004). These results establish a mechanistic 
link between the estrogen-associated divergent changes in the abundance of caveolin-
1 and eNOS protein and eNOS functional activity in cerebral arterioles. 
To date, little is known about the regulation effect of androgen on the BBB permeability 
and TJ protein composition. It is known that androgens upregulate the expression and 
function of the organic anion transporter-3 in rat cerebral capillary endothelial cells via 
AR (Krause et al., 2006). 
Literature review 
 
87 
 
Sex steroid hormones regulation of the BBB integrity appears to be dependent on a 
complex interaction of age (chapter 3), inflammatory mediation, and steroid receptor 
activity, as well as form of hormone replacement therapy used. 
2.5 Sex steroid hormones and other NVU elements, astroglia and 
microglia 
As discussed before, The BBB is constituted by endothelial cells working in concert 
with neighboring cells (pericytes, astrocytes, microglia, and neurons), which are 
collectively defined as the neurovascular unit (NVU). The NVU interacts with circulatory 
components and inflammatory cells capable of altering microvascular integrity/function 
and thereby brain homeostasis. 
2.5.1 Astrocytes 
The BBB plays an important role in regulation of water permeability and brain edema; 
and these parameters are affected by hormone concentration. The water channel 
AQP4 mRNA are detected primarily around the brain parenchymal blood vessels, 
strongly implicating their role in BBB function. In rats, AQP4 was significantly elevated 
during pregnancy and postpartum period compared with non-pregnant, suggesting that 
pregnancy and the postpartum state up-regulate AQP4. Also, AQP4 up-regulation 
could promote edema formation around blood vessels when blood pressure is acutely 
and excessively elevated, as during eclampsia (Quick and Cipolla, 2005). 
The BBB is characterized by the presence of tight junctions between endothelial cells, 
and the expression of specific polarized transport systems, and astrocytes through 
their end-feet establish the link between the endothelial blood flux and neurons. Neuro-
Literature review 
 
88 
 
endothelial communications are thought to be principally through astrocytes, and may 
well incorporate non-genomic pathways. Such pathways would fit the criteria for rapid 
signaling responses to the BBB endothelium necessary to meet the needs of the brain. 
In this regard, differences in localization of respective steroid receptors within the brain 
may account for certain regional variations in the BBB integrity. (Witt and Sandoval, 
2014b). Additionally, astrocytes come to the front as mediators of cerebral-blood flow, 
brain edema, and inflammation (Johann and Beyer, 2013; Sohrabji et al., 2013). 
Astrocyte-steroid interactions role in the maintaining the BBB function is beginning to 
be addressed (Witt and Sandoval, 2014b). 
Gonadal sex steroid hormones affect astroglia under normal and pathological 
conditions, the neurodegenerative and neuroprotective effects of sex steroids may be 
mediated in part by astroglia (García-Estrada et al., 1999). There are convincing in 
vivo and in vitro evidences that astrocytes from different brain regions and in different 
phases of life, contain estrogen receptors (Fig. 23), although it is not fully clear whether 
these receptors are always expressed constitutively or rather on demand when 
astrocytes become activated under pathological conditions (Acaz-Fonseca et al., 2014; 
Beyer et al., 2003; Dhandapani and Brann, 2002; Langub and Watson, 1992; Pawlak 
et al., 2005). In vitro studies reported that astrocytes expressed also AR (Finley and 
Kritzer, 1999; Hösli et al., 2001; Jung-Testas et al., 1992). Astrocytes express 5 α-
reductase, so they participate in the metabolism of sex hormones and in the synthesis 
of endogenous steroids (neurosteroids) in the nervous system (Melcangi et al., 1992, 
1998). 
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Figure 23: Confocal laser microscope scanning images of nuclear 
and non-nuclear estrogen receptors in cultured rat astrocytes from 
different brain regions (Johann and Beyer, 2013). 
The response of astrocytes to brain injury is modulated not only by substances present 
in the blood compartement, but also by local factors produced in the lesioned tissue. 
Among these circulating molecules, there are the gonadal hormones which are likely 
to exert a modulation on the reactivity of astrocytes, since in several normal brain 
areas, the morphology and biochemistry of astrocytes are affected by the changes in 
the levels of steroid hormones (Day et al., 1990, 1993; Garcia-Estrada et al., 1993; 
Tranque et al., 1987; Witkin et al., 1991). For example it has been found that either 
testosterone or estrogen decrease the number of GFAP-immunolabeled reactive 
astrocyte after a penetrating injury of the cerebral cortex and hypocampus of 
gonadectomized male and female rats (Garcia-Estrada et al., 1993). In another study, 
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ovariectomy of Rhesus Monkey results in a significant increase of glia cells and ovarian 
steroid replacement reduces this glial activity (Witkin et al., 1991). In addition, 
castration of adult male rats leads to an increase of GFAP mRNA in the hippocampus 
which is suppressed by gonadal steroids (estradiol, testosterone, dihydrotestosterone) 
(Day et al., 1990, 1993), while hypothalamic GFAP expression is inhibited by castration 
(Day et al., 1993). Barreto et al, have found that castrated male rats treated with either 
testosterone or estrogen have a significant decrease in the number of vimentin 
immunoreactive astrocytes, while DHT treatment have no effect (Barreto et al., 2007). 
In mice it has been found that castration increased GFAP immunoreactivity in 
substantia nigra (Khasnavis et al., 2013). In vitro studies reported that estrogen 
inhibited the glial cells proliferation in monolayer cell cultures of the rat cerebral cortex. 
On the other hand, a neurosteroid, dehydroepiandrosterone, enhances astrocytic 
differentiation and reduces astroglia proliferation in primary mouse brain culture. 
(Garcia-Estrada et al., 1993; García-Estrada et al., 1999). 
2.5.2 Microglia 
Microglial cells are the resident immune cells in the CNS and perform an essential role 
in the immune response, while they are also important components of the NVU. 
Microglia becomes activated under brain injury and immunological stimuli. This 
activation and consequent neuroinflammation are substantially involved in the 
progression of neurodegenerative diseases and impairments of the BBB (da Fonseca 
et al., 2014). 
Microglial cells are thought to be a target for sex steroid hormones, as microglial cells 
express steroid hormone receptors. There is consensus about the expression of ERα 
(Sierra et al., 2008), expression of ERβ is rather controversial (Saijo et al., 2011; Wu 
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et al., 2013). Androgen receptor (AR) is colocalized with microglia in male rat 
hypocampus (García-Ovejero et al., 2002) and in human cortex (Puy et al., 1995). 
Anti-inflammatory effects of estrogen are mediated primarily through ERα (Vegeto et 
al., 2003), but a recent study has demonstrated that the androgen metabolite 17β-
estradiol can suppress inflammatory processes of microglia and astrocytes via acting 
through ERβ (Saijo et al., 2011). Another laboratory has provided 
immunohistochemical data that support ERβ expression in mouse microglia (Wu et al., 
2013). 
Sex steroid hormones affect microglia activation. It has been shown that estrogens 
prevent the activation of microglia, and inhibit the expression of inflammatory 
mediators by microglia in vitro (Baker et al., 2004; Bruce-Keller et al., 2001; Dimayuga 
et al., 2005; Vegeto et al., 2001), and reduced LPS-microglia activation in different 
models of brain inflammation, and brain injury (Barreto et al., 2007; Tapia-Gonzalez et 
al., 2008; Vegeto et al., 2003, 2006). Estrogen depletion through female 
ovariectomization, induces microglial activity, which is attenuated by estrogen 
treatment. The effect is more potent when this treatment is associated with ERβ 
agonist (Sárvári et al., 2014). Castration induces microglia activity which is suppressed 
by testosterone treatment in male rats (Barreto et al., 2007), and male mice (Khasnavis 
et al., 2013). 
2.5.3 Pericytes 
Pericytes are located at the periphery of the microvessels wall, and warp it with their 
processes. They communicate with other cells of the NVU by direct contact through 
signaling pathways and regulate several important microcirculatory functions including 
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development and maintenance of the BBB (Dalkara et al., 2011). Up to my knowledge, 
the impact of sex steroid hormones on pericytes has been almost overlooked to date. 
2.6 Sex steroid hormones and mitochondrial metabolism 
Another critical aspect is the effect of sex steroid hormones at the level of mitochondria 
present in the BBB endothelium. Mitochondria play a central role in cellular function, 
as energy producers of the cell, they carry out oxidative phosphorylation leading to 
ATP production. Mitochondria production of ROS is an inevitable by-product of this 
process. Cerebral endothelial cells are characterized by an abundance of mitochondria 
(Nag, 2003; Wallace, 2005). Relatively high levels of energy generation are required 
in order to maintain function of critical transporters of the BBB (Vries et al., 1997). 
Mitochondrial alteration and associated shifts in bioenergetics may underlie changes 
in its function and integrity, as mitochondrial (mt) DNA is exposed to relatively high 
levels of reactive oxygen species (ROS) produced as a by-product of electron 
transport. However, mitochondria have in adequate DNA repair mechanisms, making 
them prone to oxidative damage. Thus, damage to mtDNA accumulates in 
metabolically active cells, and mitochondria energetics become less efficient. A 
decrease in energy production in cerebrovascular endothelium may compromise the 
BBB, leading to an increase in leakiness, edema, failure to maintain proper ion 
gradients and/or influx of toxic substances or inflammatory cells into the brain. 
(Ballinger et al., 2000; Duckles and Krause, 2007; Madamanchi et al., 2005; del Zoppo 
and Hallenbeck, 2000; del Zoppo and Mabuchi, 2003)  
A substantial number of signal pathways regulated by estrogens converge upon the 
mitochondria, linking cerebrovascular disease, inflammation, and aging (Rettberg et 
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al., 2014). Critically, studies have also established the presence of mitochondrial ERs, 
which emphasizes the role of estrogens play in regulating cellular bioenergetics 
(Rettberg et al., 2014). Both ERα and ERβ have been shown to directly bind mtDNA 
through mitochondrial estrogen-response elements, and the binding response is 
increased with exposure to estrogens (Chen and Yager, 2004; Chen et al., 2004). 
Furthermore, estrogens increase mitochondrial biogenesis and suppressed 
mitochondrial production of ROS in human brain microvascular endothelial cells via 
ERα (Guo et al., 2010; Razmara et al., 2008) Further works have demonstrated that 
ERβ are localized into mitochondria, considering that estrogens directly modulate 
mitochondrial function via ERβ-mediated regulation of mtDNA transcription (Irwin et 
al., 2012; Yang et al., 2004). These results give the potential impact of mtDNA damage 
associated with aging or pathology and the protective effects of mitochondrial 
estrogens, which may be essential to the preservation of the BBB function. 
2.7 Sex steroid hormones and neuroprotection 
Males are reported to have a higher incidence and risk of cardio- and cerebrovascular 
disease, particularly stroke, until an advanced age. Clinical case studies have reported 
that men are more prone to develop coronary artery disease, a known risk factor for 
stroke, compared to age-matched women (English et al., 1997). In women the 
incidence rates rise dramatically with age, and the severity of outcome is greater in 
aged-matched men (Fukuda et al., 2009; Roger et al., 2011; WRITING GROUP 
MEMBERS et al., 2010). The Framingham Heart Study supports the existence of 
gender-differences in stroke incidence and demonstrates that the reversal in stroke 
sensitivity in women occurs after the age of 85 years (Petrea et al., 2009). These data 
are confirmed by a Swedish and Oxford Study (Rothwell et al., 2005). 
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Despite the higher overall incidence of stroke in men throughout the lifespan, women 
account for 60.6% of stroke deaths (WRITING GROUP MEMBERS et al., 2010). This 
may be argued that the increased mortality may be due to the higher age of first stroke 
in women (74.5 years) compared to men (69.2 years) (Roquer et al., 2003). Functional 
recovery after stroke and stroke severity is also worse in women. The disparities in 
stroke outcome are not a reflection of stroke size, which is similar in both sexes 
(Barker-Collo et al., 2010; Lai et al., 2005; Silva et al., 2010). In addition, the incidence 
of recurrent stroke is higher in women (Roger et al., 2011). The hypothesis suggesting 
the involvement of sex steroids on the observed sex disparity in the incidence/risk of 
cerebrovascular disease have often been interpreted as reflecting the protective 
effects of estrogen, as it is related to premenopausal women and/or the less protective 
effects of testosterone in aged-matched men (Gonzales, 2013). 
Estrogen has been recognized as a neuroprotector in most animal models of stroke 
(Hurn and Macrae, 2000; Uzum et al., 2015), and most experimental studies suggest 
that this is due to an activational effect of estrogen (Alkayed et al., 1998; Dubal et al., 
1998; Simpkins et al., 1997). Estrogens administered during reperfusion after hypoxia 
decrease infarct volumes in ovariectomized females and reproductively senescent 
(aged) females as well as in males (Liu et al., 2009; McCullough and Hurn, 2003), 
suggesting the protective effects of estrogens are sex independent, at least when 
administered acutely after injury. Estrogens are produced from testosterone via the 
action of aromatase, female mice with genetic deletion of aromatase have significantly 
larger infarcts volume than wild type ovariectomized females, suggesting a role of local 
brain estrogens in neuroprotection (McCullough et al., 2003). Loss of aromatase also 
reduces stroke-induced neurogenesis and prolong the duration and the severity of 
poststroke functional defects in both male and female mice, suggesting that estrogen-
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induced increase in poststroke neurogenesis contributes to poststroke recovery (Li et 
al., 2011). These results suggesting hormonal effect, rather than a sex effect, of 
estrogen on stroke neuroprotection. 
Estrogens effects could be genomic or nongenomic and their neuroprotective effect 
are still poorly understood. Nanomolar concentrations of estrogens have been shown 
to be anti-inflammatory and can suppress the activation of both astroglia and microglia, 
iNOS and several other proinflammatory cytokines expression (Dimayuga et al., 2005; 
Garcia-Ovejero et al., 2005; Giraud et al., 2010; Kipp et al., 2007; Smith et al., 2011; 
Spence et al., 2011). Estrogens can also increase neurogenesis by enhancing 
neuronal proliferation and migration in both subventricular zone and dentate gyrus in 
both sexes (Merlo et al., 2007) (Fig.24). 
Figure 24: Astrocytes are a source and a target of sex steroids and mediate many 
of neuroprotective effects of these hormones (Garcia-Ovejero et al., 2005). 
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Estrogens promote also vascular protection through their positive effects on 
endothelium and prevent atherosclerosis by suppressing mechanisms of vascular 
smooth muscle migration. Both in vivo and in vitro estrogen treatment affects 
mitochondrial function in cerebral blood vessels, by improving mitochondrial efficiency 
of energy production, and decreases mitochondrial production of damaging free 
radicals and ROS (Duckles et al., 2006; Stirone et al., 2005b). Estrogens are also 
capable to suppress apoptosis mechanisms involving the mitochondria (Simpkins et 
al., 2005; Yang et al., 2005a) and cerebrovascular Akt protein (Stirone et al., 2005a), 
and enhance endothelial cell survival (Shi and Simpkins, 1997). Estrogens protect rat 
cerebral endothelial cell from damage induced by Ca+2 influx in cell culture (Mogami et 
al., 2002), and from amyloid β-peptides accumulation in vivo (Rhodin et al., 2003; 
Vincent and Smith, 2000). 
Despite evidence that the endogenous actions of androgens may contribute to the 
recognized sex disparities in cerebrovascular disease, emerging experimental studies 
indicate that androgens can have both deleterious and protective effects on the CNS 
following cerebrovascular insults such as stroke or cardiac arrest (Cheng et al., 2007; 
Nakano et al., 2010; Uchida et al., 2009). Clinically, elevated levels of endogenous 
testosterone are correlated with an increased risk of stroke in young boys (Normann 
et al., 2009; Siegel et al., 2010; Vannucci and Hurn, 2009). Low level of circulating 
testosterone is linked with the increased morbidity and poor recovery (Jeppesen et al., 
1996). Animal studies have shown that young castrated male rats and mice have 
decreased injury compared with intact male (Cheng et al., 2009). Testosterone 
supplementation prior to stroke exacerbated stroke damage in young castrated male 
rats with a strong positive correlation between plasma testosterone concentrations and 
ischemic lesion size (Cheng et al., 2007; Hawk et al., 1998; Yang et al., 2005b). Other 
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studies have shown that testosterone can be protective, and this protective effect is 
age and dose-dependent (Cheng et al., 2009; Uchida et al., 2009). Testosterone 
supplementation reduces stroke size in middle-aged male rats (Cheng et al., 2009) 
and enhances functional recovery in young castrated male rats (Pan et al., 2005). Low-
dose androgens pretreatment of castrated male mice reduces infarct size compared to 
untreated castrated mice, and the effects of testosterone treatment on infarct size are 
blocked by AR antagonist, flutamide (Uchida et al., 2009). These results suggest the 
potential therapeutic role for testosterone replacement in stroke recovery. Finally, 
testosterone protects cultured neurons form oxidative stress, β-amyloid toxicity, and 
serum deprivation, and these effects are mediated through AR (Ahlbom et al., 2001; 
Hammond et al., 2001). 
Together, these results indicate that levels of circulating androgens change with 
normal development and aging and these changes may contribute to vulnerability of 
male brain to cerebrovascular disease. 
  
Literature review 
 
98 
 
Chapter 3: Age-related changes in the Blood-Brain Barrier. 
A variety of age-related degenerative diseases involve the CNS. Progressive 
deterioration in cognitive function, loss of memory, and decreased ability to learn are 
natural consequence of aging. Data reported that nutritional factors, environmental 
toxins, and constitutional and genetic factors, play important roles in age-related CNS 
degenerative changes. Hence, age-related deterioration in CNS function may be 
secondary to age-related alterations in the BBB function and permeability (Bake et al., 
2009). Consequently, these alterations impair the transport of crucial nutrients and 
metabolites to enter the brain. These factors can potentially be controlled to prevent or 
delay CNS dysfunction with aging (Mooradian, 1988; Shah and Mooradian, 1997). 
In newborns, the BBB is fully developed. However, several structural changes continue 
to occur throughout development and senescence. Briefly, age-related changes in the 
cerebral microvasculature include changes in the cross-sectional area of capillary wall, 
reduce number of endothelial cells, and mitochondria in the endothelial cells, 
gliofibrillar proliferation, and increase perivascular basement membrane thickness 
(Shah and Mooradian, 1997). The capillary diameter has been found to be unaltered 
in the frontal and occipital cortex of the aging monkey (Burns et al., 1979), but is 
increased in the aging human precentral gyrus (Hunziker et al., 1978, 1979). The effect 
of age on capillary diameter, in the rat, is controversial, it is region-specific and species-
specific age-related changes [review in (Shah and Mooradian, 1997). The number of 
endothelial cells are decreased with age in rat and human cerebral cortex (Hunziker et 
al., 1979). The number of mitochondria in the endothelial cells are also decreased with 
age in the frontal cortex of monkey (Burns et al., 1979), but not in human brain (Stewart 
et al., 1987), and F344 rats (Hicks et al., 1983). In human and F344 rats’ brain, there 
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are no pinocytic vesicles, or junctional gaps alteration with age (Hicks et al., 1983; 
Stewart et al., 1987). Aging is also accompanied with an increase of the thickness of 
basement membrane on both frontal and occipital cortex region of the monkey (Burns 
et al., 1979), in different brain regions of aged rats (Topple et al., 1991), and in the 
cortex of aged mice (Nahirney et al., 2015). In both rats and monkey, mitochondrial 
content of endothelial cells are reduced with age (Burns et al., 1981), while mtDNA 
mutations increase during aging and in age-related neurologic conditions such as 
Alzheimer’s disease (Müller et al., 2010). 
Mitochondrial oxidative stress is a leading cause of vascular/endothelial dysfunction in 
aged population. With advanced age, the synthesis of ROS increases in the endothelial 
cells causing an inactivation of the vasodilator NOS, and so, reduces vasodilator 
capacity and perfusion of tissues. Aging also increases iNOS in microvessels of 
hypertensive subjects and aging male rats [reviewed in (Sohrabji et al., 2013)], and 
COX-2 and TNF-α in aged mice (Elahy et al., 2015). 
The aged brain shows distinct changes in astrocyte morphology and number (Hansen 
et al., 1987; Mouton et al., 2002; Vaughan and Peters, 1974) and GFAP expression 
(Elahy et al., 2015; Rozovsky et al., 1998). Furthermore, aging accelerates injury-
induced astrocyte reactivity (Badan et al., 2003; Gordon et al., 1997). A significant 
effect of gender on total microglia cell number in dentate gyrus and CA1 regions of the 
hippocampal, has been reported in mice (Mouton et al., 2002). Female mice have more 
microglia than age-matched males in all age groups, with a significant increase of 
microglial number in aged female mice compared to young female (Mouton et al., 
2002), and no age differences have been found in the numbers of microglia between 
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different age groups of male (Long et al., 1998). Aged rats show an accelerated 
microglial reaction that peaks during the first week after injury (Badan et al., 2003). 
It is known that BBB hyper-permeability can be associated with TJ dysregulation and 
efflux capacity. In a cortical contusion injury, barrier permeability is greater in aged 
animals as compared to young animals (Bake et al., 2009; Lee et al., 2012) and is 
accompanied with claudin-5 reduction but not occludin (Lee et al., 2012). In another 
study there are no difference in immunostaining of both claudin-5 and occludin in 
hippocampal microvessels from young and middle-aged male and female rats (Bake 
et al., 2009). In the same study, they have found a significant reduction in claudin-5 
immunostaining in microvessels of pre-menopausal women compared to post-
menopausal (Bake et al., 2009). In mice, there are no differences in the mRNA levels 
of claudin-5, occludin and P-gp in the brains of adult and aged mice (Kranz et al., 
2013). Another study have found that BBB hyper-permeability in aged mice was 
associated with reduced expression of the occludin and ZO-1 (Elahy et al., 2015). 
As discussed before, that cerebral blood vessels and NVU elements are non-
reproductive targets for endogenous sex steroid hormones, and these hormones could 
have neuroprotective effects. It is clearly known that there is significant age-associated 
decline in endogenous sex hormone levels, particularly testosterone and estradiol. In 
vivo and in vitro studies have reported the protective effect of estrogen on the vascular 
permeability, and this effect is mediated via ERs in both male and female (Childs et al., 
2010; Tharakan et al., 2009). The expression of ERα expression in the vascular 
endothelial cells is lower in estrogen-deficient postmenopausal compared with 
premenopausal women (Gavin et al., 2009; Mendelsohn, 2000). This estrogen 
deficiency, ERα down-regulation and impaired endothelial function in postmenopausal 
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women, is in part a result of reduced eNOS expression and activation. Association 
between age and estrogen effect the BBB tight junction has been reported, that 
increasing age and 17β-estradiol treatment in ovariectomized rats alter the expression 
of critical BBB tight junction proteins (claudin-5 and occludin) and without modifying 
both ERα receptor expression and without functional paracellular permeability of the 
BBB (Sandoval and Witt, 2011). Another study reported that the BBB permeability is 
increased in reproductive senescent female rats compared to young adult and the 
estrogen treatment is beneficial when given to young adult but not to senescent 
females (Bake and Sohrabji, 2004). These results argue that endothelial cells of the 
BBB may be altered with reproductive aging and, furthermore, these alterations may 
result in differential hormone effects that may explain why estrogen replacement is not 
neuroprotective to older, acyclic females.
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Thesis project 
Cerebral blood vessels are target for sex steroid hormones, estrogens and androgens, 
but their mechanism of action is still unclear. Understanding the neurovascular unit 
physiology is critical to get new insights in neurological and metabolic diseases 
involving blood-brain barrier dysfunction for the development of drugs that can cross 
the BBB.  Besides that, sex steroid hormones are considered as therapeutic agents in 
treatment of some pathological conditions as prostate and breast cancer, hormone 
replacement therapy in menopause women and hypogonadism men, and as 
contraceptives. 
The overall aim of my thesis was to determine the cellular and molecular mechanisms 
induced by sex steroid hormones which underlying physiological, structural and 
functional, plasticity of the neurovascular unit in the mouse. It is structured around two 
main parts: 
I- The involvement of sex steroid hormones in the integrity of the blood-
brain barrier and the surrounding parenchyma 
My first objective was to determine the role of gonadal testosterone on the 
neurovascular unit in male mice. To date, the effects of testosterone at both the cellular 
and molecular levels on brain microvasculature remains to be studied in details. No 
data are yet available in the literature on the role of testosterone on the structure and 
function of the BBB under physiological conditions. In this context, I investigated the 
impact of a chronic depletion of testosterone on the function and structure of the BBB 
in mice adult male. The results obtained are presented part I-A, with an article which 
is currently in submission. 
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Secondly, I started a similar study with the aim to determine the role of gonadal 
estrogen hormone effects on neurovascular unit in female mice. Indeed, female 
estrogen hormone is known to have a neuroprotective effect, but little known about the 
effect of this hormone on the integrity of the blood-brain barrier and the neurovascular 
unit. So, I investigated the effect of circulating estrogens on the blood-brain barrier 
permeability in adult female mice ovariectomized supplied or not with estradiol. The 
results obtained are presented in the part I-B. 
 
II- Involvement of sex steroid receptors on the integrity and function of the 
BBB in adult male mouse. 
In this second part, I present preliminary results describing the putative role of sex 
steroid receptors in the testosterone-mediated signaling pathways.  
Firstly, I studied the sex steroid hormones receptors involvement in the neurovascular 
unit integrity of male mouse. To identify the relative role of AR in the regulation of the 
BBB selective permeability and function, I used two animal models, 1) castrated male 
mice compared to their age-matched intact mice, and 2) transgenic model mice 
selectively lacking neural AR (ARNesCre). The results obtained are presented in the part 
II-A. 
Secondly, I analyzed the short-term action of testosterone on the neurovascular unit 
in male mouse. In order to analyze the involvement of the testosterone and different 
sex steroid receptors in the integrity and function of the BBB using an ex vivo model. 
Results obtained are presented in part II-B 
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The studies I have conducted during my thesis, focus on the medial preoptic 
area MPOA which is a brain region integrating chemosensory signals controlling 
sexual behavior, and is a seat of a hormone-dependent neural plasticity. 
The hypothalamus-pituitary-gonadal axis (HPG) 
The hypothalamus is a small area of the ventral diencephalon of the forebrain, near 
floor of the third ventricle, and is a functional link between the nervous and endocrine 
systems. The hypothalamus controls most of the endocrine glands within the body, 
largely through stimulation of the pituitary gland by secretion of neurohormones.  
Reproduction is an essential process in vertebrates, which consists of various aspects 
of physiological events throughout the lifespan, including fertilization, development, 
puberty, social and sexual behaviors, maturation, and aging. Reproductive functions 
are controlled by the hypothalamus–pituitary–gonadal (HPG) axis. The hypothalamus, 
a central brain region that is responsible for the control of reproduction, regulates 
pituitary hormone synthesis and release. Gonadotropin-releasing hormone (GnRH) is 
a pivotal hypothalamic neuropeptide that regulates vertebrate reproduction. In 
tetrapods, GnRH neurons are located in the preoptic–hypothalamic region and project 
to the median eminence to regulate gonadotropin synthesis and release from the 
anterior pituitary gland, which stimulates sex steroid secretion and gametogenesis. 
(Parhar et al., 2016). The gonadotropins include two glycoprotein hormones: follicle-
stimulating hormone (FSH) and Luteinizing hormone (LH) which stimulate the 
production and maturation of sex cells, or gametes, in both sex. In female both LH and 
FSH stimulate the production of estrogens and progesterone from theca and granulosa 
cells promote follicular growth; these follicles then release estrogens in the female 
ovaries.  
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In male, the secretion of the gonadotropins, LH and FSH, depends on release of GnRH 
from the hypothalamus into the hypophysial portal blood. Serial measurements of 
GnRH and LH have shown that GnRH and LH are secreted in a pulsatile manner 
(Tilbrook and Clarke, 2001). LH stimulates its testicular receptor and stimulates the 
production of testosterone. Testosterone and FSH activate the spermatogenesis in the 
sertoli cells (Sun et al., 1989). 
The secretion of GnRH is regulated by sex steroids (i.e. positive and negative 
feedback). Gonadal sex steroid hormones provide a negative feedback on GnRH 
secretion (and hence, LH and FSH secretion from the pituitary) in both male and 
females. While in female, in the protestors cycle, estradiol exerts a positive feedback 
on the GnRH neurons enhancing LH surge and so the ovulation (Fig 25). 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: regulation of the hypothalamus-pituitary-
gonadotropin (HPG) axis (Pinilla et al., 2012) 
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Medial preoptic area (MPOA) 
The medial preoptic area MPOA is one of the important region of the hypothalamus. It 
is located in the anterior of the hypothalamus between the anterior commissure (aco) 
and the caudal portion of the optic chiasm (och). The lamina terminalis is its rostral 
border and the median division of the bed nucleus serves as it caudal border. MPOA 
is composed of different subregions, as: medial preoptic (MPO), medial preoptic 
nucleus (MPN), ventrolateral preoptic nucleus (VLPO), anteroventral periventricular 
nucleus (AVPV) (Fig 26). This brain region is implicated in a variety of functions that 
include: feedback regulation of pituitary gonadotropin and prolactin release, 
thermoregulation, hypovolemic thirst, maternal behavior, and sexual behavior [for 
review, see (Paredes, 2003).  
 
 
 
 
 
 
 
 
 
Figure 26: Neuroanatomical localization of the medial preoptic area 
(MPOA). Anteroventral periventricular nucleus (AVPV), medial 
preoptic nucleus (MPN), ventrolateral preoptic nucleus (VLPO), 
medial preoptic (MPO). 
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MPOA is known as sexually dimorphic region. In male, it has an essential role in 
copulation and sexual motivation, it has been shown that MPOA injury impaired sexual 
behavior in rats (Hansen, 1982; Hull and Rodríguez-Manzo, 2009; Paredes, 2003). In 
females, studies have examined the influence of the MPOA on precopulatory and 
appetitive behaviors. Precopulatory behaviors involve several brain areas, including 
the MPOA as well as the medial amygdala (MeA) and bed nucleus of the stria 
terminalis (BNST). Studies using female Syrian hamsters have shown that the MPOA 
is important for sexual odor preference. Females will investigate male odors more than 
female odors, while females with bilateral lesions to the MPOA show no difference in 
odor preference, but vaginal scent marking and lordosis remained unaffected (Martinez 
and Petrulis, 2013). In MPOA, the Medial preoptic nucleus also called sexually 
dimorphic nucleus (SDN), it is five times larger in male rats than female (Gorski et al., 
1978), and releases gonadotropin-releasing hormone (GnRH) and is implicated in 
parental care in both males and females. 
Estrogen receptors as well as androgen receptor have been well characterized in 
several hypothalamic regions in adult rodents including MPOA {for review, see (Brock 
et al., 2015; Handa et al., 2008).
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All male and female mice were 8-10 weeks of age, and grouped-housed after weaning 
under a controlled photoperiod (12:12h light dark cycle – lights on at 7 am), maintained 
at 22°C and fed with a standard diet with free access to feed and water. All studies 
were performed in accordance with the National Institute of Health guidelines for the 
care and use of Laboratory Animals (NIH Guide) and French and European legal 
requirements (2010/63/UE). Experiments were performed accordingly, to minimize 
animal number and discomfort and were approved by the “Comité d’éthique en 
expermintation animale” Charles Darwin N°5 (project number 01490-01). 
Part I: Involvement of sex steroid hormones in the integrity of the blood-
brain barrier and the surrounding parenchyma in mouse. 
A- Gonadal testosterone and neurovascular unit in male mice 
Chronic depletion of gonadal testosterone leads to blood-brain barrier 
dysfunction and inflammation in male mice 
Afnan Atallah, Sakina Mhaouty-Kodja and Valérie Grange-Messent 
Actually submitting 
Abstract 
The blood–brain barrier (BBB) is a highly selective permeability barrier that separates 
the circulating blood from the brain parenchyma in the central nervous system (CNS). 
The blood–brain barrier is formed by brain endothelial cells, which are sealed by tight 
junctions with an extremely high electrical resistivity and present sparse transport 
vesicles. The BBB represents a complex cellular system consisting of these brain 
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endothelial cells associated with pericytes, basal lamina, astrocyte end-feet and 
perivascular microglia. Interactions between all these components are required for the 
induction and the maintenance of BBB function. This barrier acts as a physical and 
metabolic diffusion barrier which is essential for maintenance of homeostasis and 
normal function of the CNS. A dysfunction of the BBB is a consequence of some 
neurological and metabolic disorders. 
Cerebral blood vessels are a non-reproductive target tissue for sex steroid hormones.  
Indeed, male and female cerebrovascular tissues express sex hormone receptors, 
androgen receptors (AR) and estrogen receptors (ERs). These sex steroid hormones 
have an impact on vascular tone, endothelial function, oxidative stress and 
inflammatory response. To date, protective effects of estrogen on the cerebral 
circulation in female are the most described owing in part to interest in hormone 
replacement therapy that may prevent postmenopausal women from cardio- and 
cerebrovascular diseases. Estradiol has been described to regulate claudin-5 
expression and tight junction integrity through estrogen receptors in female mice, but 
no data is yet available in the literature about the role of testosterone on the structure 
and function of the BBB in brain capillaries, In the male brain, testosterone exerts a 
signal either directly through androgen receptor or indirectly through estrogen 
receptors ERα and ERβ, following aromatization into E2 (17β-estradiol), leading 
conclusions rather complex. Thus, cellular pathways and molecular mechanisms 
involved in male BBB function induced -testosterone signaling remains to be studied 
in greater detail.  
In this context, we investigated the effects of gonadal testosterone depletion on the 
integrity of the capillary blood-brain barrier and the surrounding parenchyma in male 
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mouse. To address this question, we used 5-weeks castrated mice compared with 
intact age-matched male mice. In order to evaluate whether the effects of the 
testosterone depletion are permanent or reversible, 5-weeks castrated males were 
supplemented with testosterone for 30 days and compared with intact male mice. 
First, we investigated the BBB permeability using functional permeability assays. Then, 
ultrastructural morphology of tight junction was assessed by electron tomographic 
reconstruction followed by 3D-modelisation. The distribution of the junction proteins 
occludin, claudin-5 and ZO-1, was determined by immunohistochemistry, and related-
protein amounts were evaluated by Western blot analysis. BBB-associated cells 
constituting the gliovascular unit were also studied by examining the status of glia and 
inflammatory mediators using immunohistochemistry, Western Blot and qRT-PCR 
analysis. All the materials and methods are included in the article presented below. 
Our results showed an increase of the blood-brain barrier permeability for exogenous 
tracers in chronically testosterone-depleted male mice. These results were confirmed 
by immunodetection of mouse endogenous immunoglobulins in the cerebral 
parenchyma. This BBB leakage is associated with tight junction protein disorganization 
and lower expression of claudin-5 and ZO-1, activation of astrocytes and microglia, 
and up-regulation of inflammatory molecules such as iNOS, COX-2, IL-6, IL-1β and 
TNF-α. Supplementation of testosterone after castration restores the blood brain 
barrier impermeability and tight junction integrity, and almost completely cancels the 
inflammatory features. 
These findings get new insights to demonstrate that gonadal testosterone controls the 
integrity and therefore impacts cerebrovascular physiology in adult male mice. 
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Abstract 
The blood–brain barrier (BBB) is a highly selective permeability barrier essential for 
maintenance of homeostasis and normal function of the central nervous system. It represents a 
complex cellular system consisting of endothelial cells sealed by tight junctions and presenting sparse 
transport vesicles, associated with pericytes, basal lamina, astrocyte end-feet and perivascular 
microglia. A dysfunction of the BBB is associated with many neurological and metabolic disorders. 
Although sex steroid hormones were shown to impact vascular tone, endothelial function, oxidative 
stress and inflammatory responses, there are still no data on the role of testosterone in the regulation 
of BBB structure and function. In this context, we investigated the effects of gonadal testosterone 
depletion on the integrity of the capillary BBB and the surrounding parenchyma in male mice.  
Our results show increased BBB permeability for different tracers in chronically testosterone-
depleted males. These results were confirmed by immuno-detection of endogenous immunoglobulins 
in the cerebral parenchyma and were associated with disorganization of tight junction structure shown 
by electron tomography and a lower amount of tight junction proteins such as claudin-5 and ZO-1. BBB 
leakage was also accompanied with activation of astrocytes and microglia, and up-regulation of 
inflammatory molecules such as iNOS, COX-2, IL-1β and TNF-α. Supplementation of castrated males 
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with testosterone restored BBB impermeability, tight junction integrity, and almost completely 
blunted the inflammatory features. 
The present demonstration that testosterone transiently impacts cerebrovascular physiology in adult 
male mice should help to get new insights into neurological and metabolic diseases linked to 
hypogonadism in aged or young hypogonadic men. 
 
Introduction 
The blood-brain barrier (BBB) is a physical and metabolic diffusion barrier, which is essential 
for maintenance of homeostasis and normal function of the central nervous system (CNS). The BBB is 
present in all the brain, except in the circumventricular organs regulating autonomic nervous system 
(Ballabh et al., 2004). It acts as a selective and highly regulated interface between the circulatory 
system, and thus the immune system, and the brain parenchyma. The main characteristic of the BBB 
is its highly selective permeability, especially due to intercellular endothelial tight junctions (TJ), which 
control the passage of molecules between the brain parenchyma and the blood through the 
paracellular pathway (for reviews see Gumbiner, 1987, 1993; Schneeberger and Lynch, 1992). This 
function provides the brain protection against potentially toxic xenobiotics, but also constitutes a 
major limitation to therapeutic treatment of the CNS. 
The BBB represents a complex cellular system not only consisting of brain endothelial cells with 
sparse transport vesicles and sealed by tight junctions, but also of pericytes, perivascular microglia, 
astrocytes end-feet and basal lamina. While these particular cerebral endothelial cell layer forms the 
barrier proper, the interaction of all cells, constituting the gliovascular unit, is necessary for the 
induction and the maintenance of the specialized functions of the BBB. This interface is increasingly 
recognized as a dynamic system, capable of responding to local changes and requirements, and able 
to be regulated via a number of mechanisms and cell types, not only in physiological but also in 
pathological conditions. A defect of impermeability of the BBB is a consequence of some acute 
pathological disorders, such as stroke and traumatic brain injury, and in some chronic 
neurodegenerative diseases like Alzheimer’s dementia and Parkinson’s disease (Wardlaw et al., 2009; 
Zipser et al., 2007). In some other cases, BBB disruption may be a precipitating event, such as with 
multiple sclerosis, epilepsy, obesity or diabetes (Kalani et al., 2015; Maysami et al., 2015; van Vliet et 
al., 2007).  
 
Population-based epidemiology studies showed that high levels of androgens increase the 
incidence of cerebrovascular disease in young adult men (Kissela et al., 2012; Wang et al., 2013). The 
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natural decline in physiological circulating levels of androgens contributes also to increase incidence 
and worsened outcome with aging (Yeap et al., 2009). Deleterious and protective effects were also 
described for testosterone in rodent models of cerebral ischemia (Cheng et al., 2007; Nakano et al., 
2010; Uchida et al., 2009). 
At the cellular level, sex steroid hormones have been found to alter vascular tone, endothelial function, 
oxidative stress and inflammatory responses in cerebral vessels of rat females and males or in cultured 
endothelial cells {see for review (Krause et al., 2011). To date, the most is known regarding the effects 
of estrogens on the cerebral circulation in females {for review, see (Pelligrino and Galea, 2001). 
Estrogens have important protective effects on endothelial function and peripheral vascular health in 
females (Miller et al., 2004; Orshal and Khalil, 2004). The prevalence of inflammatory cerebrovascular 
diseases shows a distinct male predominance, with numerous studies showing women to be relatively 
protected. In this context, the effects of testosterone at both the cellular and molecular levels on brain 
microvasculature remains to be studied in details. In particular, to our knowledge, no data are yet 
available in the literature on the role of testosterone on the structure and function of the BBB under 
physiological conditions. Understanding the BBB physiology is, indeed, critical to get new insights in 
neurological and metabolic diseases involving BBB dysfunction and for the development of drugs that 
can cross the BBB.  
In the present study, we investigated the effects of gonadal testosterone on the BBB function and 
integrity. To address this question, we analyzed a mouse model of chronic depletion of testosterone 
by using complementary approaches. We report that chronic depletion of testosterone for 5 weeks in 
young males led to a BBB leakage demonstrated by increased permeability to different tracers and 
ultrastructural studies using electron tomography. This involved altered expression of endothelial tight 
junction components. BBB leakage was associated with a glial activation and inflammatory processes. 
Interestingly, testosterone supplementation after 5 weeks of depletion was able to restore the 
majority of observed alterations.  
 
Materials and Methods 
Study design  
The present study aimed to study the role of testosterone on the integrity of the capillary BBB and 
surrounding parenchyma in male mouse under physiological conditions. In particular, we investigated 
the effects of circulating testosterone depletion on the BBB permeability and characterized its impact 
on TJ structure and protein levels and distribution, and on their cellular partners. Analyses were 
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processed using 5-weeks castrated mice compared with intact age-matched male mice. We focused 
on the hypothalamic medial preoptic area (MPOA), a highly sensitive brain area to gonadal 
testosterone, involved in male reproduction. In order to evaluate whether the effects of testosterone 
depletion was permanent or reversible, 5-weeks castrated males were supplemented with 
testosterone for 30 days and then analyzed with their intact littermates. 
Animals 
Male mice of C57BL/6j strain were group-housed after weaning under a controlled photoperiod 
(12:12h light dark cycle – lights on at 7 am), maintained at 22°C and fed with a standard diet with free 
access to feed and water. All studies were performed in accordance with the National Institute of 
Health guidelines for the care and use of Laboratory Animals (NIH Guide) and French and European 
legal requirements (Decree 2010/63/UE). Experiments were performed accordingly, to minimize 
animal number and discomfort and were approved by the “Comité d'éthique en expérimentation 
animale” Charles Darwin N°5 (project number 01490-01). 
Gonadectomy and testosterone supplementation 
Adult males (8 weeks old) were castrated under general anesthesia using a ketamine/xylazine mixture 
as previously described (Raskin et al., 2009, 2012). Mice were given 5 weeks to recover from surgery 
and to ensure depletion of endogenous testosterone prior to any experiment. For testosterone 
supplementation, castrated mice were subcutaneously implanted 5 weeks later with SILASTIC® 
implants filled with 10 mg of testosterone as previously described (Raskin et al., 2009, 2012) and 
analyzed 4 weeks later. 
BBB permeability assay 
To assess the permeability of the BBB, intact, castrated and testosterone-supplemented mice (n = 3 
per group) were injected with different molecular weight tracers: 4-kDa Evans Blue, 70-kDa FITC-
dextran and 40-kDa horseradish peroxidase (HRP; Sigma-Aldrich, France).  
Evans Blue dye and FITC-dextran injection: A 2% Evans Blue solution (4 ml/kg) diluted in normal saline 
was i.p. injected in awake mice. Ten microliters of a 70-kDa FITC-dextran solution (4 mg/ml) was 
administered with a Hamilton syringe into the left ventricle of the heart of deeply anaesthetized mice. 
Three hours after Evans blue injection and 10 min after dextran administration, mice were 
transcardially perfused with 0.9% saline solution followed by 4% paraformaldehyde (PFA) solution 
diluted in 0.1 M phosphate buffer pH 7.4. Intracardiac injection of dextran for 10 min was chosen in 
order to limit toxic and anaphylactic effects previously reported (Saunders et al., 2015). Brains were 
removed and coronal sections (40 μm thick) were obtained using a vibratome (Leica VT1000S). Sections 
Results  
117 
 
were mounted on slides and co-stained to visualize blood vessels with anti-laminin primary antibody 
(1/100; Table 1) followed by 488-Alexa Fluor conjugated secondary antibody (1/1000, Invitrogen). To 
avoid spreading of Blue Evans dye and promote optimal visualization of labelled fine structures, 
sections were quickly immersed in xylene and mounted on slides with hydrophobic mounting medium, 
by modification of the method previously described by del Valle et al. (2008). Then fluorescent staining 
was visualized under a confocal microscope. 
40-kDa horseradish peroxidase injection and transmission electron microscopy: 10 µl of a 40-kDa HRP 
solution (10 mg/ml) was injected with a Hamilton syringe into the left ventricle of the heart of deeply 
anaesthetized mice. After 10 min of circulation, mice were transcardially perfused with 0.9% saline 
solution. Brains were removed and fixed in a 2.5% glutaraldehyde solution diluted in 0.1 M cacodylate 
buffer pH 7.4 overnight at 4°C. After washes in buffer, coronal sections (100 µm-thickness) were 
processed in a standard DAB (3, 3’-diaminobenzidine; Sigma Aldrich) reaction. HRP activity was 
revealed by incubating the sections in 0.05 M Tris-HCl pH 7.6 buffer, containing 0.05% DAB and 0.006% 
H2O2 (Sigma Aldrich) for 15 min at RT. Enzymatic reaction was stopped by transferring sections in 
0.05 M Tris-HCl pH 7.6 buffer followed by several washes in PBS. Sections were then processed for 
transmission electron microscopy as described below. 
HRP-labelled sections were post-fixed in 2% osmium tetroxide (OsO4) diluted in 0.1 M sodium 
cacodylate buffer for 1 h, at RT and dehydrated through an alcohol ascending series and embedded in 
epoxy resin (Epoxy -Embedding Kit, Sigma Aldrich). Medial preoptic areas were selected and ultrathin 
sections (70 nm) were cut, collected on copper grids, stained with 2% uranyl acetate and Reynold’s 
lead citrate, and then examined under a transmission electron microscope (80-120 kV 912 Omega 
ZEISS) equipped with a digital camera (Veleta Olympus). 
Electron Tomography and three dimensional (3D)-modelisation 
Electron tomography produces 3D reconstructions from sets of 2D projections acquired at different 
tilting angles in a transmission electron microscope. 
Epon sections (200 nm thick) were cut using a Reichert Ultracut microtome (Leica Microsystems) and 
collected on formwar-coated copper/palladium grids (200 mesh) for analysis by electron tomography. 
Sections were randomly labelled on the two sides with protein A-gold 10-nm for use as fiducial markers 
during the subsequent alignment of the series of tilted images, and then contrasted with 2% uranyl 
acetate in water for 10 min and Reynold’s lead citrate for 2 min. 
Specimen were analysed in a 200-kV transmission electron microscope Technai G2 Lab6 (FEI Company) 
equipped with a TemCam F-416 CMOS camera (TVISP GmbH) and a computerized goniometer. Once 
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selected, images of capillary tight junctions were acquired at x20.000 and tilted at 1° angular increment 
over a range of 120° (± 60°) about one orthogonal axis. Alignment of tilt series and tomogram 
computing were carried out by using the IMOD 4.7 program package. Manual contouring of the 
tomograms was done by using the IMOD program. Finally, the contours were meshed and z scale was 
stretched with a factor of 1.6 to correct for resin shrinkage. 
Fluorescent immunohistochemistry and Fluoro-Jade® C staining 
Animals were deeply anaesthetized with a lethal dose of pentobarbital (25 mg/kg, i.p.) for the following 
procedures. 
Tissue preparation: For tight junction proteins (claudin-5, occludin and ZO-1), mice were transcardially 
perfused with 0.9% saline solution and brains were quickly taken out, embedded in ice-cold OCT 
(Optimal Cutting Temperature embedding medium, Tissue-Tek, Sakura, Villeneuve d’Ascq, France), 
frozen in isopentane (-50°C) and stored at -80°C until sectioning. Twenty-µm serial frozen sections 
were cut and collected on slides, and then were fixed by immersion for 2 min at -20°C in 
methanol/acetone (vol/vol). For the other proteins and Fluoro-Jade® C staining, animals were 
transcardially perfused with 0.9% saline solution followed by 4% PFA solution diluted in 0.1 M 
phosphate buffer pH 7.4. The brains were removed and post-fixed with the same fixative solution 
overnight at 4°C. After post-fixation step, the brains were cryoprotected with 20% sucrose solution for 
freezing in isopentane (-30°C) and then cut in 20 µm thickness sections using a cryostat. 
Labelling procedure: Nonspecific sites were blocked by incubating slide-mounted sections in 0.1 M 
phosphate buffer saline (PBS) pH 7.4, 1% bovine serum albumin (BSA) and 0.2% Triton X-100 for one 
hour at room temperature. Then, sections were incubated with one or more primary antibodies 
overnight at 4°C diluted in the same PBS/BSA/Triton solution (Table 1). Immune complexes were 
revealed using secondary Alexa-conjugated anti-mouse or anti-rabbit IgG (1:1000; Invitrogen, France). 
Fluorescence was observed with a confocal microscope. 
Fluoro-Jade® C staining of 20 µm-thick sections was performed according to the manufacturer’s 
instructions (Millipore, USA). Fluorescent staining was visualized under a confocal microscope. 
Confocal microscopy 
Simple and multiple fluorescent labeling were visualized with a SP5 upright Leica confocal laser 
scanning microscope (Leica Microsystems) equipped with the Acousto-Optical Beam Splitter (AOBS) 
and using 20X or 63X oil immersion objectives. Alexa 488 was excited at 488 nm and observed from 
495 to 580 nm, Alexa 594 was excited at 594 nm and observed from 599 to 680 nm. The gain and offset 
for each photomultiplier were adjusted to optimize detection events. Images (1,024 x 1,024 pixels, 16 
bits) were acquired sequentially between stacks to eliminate cross-over fluorescence. The frequency 
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was set up to 400 Hz and the pinhole was set to 1 Airy. Each optical section (0.5 to 1µm) was frame-
averaged four times to enhance the signal/noise ratio. Overlays and projection of the z-stack files were 
performed by using the Fiji software (NIH, USA). Presented pictures were the projection of ten to 
twenty successive optical sections into one image. 
Western blot protein analysis 
Tissue preparation and protein extraction: Brains were taken out and the hypothalami were quickly 
removed and placed on ice. Preparation of microvessel-enriched fractions was performed by 
harvesting hypothalamic microvessels according to a method adapted from procedures described 
previously (Campos et al., 2012; Cartwright et al., 2013; Sandoval and Witt, 2011). Briefly, samples 
were homogenized in a buffer pH 7.4 containing 2.7 mM KCl, 137 mM NaCl, 1.5 mM KH2PO4, 8 mM 
Na2HPO4, 1 mM CaCl2, 0.5 mM MgCl2, 6 H2O, 5 mM D-glucose, 1 mM sodium pyruvate, 1 M HEPES, and 
1% BSA. Homogenates were then centrifuged in an equal volume of 30% Ficoll for 15 min at 5,800 g at 
4°C, supernatants were aspirated, and pellets suspended in isolation buffer without BSA and passed 
through a 70-µm nylon filter. Filtrates were centrifuged for 10 minutes at 3000 g at 4°C, and then 
protein content was extracted from the pellets with RIPA buffer containing 50 mM Tris – base (pH 7.2), 
150 mM NaCl, 0.1% SDS, 0.5% DOC, 1% Triton X-100 and 1% protease inhibitor cocktail (Sigma Aldrich) 
and sonicated five times for 30 seconds. 
Electrophoresis and immunoblotting: 10 to 25 µg of proteins were subjected to electrophoresis on 
NuPAGE 4-12% Bis-Tris Gel (Invitrogen, France) or 7.5% and 10% polyacrylamide gels. The resolved 
proteins were electrotransfered onto polyvinylidene difluoride (PVDF) membranes (Millipore, France). 
Membranes were blocked for 1 h, at RT with a solution of 5% nonfat milk-Tris-buffered saline (TBS, 20 
mM Tris base, 137 mM NaCl, pH 7.6) with 0.1% Tween, and were incubated overnight at 4°C with 
primary antibodies diluted in the same blocking solution (Table 1). Primary antibody binding to blots 
was detected by incubation with respective secondary HRP–conjugated anti-rabbit or anti-mouse 
(1:5000; Jackson, France, 111-035-144 or 115-035-062 respectively) for 1 h, at RT, and then, immune 
complexes were revealed by the SuperSignal™ West Pico Chemiluminescent Substrate kit (Thermo 
Scientific, France). Signals were quantified by using FiJi software (NIH, USA) and normalized to the 
value obtained for the corresponding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) band. 
Quantitative RT-PCR 
Total RNA was extracted from hypothalamic microvessel-enriched fractions using the RNeasy Plus 
Micro kit from Qiagen (Qiagen, France). RNA (250 ng per sample) was reverse transcribed using the 
Transcriptor First Strand cDNA Synthesis kit (Roche Diagnostics GmbH, Germany). Then, qPCR 
reactions were performed with primers previously described (gift from S. Vyas, (Carrillo-de Sauvage et 
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al., 2013; Ros-Bernal et al., 2011), and SYBR Green Real-time PCR Master Mix (Thermofisher Scientific, 
France). Experiments were performed in triplicates for each sample in order to obtain an average cycle 
threshold (Ct) value. Transcript levels of each gene were normalized to the level of hypoxanthine 
phosphoribosyl transferase 1 (HPRT), the endogenous reference gene chosen for its insignificant 
variation across experimental groups. Relative expression of each target gene was determined using 
the comparative Ct method (Pfaffl, 2001). 
 
Statistical analysis 
Data were expressed as means ± S.E.M. Comparison between intact and castrated mice was performed 
using unpaired student’s t-test. Differences were considered statistically significant if p < 0.05. 
 
Results 
Depletion of gonadal testosterone induced heightened permeability of the BBB in the MPOA 
Permeability of the BBB was evaluated for different tracers as Evans Blue dye, FITC-dextran 70 kDa, 
and Horse Radish Peroxidase (HRP) in intact and 5-weeks castrated males. Confocal microscopy 
analysis showed extravasation of Evans Blue outside perfused brain capillaries labeled by anti-laminin 
in castrated males, while it was almost absent in intact mice (Fig. 1A). Similar data were obtained for 
FITC-Dextran 70 kDa (Fig. 1B). At the ultrastructural level, some DAB-precipitates reflecting the 
presence of exogenous injected-HRP enzyme were observed within the endothelial cell cytoplasm, 
joined to the abluminal endothelial cell membrane and the basal lamina, and within perivascular 
astrocytic end-feet in castrated males (Fig. 1C). 
The BBB integrity was also considered by using immunolabelling of endogenous circulating IgG. 
Circulating IgG were observed into the capillary wall and cerebral parenchyma of perfused- castrated 
mice, whereas no labeling was detected in perfused-intact mice (Fig. 1D).  
 
Castration induced-BBB leakage affects endothelial tight junctions  
The relationship between structure and function of tight junctions was first assessed by using 3D-
ultrastructural analysis. Ultrastructural details of capillary endothelial tight junctions were examined 
by electron tomography with a 3D-reconstruction from electron microscopy projection images of 
resin-embedded thin sections (200 nm) of the MPOA. At the nanoscale, tomographic volumes from 
consecutive serial sections were stacked slice by slice. Such reconstruction allowed visualizing the 
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morphological arrangements of capillary inter-endothelial tight junctions, as a TJ opening could be the 
cause of paracellular transport of components. In intact male mice, TJ exhibited a series of discrete 
sites of apparent fusion, involving the outer leaflet of the plasma membranes (Fig. 2A and SI movie 1). 
By contrast, in castrated mice, these closely associated membrane areas were never observed and 
large intercellular space were clearly highlighted (Fig. 2B and SI movie 2). 
Tightly apposed–adjacent endothelial membranes comprise a complex of transmembrane proteins 
claudin-5 and occludin, which are associated with peripheral membrane proteins such as ZO-1. We 
thus assessed the protein levels of these main TJ proteins by Western blot performed on microvessel-
enriched fractions. Significantly lower amounts of claudin-5 (-52.7% vs intact, p ≤ 0.05) and ZO-1 (-
59.7% vs intact, p ≤ 0.05) were observed in capillaries of the medial preoptic area of castrated mice 
compared with their aged-matched intact mice (Fig. 3A-B). In contrast, no difference in the protein 
amount of occludin was detected between the two groups (Fig. 3C). Immunofluorescence analysis 
show fainter immunolabelling for claudin-5 and ZO-1 in castrated mice compared with aged-matched 
intact mice (Fig. 3D-E). The distribution of these proteins did not seem to be affected. 
Castration induced glial activation  
As extravasated circulating IgG appeared to be associated with cells of the parenchyma, we focused 
on the identification of these cellular targets in the MPOA. Our results show that extravasated IgG in 
castrated mice were all co-labeled with Iba-1, a specific marker of microglial cells (Fig. 4A). 
Interestingly, the number of these Iba-1-immunopositive cells was significantly higher in the MPOA of 
castrated mice compared with aged-matched intact mice (+43.8% vs intact, p ≤ 0.0001; Fig. 4B). In 
agreement with this result, Western blot analysis performed on microvessel-enriched fractions 
revealed a significant increase in Iba-1 protein amount in castrated males (+119.8 % vs intact, p ≤ 0.001; 
Fig. 4C). This activation was accompanied with a significant enhancement of GFAP 
immunofluorescence density in the MPOA (+362% vs intact males, p ≤ 0.0001) (Fig. 4D-E). Western 
blot analysis performed on microvessel-enriched fractions also showed a higher level of GFAP amount 
in castrated mice (+44.6% vs intact males, p ≤ 0.01) compared with age-matched intact mice (Fig. 4F). 
Castration induced inflammatory molecules 
Since microglial and astrocytic activation occurred in the MPOA of castrated males, we asked whether 
it was associated with an up-regulation of inflammatory molecules, such as COX-2 and iNOS. 
Immunofluorescence analysis showed an intense signal for iNOS colocalized with GFAP labeling 
surrounding capillaries of castrated mice corresponding to perivascular astrocytes end-feet (Fig. 5A).  
This signal was absent in intact control mice. Western blot analysis performed on microvessel-enriched 
fractions showed a significant increase of iNOS protein level (+360.4% vs intact male, p ≤ 0.01; Fig. 5B). 
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COX-2 protein was immuno-detected into Iba 1-immunopositive microglial cells in the MPOA, and the 
labeling appeared more intense in cells surrounding capillaries (Fig. 5C). Western blot analysis 
performed on capillary-enriched fractions homogenates revealed a significant increase of COX-2 
protein level (+86.4% vs intact male, p ≤ 0.05) (Fig. 5D).  
In order to check whether these protein modifications were due to a potential regulation at the 
transcriptional level, we quantified transcript levels of iNOS and COX2 and its regulator IL-1β. We also 
assessed other pro-inflammatory cytokines such as IL-6 and TNF-α, which can induce inflammation in 
the CNS. Quantification by qRT-PCR showed a significant increase of the transcript levels of IL-1β 
(+338.7 %, p ≤ 0.05) and TNF-α (+119.4%, p ≤ 0.01) in capillary-enriched fractions of 5-weeks castrated 
mice compared with their controls (Fig. 5E), while no significant changes were detected for iNOS, COX2 
and IL-6 (Fig. 5E).  
Further, we investigated whether these high expression levels of IL-1β and TNF−α were associated 
with neuronal cytotoxicity. Apoptotic cell death was assessed by the fluorescent marker Fluoro-Jade® 
C, which is commonly described as a useful specific tool for identifying either degenerating neurons or 
activated astrocytes and microglia during chronic neuronal degenerating process (Damjanac et al., 
2007). Our results show a significant increase of Fluoro-Jade-labeling (+673%, p ≤ 0.0001) in the MPOA 
of castrated mice (Fig. 5F). 
 
Supplementation of castrated mice with testosterone restored the integrity of the BBB and 
annihilated inflammation 
To find out whether the observed alterations induced by castration were permanent or reversible, 5-
weeks castrated males were supplemented with testosterone. Thirty days later, they were analyzed 
with their age-matched intact mice for BBB permeability, tight junction integrity and glial activation. 
As shown in Fig. 6A, no extravasation of fluorescent Evans Blue was detectable either within the 
capillary wall or outside in the surrounding parenchyma in castrated males supplemented with 
testosterone. Similarly, exogenous injected-HRP enzyme visualized by its DAB precipitate remained 
confined in the microvessel lumen, endothelial cell cytoplasm and surrounding parenchyma lacking 
DAB precipitates in testosterone-supplemented castrated mice compared with intact male mice (Fig. 
6B). Concerning the TJ structure, Western blot analysis performed on microvessel-enriched fractions 
revealed no significant difference in the protein amounts of claudin-5 and ZO-1 between 4-weeks 
testosterone-supplemented and intact males (Fig. 6C-D). Glial activation assessed by measurement of 
GFAP protein amount showed no significant difference in GFAP levels in capillary-enriched fraction 
(Fig. 6E), while a significant decrease of Iba-1 immuno-positive cells was observed in the MPOA of 
testosterone-supplemented castrated mice compared with intact mice (-12.2% vs intact, p ≤ 0.01). No 
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significant differences were observed for iNOS and COX-2 protein amounts in microvessel-enriched 
fractions (Fig. 6F-G). However, Fluoro-Jade-fluorescence density was still significantly higher (+174.6% 
vs intact, p ≤ 0.0001) in the MPOA of testosterone-supplemented castrated mice compared with intact 
mice (Fig. 6H). However, this increase was lower than that found between castrated and intact animals. 
 
Discussion 
Our results highlight a potential physiological regulation by testosterone of BBB integrity in adult 
male mice. We show that depletion of gonadal testosterone increased permeability of the BBB. This 
was demonstrated by using different approaches in order to overcome misleading data obtained from 
a single approach (Saunders et al., 2015). First, injection of two different tracers of different molecular 
size, such as Evans blue and dextran, showed similar BBB leakage in chronically depleted males. 
Second, administration of HRP combined to ultrastructural analysis using transmission electron 
microscope demonstrated also the presence of extravasated DAB-precipitates within endothelial cells 
and the surrounding of brain capillaries. Finally, immuno-detection of endogenous circulating IgG in 
the brain parenchyma of castrated mice confirmed the permissiveness of the BBB of circulating 
molecules in testosterone-depleted mice.  
To determine whether this increased permeability of the BBB involved altered structure of tight 
junctions at the endothelial cell level, we used for the first time electron tomography and 3D-
modelisation. This powerful technology allows 3D-reconstructions from sets of 2D-projections and 
then the analysis of ultrastructural details difficult to observe with the 2D-conventional electron 
microscopy. Three-dimensional electron microscopy analysis showed disorganized endothelial TJ, 
which exhibit opening areas.  
 
Analysis of the protein levels of the two main transmembranous proteins required for formation 
and maintenance of the BBB, showed a significant reduction of claudin-5 but not of occludin in mice 
castrated for 5 weeks. Claudin-5 and occludin are linked to the actin cytoskeleton by submembranous 
accessory scaffolding proteins including the zonula occludens ZO-1 (see for review Abbott et al., 2010). 
The amount of ZO-1 was also reduced in in mice castrated for 5 weeks. At the functional level, claudin-
5, specifically expressed in brain endothelial cells has been identified as a primary regulator of TJ 
paracellular permeability to small molecules in physiological conditions (Nitta et al., 2003; Piontek et 
al., 2008). Interestingly, a down-regulation of claudin-5 expression has been correlated with a 
breakdown of the BBB in an experimental pathological situation (Argaw et al., 2009). Loss or 
dissociation of ZO-1 from the junctional complexes was also associated with increased barrier 
permeability (Choi and Kim, 2008). Taken together, these observations strongly suggest that despite 
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the unaffected protein amount of occludin, the reduced levels of claudin-5 and ZO-1 proteins must be 
sufficient to explain the disorganized and increased permeability of the BBB in castrated males. We 
cannot exclude, however, changes in the phosphorylation state of occludin in castrated mice since TJ 
formation was also shown to be regulated by serine/threonine phosphorylation of occludin 
(Sakakibara et al., 1997).  
 
These data show here, for the first time, that testosterone modulates protein levels of claudin-5 
and ZO-1 in the BBB of male mice. In agreement with these observations, a recent in vitro study 
reported that a pro-androgen sulfated steroid stimulates expression of claudin-5 protein and tight 
junction formation in Sertoli cells (Papadopoulos et al., 2016). Selective ablation of the androgen 
receptor (AR) in mouse Sertoli cells of the blood-testis barrier induced abnormal distribution of ZO-1 
protein in seminiferous tubules, leading to a delayed and defective blood-testis barrier formation 
(Willems et al., 2010). Our findings together with these observations indicate that the regulation of the 
BBB by testosterone is not specific to the testis but extends to the CNS. Whether or not it involves the 
cerebral AR still needs to be identified. In the central nervous system, gonadal testosterone acts either 
directly through the AR or indirectly after metabolization into estradiol, which then activates estrogen 
receptors (ER). Therefore, AR- as well as ER-signalling pathways could be involved in testosterone-
induced regulation of the formation and / or maintenance of tight junction in males. Two studies using 
rat models of injured male brains showed ameliorated BBB impairment or microvessel growth after 
estrogen or tamoxifen treatment (Samantaray et al., 2016; Sun et al., 2013), while an in vitro study 
reported an involvement of the AR in the BBB regulation (Ohtsuki et al., 2005). 
 
Testosterone depletion in male mice induced also astroglial and microglial activation as well as an 
up-regulation of inflammatory molecules such as COX-2, iNOS, IL-1β and TNF-α. It is, indeed, well 
established that glial activation is often associated with an up-regulation of various proinflammatory 
molecules including IL-1β, TNF-α and iNOS (Ghoshal et al., 2007; González-Scarano and Baltuch, 1999). 
Interestingly, BBB impairment together with increased neuroinflammation have been also reported in 
healthy aged female mice where extravasation of circulating IgG into parenchyma was associated with 
significantly elevated neurovascular inflammation (increased expression of GFAP, COX-2 and TNF-α) 
(Elahy et al., 2015). Furthermore, accumulating evidence suggest that BBB function is compromised 
during inflammation (Carvey et al., 2009). Since astrocytes and microglia cells are targets of sex 
steroids (see for review Johann and Beyer, 2013), it is therefore possible that in the absence of 
physiological levels of testosterone, glial cells get activated and promote neuroinflammatory 
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processes, which then impact the BBB integrity. Alternatively, it seems that BBB breakdown leads to 
neuroinflammatory diseases {see for reviews (Zlokovic, 2008, 2011).  
Regardless of the sequence of events induced by testosterone depletion, BBB failure and 
neuroinflammation observed in castrated males were accompanied with a significant increase of 
Fluoro-Jade-fluorescence density, a known marker for neuronal degeneration (Collombet et al., 2006; 
Schmued and Hopkins, 2000; Wu et al., 2005). In agreement with these observations, castration of 
young adult male mice induced Parkinson disease pathologies involving iNOS (Khasnavis et al., 2013). 
In this study, the authors proposed a link between circulating levels of testosterone, 
neurodegenerative diseases and neuroinflammation. Furthermore, BBB failure and 
neuroinflammation were also associated with other neurological diseases such as Alzheimer’s disease 
(Deane and Zlokovic, 2007; Matsumoto et al., 2007; Zipser et al., 2007), vascular dementia and multiple 
sclerosis (Zlokovic, 2008, 2011). Here again, dysfunction of the BBB may be the cause or consequence 
of degenerative processes (see for review Carvey et al., 2009).  
 
It was of great interest that supplementation of testosterone to castrated mice restored the 
impermeability of the BBB, the integrity of the capillary endothelial TJ, and suppressed the 
inflammatory features. However, Fluoro-Jade-labeling persisted although it seemed less important. 
This could be due to the fact that during the five weeks of depletion, some cells have gone so far in 
neurodegenerative processes that testosterone was not able to reverse them. Alternatively, 4 weeks 
of testosterone supplementation might be insufficient to drive this reversibility. Further experiments 
will explore whether longer periods of testosterone supplementation could blunt or not this process.  
Except for the neurodegenerative cells, these results highlight the activational and transitory effects 
of circulating testosterone on these cerebrovascular functions. We propose that, as for estrogens in 
females, physiological levels of testosterone plays a protective effect in male mice. This is of particular 
interest since aging in males is associated with hypogonadism, which seems to contribute to the 
increased incidence of cerebrovascular disease (Yeap et al., 2009). Whether testosterone-effects 
involve genomic and/or non-genomic effects still need to be defined. To our knowledge, this is the first 
in vivo study exploring the reversible effect of a steroid hormone on cerebrovascular functions. These 
data open new perspectives for the use of testosterone or analogs as physiological modulators of BBB 
permeability in therapeutic treatments.  
 
In conclusion, we demonstrate that depletion of gonadal testosterone for 5 weeks is 
deleterious for normal brain functioning since it leads to BBB dysfunction and inflammation in the 
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preoptic area of male mice. Supplementation of testosterone was sufficient to restore these deficits, 
except for cellular degeneration, which persisted although at a lower level after for 4 weeks of 
treatment. This highlights the transitory activational role of testosterone on the BBB physiology and 
neuroinflammation. Understanding, in this physiological model, how testosterone operates to impact 
these processes is of great relevance. Indeed, this could provide new insights into neurological and 
metabolic diseases, which are linked to the hormonal status, and help to improve the outcome of 
hormone replacement in aged and young hypogonadic men.  
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Figure legends 
Fig. 1. Depletion of gonadal testosterone increased BBB permeability. (A) Representative images of 
Evans blue dye (red) in the MPOA of perfused intact (left panel) and castrated mice (right panel) where 
capillaries were labeled with anti-laminin (green). Scale bar: 10 µm. (B) Representative images of FITC-
Dextran (blue) in the MPOA of perfused intact (left panel) and castrated mice (right panel) where 
capillaries were labeled with anti-laminin (red). Scale bar: 10 µm. (C) Representative electron 
micrographs showing portion of capillaries located in the MPOA after parenteral injection of HRP 
solution in intact (left panel) and castrated mice (right panel). DAB-precipitates are detected in the 
lumen of capillaries of both intact and castrated mice. In castrated male, they are also observed within 
the endothelial cell cytoplasm, joined to the abluminal endothelial cell membrane and the basal 
lamina, and within perivascular astrocytic end-feet (insert, arrows). Scale bar: 1 µm. (D) Representative 
images showing the presence of endogenous circulating IgG (red) in the MPOA of intact (left panel) 
and castrated mice (right panel). Scale bar: 40 µm. 
Ast: astrocyte end-foot, EC: endothelial cell, L: lumen; Per: pericyte 
 
Fig. 2. Depletion of gonadal testosterone affected endothelial tight junction morphology. (A, B) 
Three-dimensional model following electron tomographic reconstruction of capillary inter-endothelial 
tight junction. (A) Endothelial tight junction in cerebral capillaries of intact male mice, involving two 
adjacent plasma membranes (light blue and pink in the right panel). A series of discrete sites of 
apparent fusion involving the outer leaflet of the plasma membranes were observed (left panel and 
Movie S1). (B) Endothelial tight junction in cerebral capillaries of castrated male mice, involving two 
adjacent plasma membranes (light blue and pink in the right panel). Large intercellular spaces are 
observed (left panel and Movie S2). The luminal and abluminal membranes of the endothelial cell are 
in green. The limiting membrane of astrocyte end-foot contacting basal lamina surrounding capillary 
is in dark blue. Scale bar: 150 nm. 
Ast: astrocyte end-foot; BL: basal lamina; EC: endothelial cell; L: lumen; TJ: tight junction; Per: pericyte. 
 
Fig. 3. Depletion of gonadal testosterone affected endothelial tight junction proteins. (A-C) Western 
blot analysis of tight junction proteins performed on microvessel-enriched fractions from castrated 
mice compared with age-matched intact mice, claudin-5 (A), ZO-1 (B), and occludin (C). Data were 
normalized to GAPDH level. Values represent means ±. S.E.M. of 4-5 mice per group. *, p ≤ 0.05 by 
Student’s t test compared to control intact group. (D) Representative images of capillaries located in 
the MPOA of intact mice (left panel) and castrated mice (right panel), labeled with anti-claudin-5 (red). 
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Scale bar: 10 µm. (E) Representative images of capillaries located in the MPOA of intact (left panel) 
and castrated mice (right panel), labeled with anti-ZO-1 (red). Scale bar: 10 µm.  
 
Fig. 4. Depletion of gonadal testosterone induced glial activation. (A) Representative images of co-
immuno-detection of circulating IgG (red) and Iba-1 (green) in the MPOA of intact (left panel) and 
castrated mice (right panel). Scale bar= 40 µm. (B) Quantitative analysis of Iba-1-positive cells. #, p ≤ 
0.0001 compared to the intact group (n = 4-5 mice per group). (C) Western blot analysis performed on 
microvessel-enriched fractions showing Iba-1 protein amounts in castrated mice compared with age-
matched intact mice. Data were normalized to GAPDH level. Values represent means ±. S.E.M. of 4-5 
mice per group. ***, p ≤ 0,001 compared to the intact group. (D) Representative images of GFAP 
labeling (green) in the MPOA of intact (left panel) and castrated mice (right panel); n = 3 mice per 
group. Scale bar= 50 µm. 3V: third ventricle. (E) Quantitative analysis of GFAP labeling in the MPOA of 
castrated mice compared with intact mice. Values represent means gray values per µm2 ±. S.E.M. #, p 
≤ 0.0001 compared to the intact group (n = 3 mice per group). (F) Western blot analysis performed on 
microvessel-enriched fractions showing level of GFAP amount in castrated mice compared with age-
matched intact mice. Data were normalized to GAPDH level. Values represent means ±. S.E.M. **, p ≤ 
0.01 compared to the intact group (n = 6 mice per group). 
 
Fig. 5. Depletion of gonadal testosterone induced inflammatory molecules. (A) Representative 
images of co-immuno-detection of iNOS (red) and GFAP (green) performed in three independent 
experiments per group in the MPOA of intact (left panel) and castrated mice (right panel). iNOS labeling 
colocalized with GFAP labeling (yellow) surrounding capillaries of castrated mice corresponding to 
perivascular astrocytes end-feet. Scale bar= 10 µm. (B) Western blot analysis performed on 
microvessel-enriched fractions showing iNOS amount in castrated mice compared with age-matched 
intact mice. Data were normalized to GAPDH level. Values represent means ±. S.E.M. **, p ≤ 0.01 
compared to the intact group (n = 4-5 mice per group). (C) Representative images of co-immuno-
detection of COX-2 (red) and Iba-1 (green) performed in three independent experiments per group in 
the MPOA of intact (left panel) and castrated mice (right panel). COX-2 and Iba-1 were co-localized 
(yellow), and the labeling appeared more intense in cells surrounding capillaries. Scale bar= 10 µm. (D) 
Western blot analysis performed on microvessel-enriched fractions showing COX-2 amount in 
castrated mice compared with age-matched intact mice. Data were normalized for GAPDH level. 
Values represent means ±. S.E.M. *, p ≤ 0.05 compared to the intact group (n = 4-5 mice per group). 
(E) Quantitative analysis by qRT-PCR of transcript levels of iNOS, COX-2, Il-6, IL-1β and TNFα in 
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capillary-enriched fractions of 5-weeks castrated mice compared with their controls. Data were 
normalized to HPRT levels. *, p ≤ 0.05 and **, p ≤ 0.01 compared to the intact group (n = 4 mice per 
group). (F) Representative labeling of MPOA sections with Fluoro-Jade® C performed in two 
independent experiments per group in intact (left panel) and castrated mice (right panel). Scale bar: 
80 µm. L: Lumen; 3V: third ventricle 
 
Fig. 6.Testosterone supplementation restored BBB permeability and TJ integrity and annihilated 
inflammation. (A) Representative images of three independent experiments per group showing the 
absence of Evans blue dye extravasation (red) from capillaries labeled with anti-laminin (green) 
perfused intact (left panel) and testosterone-supplemented mice (right panel). Scale bar: 10 µm. (B) 
Representative electron micrographs of two independent experiments per group showing a portion of 
capillaries located in the MPOA after parenteral injection of HRP in intact (left panel) and testosterone-
supplemented mice (right panel). DAB-precipitates are detected only in the lumen of capillaries of both 
intact and testosterone-supplemented mice. Scale bar: 1 µm. (C-G) Western blot analysis of protein 
amounts performed on microvessel-enriched fractions from castrated mice compared with 
testosterone-supplemented mice, claudin-5 (C), ZO-1 (D), GFAP (E), iNOS (F) and COX-2 (G). Data were 
normalized for GAPDH levels. Values represent means ±. S.E.M. of 4-6 mice per group. There were no 
significant differences in these protein amounts. (H) Representative images of MPOA sections labeled 
with Fluoro-Jade® C in intact (left panel) and testosterone-supplemented mice (right panel). Scale bar: 
80 µm. 
Ast: astrocyte end-feet; EC: endothelial cell; L: lumen; Per: pericyte 
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Table 1:  
Antibody Manufacturer Catalog no. Host Application* Working dilution 
GFAP Sigma Aldrich G3893 Mouse WB/IHC 1:500/ 1:400 
GFAP DAKO Z0334 Rabbit IHC 1:500 
Laminin Sigma Aldrich L9393 Rabbit IHC 1:100 
ZO 1 Invitrogen 61-7300 Rabbit WB/IHC 1:500/ 1:250 
iNOS Sigma N9657 Mouse IHC 1:1000 
iNOS Santa Cruz sc-7271 Mouse WB 1:200 
GAPDH Santa Cruz sc-32233 Mouse WB 1:10000 
Claudin- 5 Invitrogen 34-1600 Rabbit WB/IHC 1:500 
Occludin Invitrogen 40-4700 Rabbit WB 1:500 
Iba-1 Wako 019-19741 Rabbit IHC 1:1000 
* WB: western blot, IHC: immunohistochemistry 
  
Results  
141 
 
Supplemental Information 
Movie S1. Tomographic reconstruction and 3D model of an endothelial tight junction in the MPOA of 
intact male mice. Note the discrete sites of apparent fusion involving the outer leaflet of the 
endothelial plasma membranes (light blue and pink). 
 
Movie S2. Tomographic reconstruction and 3D model of an endothelial tight junction in the MPOA of 
castrated male mice. Note the large intercellular space between the outer leaflet of the endothelial 
plasma membranes (light blue and pink). 
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B- Gonadal estrogen hormone effect on neurovascular unit in female mouse 
Epidemiological incidence of degenerative changes in the CNS is significantly higher 
in postmenopausal women than in men, suggesting an important role of ovarian 
steroids for CNS integrity in women. (Manwani and McCullough, 2011; Mayeux, 2003). 
Brain blood vessels are also target for estrogen hormone, and estrogen hormone is 
considered as a neuroprotective hormone, as described above in the bibliographic data 
(chapter 2). Briefly, cerebral vessels express estrogen receptors, and the level of ERα 
expression is increased in female treated with estrogen (Stirone et al., 2003a), while, 
little is known regarding ER-β in the cerebral vasculature (Dan et al., 2003). Chronic 
exposure to either endogenous or exogenous estrogen (after gonadectomy), resulted 
in cerebral arteries more dilated than arteries from female ovariectomized and not 
treated with estrogen. This dilatation effect of estrogen is mediated by an increase in 
the production of eNOS, COX-1, and prostacyclin, and via activation of the 
phosphatidylinositol 3-kinase/Akt pathway. Estrogen receptors have also been 
localized into mitochondria isolated from cerebral blood vessels and exposure to 
estrogen have increased the efficiency of energy production capacity with decreased 
production of reactive oxygen species (Stirone et al., 2005b). Estrogens have potent 
anti-inflammatory effect on cerebral vessels that may have important implications for 
the incidence and severity of cerebrovascular disease. LPS or IL-1β have induced 
cerebrovascular COX-2 and iNOS in ovariectomized female rats, the level of increase 
of COX-2 and iNOS is vary with the stage of estrous cycle, estrogens treatment 
suppress the cerebrovascular inflammatory response. Cerebrovascular dysfunction 
and BBB hyper-permeability contribute to some pathological status as stroke, brain 
trauma, and some neurodegenerative diseases as Alzheimer’s disease, in female as 
well as in male {review in (Duckles and Krause, 2007). 
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To elucidate the role estrogen in the maintenance of the selective barrier in the CNS 
and to better understanding the role of estrogen, changes in the integrity of the BBB 
following ovariectomy were examined in the adult female mice. 
Materials and methods 
Animals 
18 Adult female C57BL/6j mice were anesthetized (xylazine 10 mg/kg and ketamine 
100 mg/kg), and bilateral ovareiectomies were performed using a dorsal midline 
incision inferior to palpated rib cage and kidneys. Ovaries were removed and 9 female 
are implanted with Silastic tubes containing 50 µg of estradiol-benzoate (Sigma–
Aldrich) in 30 µl of sesame oil, these females implanted with estradiol are considered 
as control group with constant plasmatic estrogen level. Subcutaneously injection with 
the analgesic buprenorphine (0.05 mg/kg) after surgery was given. Mice were given 
four weeks to recover from surgery. 
BBB permeability assay 
To assess the permeability of the BBB. All females with or without estradiol were 
injected with different molecular weight tracers: 4-kDa Evans Blue, and 40-kDa 
horseradish peroxidase (HRP) (Sigma-Aldrich). 
Evans Blue dye: A 2% Evans Blue solution (4 ml/kg) diluted in normal saline was 
intraperitoneal injected in awake mice. Three hours after Evans blue, injection mice 
were transcardially perfused with 0.9% saline solution followed by 4% 
paraformaldehyde solution diluted in 0.1 M phosphate buffer pH 7.4. Brains were 
removed and coronal sections (40 μm thick) were obtained using a vibratome (Leica 
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VT1000S). Sections were mounted on slides and co-stained to visualize blood vessels 
with anti-laminin primary antibody (1/100, Sigma-Aldrich) followed by 488-Alexa Fluor 
conjugated secondary antibody (1/1000, Invitrogen). To avoid spreading of Blue Evans 
dye and promote optimal visualization of labelled fine structures, sections were quickly 
immersed in xylene and mounted on slides with hydrophobic mounting medium, by 
modification of the method previously described by (del Valle et al., 2008). Then 
fluorescent staining was visualized under a confocal microscope. 
40-kDa horseradish peroxidase injection and transmission electron microscopy: 
10 µl of a 40-kDa HRP solution (10 mg/ml) was injected with a Hamilton syringe into 
the left ventricle of the heart of deeply anaesthetized mice. After 10 minutes of 
circulation, mice were transcardially perfused with 0.9% saline solution. Brains were 
removed and fixed in a 2.5% glutaraldehyde solution diluted in 0.1 M cacodylate buffer 
pH 7.4 overnight at 4°C. After washes in buffer, coronal sections (100 µm-thickness) 
were processed in a standard DAB (3.3’-diaminobenzidine; Sigma Aldrich, France) 
reaction. HRP activity was revealed by incubating the sections in 0.05 M Tris-HCl, pH 
7.6 buffer, containing 0.05% DAB and 0.006% H2O2 (Sigma Aldrich, France) for 15 min 
at RT. Enzymatic reaction was stopped by transferring sections in 0.05 M Tris-HCl, pH 
7.6 buffer followed by several washes in PBS. Sections were then processed for 
transmission electron microscopy. 
HRP-labelled sections were post-fixed in 2% osmium tetroxide (OsO4) diluted in 0.1 M 
sodium cacodylate buffer for 1h at RT and dehydrated through an alcohol ascending 
series and embedded in epoxy resin (Epoxy Embedding Kit, cat. N° 45359, Sigma 
Aldrich, Switzerland). Medial preoptic areas were selected and ultrathin sections (70 
nm) were cut, collected on copper grids, stained with 2% uranyl acetate and Reynold’s 
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lead citrate, and then examined under a transmission electron microscope (80-120 kV 
912 Omega ZEISS) equipped with a digital camera (Veleta Olympus). 
Tissue preparation and Immunodetection procedure 
Animals were transcardially perfused with 0.9%NaCl then 4% PFA in 0.1 M PB. The 
brain was taken out; post fixated with PFA overnight at 4°C and then cryoprotected in 
sucrose solution 20% in PB 0.1 at 4°C, and then froze on isopentane (-30°C), the 
brains were cut into 20µm thickness slices using cryostat. Sections were blocked in 
0.1 M PBS, 1% BSA, and 0.2% Triton X-100 one hour at room temperature and 
incubated with one or more primary antibody (GFAP, Laminin and iNOS) over night at 
4°C diluted in PBS/BSA/Triton. Antigen-antibody complex were revealed using Alexa 
conjugated anti-mouse or anti-rabbit IgG antibody (1:1000; Invitrogen, France). 
Fluorescence was observed with confocal microscopy. 
Results and discussion 
To assess the role of estradiol in the maintenance of the BBB in young adult females, 
mice were ovariectomized and 4 weeks later the animals were injected with Evans blue 
dye. Confocal analysis showed extravasation of Evans blue in the parenchyma 
surrounding perfused brain capillaries labeled by anti-laminin in ovariectomized 
females while no fluorescence corresponding to this dye was displayed on the outside 
of the vessels in estradiol-treated ovariectomized mice (Fig. 1A-B). This observation 
was confirmed at the ultrastructural level. DAB-precipitates, indicating the presence of 
exogenous injected-HRP, were detected within the endothelial cell cytoplasm, 
associated to the abluminal endothelial cell membrane and the basal lamina in 
estrogens-depleted female mice (Fig 1C-D). Furthermore, GFAP immunostaining 
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appeared higher in the MPOA of ovariectomized mice compared to mice implanted 
with estradiol as controls, (Fig. 2 A-B). This observation indicates an activation of 
astrocytes in this brain region. In order to determine whether this could be associated 
with an up-regulation of inflammatory molecules, co-immunodetection of GFAP and 
iNOS was performed. Immunofluorescence observations suggested a more intense 
signal surrounding and close to brain vessels, but iNOS labeling did not seem to be 
colocalized with GFAP staining (Fig. 2 C-D). These observations suggest that iNOS 
could be present in other glial cells than astrocytes, such as microglial cells. 
These preliminary results suggest that depletion of gonadal estrogen have a negative 
effect on the selective permeability of the BBB. This deleterious effect could be 
accompanied by brain inflammation. 
The ovariectomy-induced changes in the permeability of the BBB may result from 
increase in paracellular and/or transcellular permeability, involving tight junction 
integrity or caveolae-mediated transcytosis respectively. Previous studies had 
reported that estrogen treatment had a positive impact on claudin-5 and occludin 
expression in female mice and rats (Burek et al., 2010, 2014; Kang et al., 2006; 
Sandoval and Witt, 2011). In these studies ovariectomized female treated with 
estradiol increased expression of both claudin-5 and occludin proteins compared to 
ovariectomized female without estradiol in both mice and rats (Kang et al., 2006; 
Sandoval and Witt, 2011). Both ERα and ERβ are involved in the regulation of claudin-
5 expression in the brain (Burek et al., 2014). Our findings suggest that chronic 
depletion of estrogen could decreased tight junction composition which increased 
paracellular permeability and so increased the BBB permeability in the ovariectomized 
female. It had been found that ovariectomy of rats was associated with increased 
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cerebral endothelial caveolin-1 (Cav-1) expression in the pial artery, and estradiol 
treatment suppressed this up-regulation (Pelligrino et al., 2000b; Santizo et al., 2002; 
Xu et al., 2001). These studies suggest that the increase of the BBB permeability 
observed in ovariectomized female could be also due to an increase of Cav-1 
expression which leads to an increase of paracellular transport. 
To confirm these suggestions that estrogen hormone depletion have an impact on the 
BBB integrity and function, more studies confirming the defect in the BBB is needed, 
as detection of extravasation of endogenous IgG, tight junction proteins (claudin-5, 
occludin, and ZO-1) and caveolin-1 detection and quantitative analysis by Western blot 
are needed.  
The increase of astrocytes activity and iNOS expression confirmed the anti-
inflammatory effect of estrogens. Further analysis is needed for studying other 
inflammatory parameters. Involvement of microglial cells, detection if the absence of 
estradiol is associated with an enhancement of inflammatory molecules as iNOS and 
COX-2, and cellular colocalization of these molecules in addition to pro-inflammatory 
cytokines production will be performed. 
 
 
 
 
 
Results  
148 
 
Figure 1 
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Figure 2 
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Figure legends 
Fig. 1. Depletion of gonadal estrogen increases BBB permeability. (A, B) 
Representative images showing Evans blue dye extravasation (red) from capillary 
labeled with anti-laminin (green) of ovariectomized female mice treated with estradiol 
(left panel) and ovariectomized female mice (right panel), n= 2  mice per group. Scale 
bar: 10 µm. (C, D) Representative electron micrographs showing portion of capillaries 
located in the MPOA after parenteral injection of HRP solution in ovariectomized 
female mice treated with estradiol (left panel) and ovariectomized mice (right panel), 
n=2 mice per group. DAB-precipitates are detected in all the lumen of capillaries of 
both group, but in ovariectomized mice, they are also observed within the endothelial 
cell cytoplasm, joined to the abluminal endothelial cell membrane and the basal lamina, 
(insert, arrows). Scale bar: 1 µm. EC: endothelial cell, BL: basal lamina L: lumen. 
Fig. 2. Depletion of gonadal estrogen induces glial activation and inflammatory 
molecules. (A, B) Representative images of GFAP labeling (green) in the MPOA of 
ovariectomized female mice treated with estradiol (left panel) and ovariectomized mice 
(right panel), 3 mice per group. Scale bar= 50 µm. 3V: third ventricle. (C, D) 
Representative images of co-immuno-detection of iNOS (red) and GFAP (green) in the 
MPOA of ovariectomized female mice treated with estradiol (left panel) and 
ovariectomized female mice (right panel), 3 mice per group. Scale bar= 10 µm. 
Results  
151 
 
Part II: Involvement of sex steroid receptors on the integrity and function 
of the BBB in adult male mouse 
Sex steroid hormones, in particular androgens, mediate biological effects on all 
manner of cellular mechanisms including proliferation, differentiation, and 
homeostasis. Testosterone, and its metabolite, 5α-dihydrotestosterone (DHT) are 
known to mediate their effects through binding to the intracellular androgen receptor 
(AR) (Foradori et al., 2008). In the classic genomic model of androgens action, 
testosterone and DHT diffuse through the plasma membrane and bind to intracellular 
androgen receptors (AR). ARs are members of the nuclear receptor family, and 
function as ligand-inducible transcription factors. Binding of androgens to ARs induces 
receptor dimerization, facilitating the ability of ARs to bind to specific DNA sequences, 
called androgen response element (ARE), and recruit coregulators to promote the 
expression of target genes (Michels and Hoppe, 2008) (Fig. 27). 
Figure 27: Biological actions of androgens via androgen 
receptors (Sukocheva et al., 2015) 
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This mechanism of androgen action is known as the genomic pathway. However, rapid 
non-genomic effects of androgens that occurs very quickly are now generally accepted 
as contributing to the physiological effects of the steroids (Losel et al., 2003). Whereas 
genomic effects take hours or days to produce their actions (reflecting the time required 
to alter protein synthesis), rapid non-genomic steroids effects are activated within 
seconds or minutes. This timing suggests that there is no direct involvement of nuclear 
receptors, and the response involves membrane-embedded or membrane-associated 
receptors or binding proteins. This interaction prohibits testosterone from entering 
deep into cytoplasm or from AR translocating to the nucleus (Foradori et al., 2008; 
Rahman and Christian, 2007). 
Previous results obtained in our team (master's internship of Danaé Nuzzaci, not 
published), using immunohistochemistry associated with colloidal gold particles 
intensified by silver, confirm the presence of nuclear AR and ERα in the MPOA of the 
C57BL/6j mice. In addition to the nuclear receptors in neural cells (neurons and 
astrocytes), receptors are detected in the cells forming the blood vessels wall (Fig.28). 
 
 
 
 
Figure 28: Detection of sex steroid hormone receptors AR and ERα in MPOA’s 
capillary of adult male mice. Colloidal gold particles intensified by silver exhibit 
AR (A) and ERβ (B). Arrows: Nuclear receptors, arrows head: receptors in the 
cells forming blood vesseles, Cap: blood capillary. 
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Ultrastructural analysis using transmission electron microscopy showed that both AR 
and ERα receptors are present in the cytoplasm of endothelial cells of the MPOA's 
capillaries of adult male mice (Fig. 29). These observations suggest that these 
receptors may be involved in the short-term response to regulate the BBB.  
 
 
 
 
 
 
 
 
 
 
 
 
The cytoplasmic ERα was detected in different parts of endothelial cells that form the 
brain blood vessels wall in male mice: in the cytoplasm, associated to the luminal cell 
membrane, and associated to the outer membrane of the mitochondria. These 
observations are in agreement with the results obtained from male rat (Dan et al., 2003; 
Stirone et al., 2003a). In vitro study using primary human brain microvascular 
A 
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Figure 29: Ultrastructural immuno-detection of sex 
steroid hormones receptors AR and ERα in MPOA’s 
capillaries of adult male mice. Colloidal gold particles 
intensified by silver exhibit AR (A) and ERα (B) in the 
cytoplasm of endothelial cells. BL: basal lamina, EC: 
endothelial cells, L: lumen, mit: mitochondria. 
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endothelial cells (HBMECs) has showed that the production of reactive oxygen species 
(ROS) by the mitochondria is decreased after treatment with 17β-estradiol, this effect 
occurs through ERα These results suggest that sex steroid hormones have a 
protection role in the CNS through their action on endothelial cells either under 
physiological or pathological conditions. (Razmara et al., 2008). To our knowledge, 
there is no studies in the literature reported the presence or cytoplasmic AR in the 
endothelial cells of the brain blood vessels in male mice. 
A- Sex steroid hormones receptors involvement in the neurovascular unit 
integrity of male mouse 
Sex steroids, especially estrogen, are described to contribute critically in the regulation 
of energy homeostasis and play protective roles in the development of some clinical 
and metabolic complications. Estradiol, testosterone, and 5α-dihydrotestosterone 
(DHT) bind to specialized intracellular receptors, which are inducible transcription 
factors belonging to the nuclear receptor superfamily. Estrogen receptors (ERs), ERα 
and ERβ, and androgen receptor (AR) have been cloned and characterized in the 
mouse brain. In male, AR expression have been well characterized in several 
hypothalamic regions in adult rodents and sex differences have been reported in the 
bed nucleus of the stria terminalis (BNST), in the medial preoptic area (MPOA), in the 
anteroventral periventricular nucleus (AVPV), and in the ventromedial nucleus of the 
hypothalamus {for review, see (Brock et al., 2015). Brain regions such as the MPOA, 
BNST, medial amygdala (MeA), periaqueductal grey and nucleus of the solitary tract, 
have been reported to express both ERs. Moreover, ERα is the predominant receptor 
found in the ventromedial nucleus of the hypothalamus, whereas ERβ is the 
predominant form found in the suprachiasmatic, supraoptic, paraventricular 
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hypothalamic nuclei and cerebellum. ERα has also been reported to be more prevalent 
in neurons of the arcuate nucleus, whereas ERβ predominates in the dorsal raphe, 
hippocampus and cortex (Handa et al., 2012). Recent studies have also shown that 
sex steroid hormones may be expressed by glial cells and neurons as well (García-
Ovejero et al., 2002; Mhyre and Dorsa, 2006; Sakuma et al., 2009). 
The role of androgen receptor on the blood brain barrier permeability. 
As we noticed previously (Part I, article, page 114) the depletion of gonadal 
testosterone achieved by male mice castration, caused an increase of the BBB 
permeability. This permeability increase was due to a structural modification in the 
endothelial tight junction (TJ). As previously described, testosterone can signal either 
directly through activation AR or indirectly by stimulation of ERs. In this study, we 
aimed, first: to identify the effect of the chronic testosterone depletion on the expression 
and distribution of AR and ERα in the hypothalamic medial preoptic area; second: to 
evaluate more precisely the specific role of AR in the integrity and function of the BBB 
and NVU using conditional transgenic mice model lacking of AR specifically in neural 
cells of the CNS (neurons and astrocytes). This mice model is generated and 
characterized in our team (Raskin et al., 2009) 
Concerning ERβ, analysis antibodies against the protein murine ERβ commercially 
available are not specific. The team chose to generate an anti-ERβ antibody specific 
against the mouse ERβ protein. This will be of great benefit to identify the role of this 
receptor in the integrity and maintenance of the BBB. 
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Materials and methods 
Animal models 
A- Castrated animals 
To investigate the effect of gonadal testosterone depletion on the expression and 
distribution of sex steroid hormones receptors (AR and ERα), Adult males (n= 5) of 8 
weeks of age were castrated under general anesthesia using a ketamine/xylazine 
mixture. Bilateral ventral midline incisions were made and testes and their surrounding 
fatty tissue were removed. Then incisions were closed using clips and post-operative 
care including intraperitoneal. Injection with analgesic was done. Mice were given 5 
weeks to recover from surgery in order to ensure depletion of endogenous testosterone 
prior to any experiment. Five intact age-matched adult mice were used as control 
group. 
B- Conditional transgenic mice ARNesCre 
ARNesCre mice, these transgenic mice where obtained using the Cre-loxP system. In 
theory, by using specific promotor constructs, deletion of the AR can be controlled in a 
tissue- and/or time-specific manner. The Cre-loxP system utilizes two genetically 
modified mouse lines. The Cre (Cyclase recombination) line contains the Cre 
recombinase enzyme, the expression of which is driven by a tissue-specific promoter. 
The genome of the loxP (Locus of X-over of P1) or "floxed" line contains two loxP 
sequences flanking the region of the target gene to be deleted. The loxP sites are 
inserted in such a way as to not modify the function of the target gene. When the two 
lines are crossed, the Cre enzyme recognizes the two loxP sequences and deletes the 
sequence between the two sites leaving a single loxP sequence only in tissues where 
the Cre is expressed. LoxP sites are introduced into mice by homologous 
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recombination in embryonic stem cells and the Cre mice are generated using standard 
transgenic technology. The power of this system derives from the ability to use a large 
variety of available promoter sequences to target expression of the Cre recombinase 
in a tissue- or cell-specific and/or in a time-specific manner (Rana et al., 2014). To 
selectively inactivate AR gene in the CNS, Raskin et al (Raskin et al., 2009), crossed 
females carrying floxed AR gene allele (De Gendt et al., 2004) with males expressing 
Cre recombinase under the control of the rat nestin (Nes) promoter and neural specific  
enhancer (Tronche et al., 1999) (Fig.30).  
 
 
Figure 30: Obtaining of ARNesCre transgenic mice. 
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ARNesCre mutant males have higher circulating testosterone levels than control ARfl/fl 
mice (Raskin et al., 2009), Therefore, in order to normalize testosterone levels between 
control and mutant males, all males used in this study were subjected to gonadectomy 
under general anesthesia (xylazine 10 mg/kg and ketamine 100 mg/kg) as described 
in (Raskin et al., 2009, 2012) and supplemented with subcutaneous Silastic tubes 
containing 10 mg of testosterone (Sigma–Aldrich). Males were subcutaneously 
injected with the analgesic buprenorphine (0.05 mg/kg) after surgery. 
BBB permeability assay in ARNesCre male mice 
Mutant ARNesCre and their littermates ARfl/fl were subjected to permeability study to the 
different molecular weight tracers, Evans Blue and HRP. As I previously described. 
This experiment was conducted to support previous results obtained by Danaé 
Nuzzaci for her master 2 internship. In this context, permeability study was assessed 
using lanthanum hydroxide tracer followed by transmission electron microscopy 
analysis in the mutant ARNesCre. Mice were perfused with a solution containing 
glutaldehyde, for preservation the cellular morphology added with the electron-dense 
lanthanum hydroxide tracer. Epoxy-embedding method is used to prepare the slices 
for transmission electron microscopy analysis, as previously described. 
Electron Tomography and 3D-modelisation of ARNesCre male mice  
Three-dimensional model following electron tomographic reconstruction of capillary 
inter-endothelial tight junction was performed, as previously described. 
Immunodetection of AR and ERα in castrated mice and ARNesCre male mice 
Briefly, all animals were transcardiaclly perfused with 0.9%NaCl alone or with 4% PAF. 
Brains were taken out for post-fixation or freezing. 
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After brain cutting using cryostat (20 µm thickness).  All sections were incubated with 
(0.1 M PBS, 1%BSA, and 0.2% triton X-100) for one hour at room temperature, 
followed by overnight incubation with one or more primary antibody (claudin-5, 
caveolin-1, ZO-1 GFAP, iNOS) diluted in PBS/BSA/Triton at 4°C. Or incubation with 
anti- ERα and anti-AR (1/200, Santa Cruz) for 48 hours and 72 hours respectively, at 
4°C. Immune complex revealed using secondary Alexa-conjugated anti rabbit IgG 
(1:1000, Invitrogen, France) fluorescence was observed with a confocal microscopy. 
Western blot protein analysis of castrated mice 
After anesthesia of animals (4 intact and 5 castrated), brains were quickly removed, 
and cut into 400 µm-thickness slices. Punches of the MPOA were collected from 3-4 
slices per brain in ice-cold PBS using a vibroslice. Tissues were homogenized in RIPA 
buffer containing 50 mM Tris – base (pH 7.2), 150 mM NaCl, 0.1% SDS, 0.5% DOC, 
1% Triton X-100 and 1% protease inhibitor cocktail (Sigma Aldrich) and sonicated five 
times for 30 seconds. 
Results  
1- Effect of chronic testosterone depletion on AR and ERα expression and 
distribution 
Immunodetection of androgen receptor (AR) showed that a depletion of gonadal 
testosterone for 5 weeks caused a modification of its cellular distribution: in castrated 
mice labelling was not observed as nuclear and intense but appeared cytoplasmic and 
weaker (-90.18% versus intact) (Fig.1A). Western Blot analysis performed on medial 
preoptic area (MPOA) homogenates confirmed a significant decrease in the 
expression of AR (-63.9% versus intact) (Fig.1B). Concerning the estrogen receptor 
alpha (ERα), its localization remained nuclear but ERα-IR expression was significantly 
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increased in 5 weeks castrated mice compared to the intact mice (+42.53% versus 
intact) (Fig. 1C). 
2- Effect of neural AR deletion ERα expression and distribution 
Our results showed that neural AR deletion has an impact on ERα expression. As we 
noticed that ERα expression increased in the MPOA of ARNesCre compared to ARfl/fl 
control mice (Fig.1D). These results are the same results previously obtained by the 
team (Raskin et al., 2009) 
3- Effect of neural AR deletion on the BBB permeability 
Confocal microscopy analysis showed the extravasation of Evans blue in the 
surrounding brain capillaries in the mutant ARNesCre mice compared to the control ARfl/fl 
(Fig.2A). Using HRP injection associated with transmission electron microscopy 
analysis, we detected some DAB-precipitates within the endothelial cells of brain 
capillaries of the mutant mice but not in their controls (Fig.2B). 
Permeability study using lanthanum hydroxide tracer confirmed the modification in the 
permeability in the mutant ARNesCre. At the ultrastructural level, we identify the 
endothelial TJ, the basal lamina separating the endothelial cell from parenchymal cells, 
pericyte and astrocyte end-feet. The presence of transport vesicles in the endothelial 
cell cytoplasm, can be observed. In the control ARfl/fl mice the lanthanum hydroxide 
was not detected neither in the endothelial cell nor in the surrounding parenchyma, in 
contrast, the transport vesicles in ARNesCre mutant mice appeared to be denser and 
contained lanthanum hydroxide particles with an increase in their number (Fig.3A).  
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4- Effect of neural AR deletion on the structural composition of endothelial 
tight junction 
For investigating the effects of neural AR deletion on the structure of endothelial TJ 
and, 3D ultrastructural analysis performed to assess the ultrastructural details of TJ 
using electron tomography reconstruction with a 3D-modelisation. Results obtained by 
Danaé Nuzzaci in her master 2 internship, showed that in control mice, the TJ 
appeared intact, exhibiting closely associated endothelial cell membrane joined 
together, with small spherical vesicles in the cytoplasm of the endothelial cells 
(Fig.3B). In contrast, mutant ARNesCre male mice did not show these closed areas 
between cell membranes but large intracellular space was observed, with larger 
cytoplasmic vesicle (Fig.3B). 
Immunohistochemistry of TJ proteins claudin-5 and ZO-1 showed that both proteins 
seem to be modified with a lower expression in mutant ARNesCre mice (Fig 4A and B), 
whereas, caveolin-1 expression seem to be higher (Fig.4C). 
5- Effect of neural AR deletion on astrocyte activation 
As we noticed in castrated mice, ARNesCre mutant mice also showed an increase in 
GFAP immunoreactivity, which reflect an increase in astrocytic activity with an up-
regulation of pro-inflammatory molecule iNOS (Fig.4D) surrounding blood 
microvessels.  
These preliminary results reflect that absence of neural AR has an impact on the BBB 
integrity, and the effect of testosterone on the permeability and integrity of the BBB 
may be regulated through AR. But all these investigations need to be confirmed. 
Immune detection of AR in the endothelial cells of blood vessels in ARNesCre mice using 
colloidal gold particles intensified by silver was performed (results still not satisfactory). 
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Figure 1 
 
 
 
Results  
163 
 
Figure 2 
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Figure 3 
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Figure 4 
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Figure legends 
Fig. 1 Distribution of sex steroid hormone receptors. (A) Representative images of AR 
labeling (green) in the MPOA of intact mice (left panel) and castrated mice (right panel),. Scale 
bar= 50 µm, quantitative analysis of AR labeling in the MPOA castrated mice compared with 
age-matched intact mice. Values represent means gray values per µm² ± S.E.M. ***, p ≤ 0.001 
by student’s t test, 3 mice per group. (B) Western blot analysis of AR showing level of AR in 
mice compared with age-matched intact mice. Data were normalized for GAPDH level and 
expressed as relative level. Values represent means gray values per µm² ± S.E.M. *, p ≤ 0.05 
by student’s t test, 4-5 mice per group. (C) Representative images of ERα labeling (green) in 
the MPOA of intact mice (left panel) and castrated mice (right panel), Scale bar= 50 µm, 
quantitative analysis of ERα positive cells. Values represent the number if immuno-positive 
cells. *, p ≤ 0.05 by student’s t test, 3 mice per group. (D) Representative images of ERα 
labeling (green) in the MPOA of ARfl/fl control mice (left panel) and ARNesCre mutant mice (right 
panel),. Scale bar= 40 µm. 
Fig. 2 Deletion of neural AR increases BBB permeability (A) Representative images 
showing Evans blue dye extravasation (red) from capillary labeled with anti-laminin (green) of 
the ARfl/fl control mice (left panel) and ARNesCre mutant mice (right panel). Scale bar: 10 µm. (B) 
Representative electron micrographs showing portion of capillaries located in the MPOA after 
parenteral injection of HRP solution in ARfl/fl control mice (left panel) and ARNesCre mutant mice 
(right panel). DAB-precipitates are detected in all the lumen of capillaries of both group, but in 
ARNesCre, they are also observed within the endothelial cell cytoplasm, (insert, arrows). Scale 
bar: 1 µm. 
Fig. 3 Deletion of neural AR affects endothelial tight junction morphology. (A) 
Representative electron micrographs showing portion of capillaries located in the MPOA after 
perfusion with lanthanum hydroxide in ARNesCre mutant mice (left panel) and ARfl/fl control mice 
(right panel). Lanthanum hydroxide are detected in the transport vesicles of ARNesCre mutant 
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mice (arrows). (B) Three-dimensional model following electron tomographic reconstruction of 
capillary inter-endothelial tight junction. Endothelial tight junction in cerebral capillary of ARfl/fl 
control mice, involving two adjacent plasma membranes (blue and green) (right panel). A 
series of discrete sites of apparent fusion involving the outer leaflet of the plasma membranes 
is observed (left panel). Endothelial tight junction in cerebral capillary of ARNesCre mutant mice, 
involving two adjacent plasma membranes (blue and green) (right panel). Large intercellular 
space are observed (left panel). Transport vesicles appear in pink. Scale bar: 150 nm. 
Ast: astrocyte end-foot, Per: pericyte; BL: basal lamina; EC: endothelial cell; L: lumen; TJ: 
tight junction; mb: cell membrane. 
Fig. 4 Deletion of neural AR affects endothelial tight junction, transport proteins and 
glial activation. Representative images of capillaries located in the MPOA of ARfl/fl control 
mice (left panel) and ARNesCre mutant mice (right panel), labeled with (A) anti-claudin-5 (red), 
(B) anti-ZO-1 (red), (C) anti-caveolin-1 (green). (D) co-immuno-detection of iNOS (red) and 
GFAP (green). Scale bar: 10 µm, 2 mice per group. 
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B- Short-term action of testosterone on the neurovascular unit in male 
mouse 
In this study we aimed to evaluate the short-action of testosterone on the structure of 
the NVU, in order to analyze the involvement of the different sex steroid receptors in 
the integrity and function of the BBB, leading to investigate the molecular mechanisms 
of testosterone-mediated signaling pathways. This purpose has been achieved using 
an ex-vivo model, where the hypothalamus slices are perifused with a solution similar 
to the cerebrospinal fluid (CSF), in an incubation chamber oxygenated and maintained 
at a temperature between 32 and 34 °C. Thus, local metabolic and structural integrity 
are preserved. This experimental model presents the advantage of controlling the ion 
environment, neurotransmitters and hormones while preserving local cellular 
interactions (neural networks, neuron-glia interactions). The addition of 
pharmacological agents in the perifusion liquid allow to examine their respective effect, 
to analyze the molecular mechanisms, and signaling pathways. 
Material and methods  
Slice preparation 
5-weeks-castrated adult male C57BL/j6 mice (n=14) were used. After anesthesia and 
decapitation, brains were quickly removed and immersed in cooled artificial 
cerebrospinal fluid (aCSF) containing (in mM): 117NaCl, 4.7 KCl, 1.2 Na2H2PO4, 25 
NaHCO3, 2.5 CaCl2, 2H2O, 1.2 MgCl2, 6H2O, 10 glucose. Coronal hypothalamic slices 
(400 µm) were cut with a vibrating microtome, three slices for each brain were selected 
including MPOA region and transferred to a brain slice chamber system (Fig. 31) and 
allowed to equilibrate for 1 hour in aCSF before being exposed to pharmacological 
conditions. 
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Drug application  
Slices were incubated with testosterone after the first hour of equilibration. 
Testosterone ( Sigma Chemical Co., St. Louis, MO), dissolved in artificial CSF, was 
bath-applied at a final concentration of 1nM for 4 hr. Control slices obtained from other 
mice brains were so incubated for 5 hours with artificial CSF (Fig. 31). This 
testosterone concentration reflects the plasma testosterone level in the adult C57BL/6j 
male mice (0.19 to 12.18 ng/ml) (Nelson et al., 1975). 
Immunohistochemistry 
After incubation, slices were fixed with 4% paraformaldehyde in 0.1 M phosphate 
buffer, pH 7.4, overnight at 4°C and cryoprotected in 20% sucrose for 24 hours. Then, 
serial frozen sections (20 µm) were cut at -20°C. Sections then incubated one hour 
with blocking solution (0.1 M PBS, 1%BSA, and 0.2% triton X-100) at room 
temperature. Then sections were incubated with one or more primary antibodies 
(claudin-5, ZO-1, caveolin-1, GFAP, and iNOS) overnight at 4°C. Immune complex 
Figure 31: Representative schema of the incubation system of the ex vivo slice. 
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were revealed using secondary Alexa-conjugated anti-mouse or anti-rabbit IgG. 
Fluorescence staining was visualized under a confocal microscope. 
Results and discussion 
After four hours of incubation with testosterone, the labelling of the TJ protein claudin-
5 and ZO-1 seems to be increased in the castrated mice incubated with testosterone 
compared to the castrated mice incubated with CSF (Fig.1A - D). On tha other hand, 
testosterone decreases the immunolabelling of caveolin-1 (Fig.1E - F). 
The effect of testosterone on the inflammatory processes was studied. Astrocytic 
activity was assessed using GFAP immunohistochemistry. GFAP immunoreactivity 
appeared lower in the slices of castrated animals incubated with testosterone 
compared to those incubated with CSF (Fig.2A-B). In addition, testosterone seemed 
to decrease the proinflammatory iNOS immunolabelling (Fig.2C - D). 
These preliminary results, obtained using this ex vivo model, confirm that testosterone 
is involved in the maintenance of the BBB composition. Testosterone is able to 
modulate tight junctions and caveolae, meaning that testosterone could affect 
paracellular and transcellular transport. 
Caveolae regulate many endothelial functions, especially nitric oxide (NO) production 
by endothelial NO synthase (eNOS). Caveolin-1 negatively impacts eNOS activity 
through direct interaction with this enzyme (Mineo and Shaul, 2012). In addition to its 
transport activity, caveolin-1 plays an important role in cellular signaling by 
sequestering receptors and intracellular signaling proteins within caveolae and is 
considered as AR co-regulator by enhancing AR transcriptional activation in the 
presence of androgen {for review, see (Bennett et al., 2009)}. Our results allow to 
assume that testosterone may activate an interaction between caveolin-1 and AR or 
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ERs, which may enhance a transcriptional activity at the level of endothelial cells. 
Indeed, it has been recently mentioned that caveolin-1 mediates redistribution of 
claudin-5 causing BBB disruption in early ischemic stage, and treatment with caveolin 
siRNA restored the claudin-5 distribution (Liu et al., 2012). Thus, the hypothesis can 
be made that the increase in claudin-5 expression could be induced by the decrease 
in caveolin-1 within the endothelial cells of the brain blood vessels. All these preliminary 
results make arguments for a short-term action of sex steroid hormones on the BBB 
which may contribute in the regulation of the transport of substances from the 
circulation to the brain parenchyma, and that would be maintained in the long term. 
In addition, our results suggest that testosterone may have an anti-inflammatory effect, 
and this effect can take place through activation of AR and/or ERs in a few hours. 
This work needs to be completed with further studies to identify short-term effects of 
testosterone on the other components of the NVU. Likewise, further studies using 
different testosterone concentration and different time of incubation will be performed. 
To better understand the signaling pathway of testosterone, incubation with 
pharmacological reagents alone or in combination as AR antagonist (flutamide), ERs 
antagonists (ICI 182,780), or inhibitors of enzymes of testosterone metabolism will be 
used. 
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Figure 1 
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Figure 2 
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Figure legends 
Fig. 1 Testosterone induces an increase of endothelial tight junction proteins and 
decreases endothelial transport protein in castrated male mice. (A to D) Representative 
images of capillaries located in the MPOA in ex vivo slices from castrated mice incubated with 
aCSF for 4 hours (left panel) and incubated with 1 nM testosterone for 4 hours (right panel), 
labeled with anti-claudin-5 (red), anti-ZO-1 (red), anti-caveolin-1, 3 mice per group. Scale bar: 
10 µm.  
Fig. 2 Testosterone decreases glial activation and inflammatory molecule production. 
(A, B) Representative images of GFAP labeling (green) in capillaries located in the MPOA of 
ex vivo slices from castrated mice incubated with aCSF for 4 hours (left panel) and incubated 
with 1 nM testosterone for 4 hours (right panel), 2 mice per group. Scale bar= 60 µm. (C, D) 
Representative images of co-immuno-detection of iNOS (red) and GFAP (green) in capillaries 
located in the MPOA of ex vivo slices from castrated mice incubated with aCSF for 4 hours 
(left panel) and incubated with 1 nM testosterone for 4 hours (right panel), 2 mice per group. 
Scale bar 10 µm. 
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Discussion  
The blood-brain barrier (BBB) protects the central nervous system (CNS) from 
modifications of the blood stream involving in the CNS homeostasis, which is pre-
request for proper neuronal function. The BBB is present in all brain regions, except 
for the cirumventricular organs in which the blood vessels are fenestrated allowing 
diffusion of blood-borne molecules across the vessel wall. These unprotected areas of 
the brain regulate autonomic nervous system and endocrine glands of the body 
(Ballabh et al., 2004). BBB endothelial cells establish a physical barrier by an elaborate 
network of tight junctions (TJs) between adjacent endothelial cells combined with a 
very low pinocytosis activity and a lack of fenestration thus preventing the paracellular 
and transcellular diffusion of water soluble-molecules across BBB endothelial cells 
(Kniesel and Wolburg, 2000). Besides that, BBB endothelium establishes a metabolic 
barrier by the expression of many constitutive active transmembrane transporters and 
cytoplasmic enzymes, which ensure the transport of nutrients from the blood to the 
CNS and the rapid exclusion of toxic metabolites out of the CNS. In addition, the BBB 
is protected from oxidative stress by the presence of high levels of antioxidant 
enzymes, which are essential for proper brain functions (Méthy et al., 2004; Plateel et 
al., 1995). Finally, while the endothelial cells form the BBB properties, interactions with 
adjacent components of the neurovascular unit (astrocytes, pericytes, neurons, and 
basement membrane) are prerequisites for barrier function. The fully differentiated 
BBB consists of a complex system comprising the highly specialized endothelial cells 
and their underlying basement membrane in which a large number of pericytes are 
embedded, perivascular astrocytic end feet and associated parenchymal basement 
membrane (Engelhardt and Sorokin, 2009). Thus, endothelial function and vascular 
morphology make the BBB unique and distinguishable from any other microvessels in 
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the body (Coisne and Engelhardt, 2011). In many neurological pathologies, barrier 
characteristics of the BBB are altered, leading to edema formation and recruitment of 
inflammatory cells into the CNS (Engelhardt and Sorokin, 2009). 
Reproductive effect of sex steroid hormones is well-known. However, it is increasingly 
apparent that these hormones have important action on non-reproductive tissues such 
as blood vessels and brain, and these effects can be relevant through the life span, 
not limited only to reproductive years and not restricted only to one gender. Estrogen 
is not only a ‘female’ hormone nor is testosterone not exclusively a ‘male’ hormone. 
Moreover, it is clear that cerebral vessels are directly targeted by sex steroid 
hormones, as they express metabolizing enzymes for sex steroid hormones and also 
their receptors {for review, see (Krause et al., 2006, 2011)}.  
The general aim of my thesis was to study the role of sex steroid hormones on 
the neurovascular unit in the mouse hypothalamus. I focused more specifically 
on the medial preoptic are (MPOA) of the hypothalamus. Indeed, this region is 
implicated in variety of functions including: regulation of pituitary gonadotropin 
and prolactin release, thermoregulation, hypovolemic thirst, maternal behavior, 
and sexual behavior, and is considered as a seat of a hormone-dependent neural 
plasticity  
The major results I obtained during my thesis show that testosterone impacts 
cerebrovascular physiology in adult male mouse by regulating integrity and 
maintenance of the BBB (Atallah et al., submitted).  
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Our conclusion is based on the following data: 
1)  Lack of gonadal testosterone after castration leads to a discrete leakage of 
different molecular weight tracers from the blood compartment to the parenchyma. 
Immunodetection of endogenous circulating IgG in the brain parenchyma confirm 
these results.  
2) This lower selective permeability induced by castration, is associated with a 
disorganization of tight junction structure shown by electron tomography and a lower 
amount of tight junction proteins claudin-5 and ZO-1 
3) BBB leakage is also accompanied by a glial activation, an up-regulation of 
inflammatory molecules, and an increase of a cellular degeneration.  
4) Testosterone supplementation after castration restores the BBB selective 
permeability and TJ proteins expression, and lessen inflammatory features. 
This BBB dysfunction induced by depletion of circulating testosterone, is maintained 
over time. Indeed, similar results were obtained in mice castrated for 4 months (data 
not shown), reinforcing the concept of the regulatory role of testosterone in the integrity 
and maintenance of the BBB 
Tight junctions have been shown to be responsible for intercellular sealing, which 
control the passage of molecules between blood and brain parenchyma {for reviews 
see (Gumbiner, 1987, 1993; Schneeberger and Lynch, 1992). It has been reported that 
transmembrane proteins claudin-5 and occludin are important component of TJ and 
are both needed for the formation and maintenance of the BBB (Sonoda et al., 1999). 
Occludin, a ∼65-kDa integral membrane protein bearing four transmembrane domains, 
was identified as the first component of TJ strands. Occludin was shown to be not only 
a structural but also a functional component of TJ strands; occludin has been shown 
to be directly involved in barrier functions (McCarthy et al., 1996; Wong and Gumbiner, 
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1997). On the other hand, recent evidences reported that occludin as a critical 
regulatory protein and its presence in the TJ may act as a primary shock-absorber, 
mediating TJ responses to acute changes in vascular dynamics (Feldman et al., 2005; 
Sandoval and Witt, 2008). Our results showed that castration was of no significant 
effect on occludin expression. Studies showed that occludin is phosphorylated at 
serine and threonine residues and this phosphorylated protein is directly involved in TJ 
formation (Sakakibara et al., 1997). Thus, we cannot exclude a change in occludin 
phosphorylation level which may be modulated by testosterone. 
Claudins constitute a large family of 20-27 KDa membrane proteins (with four 
transmembrane domains) expressed in TJs in various cell types (Morita et al., 1999b; 
Tsukita et al., 2001). Claudins shear with occludin the four transmembrane domain in 
a tissue specific combination resulting in tissue specific barrier characteristics {for 
review, see (Krause et al., 2008). Thus, it is hypothesized that claudins form the 
primary “seal” of the TJ, and occludin acts as additional support structure. The 
expression patterns of claudins vary among different tissues. In cerebral capillary 
endothelial cells, claudin-1, -3, and -5 have been detected {for review, see (Hawkins 
and Davis, 2005; Vorbrodt and Dobrogowska, 2003)}. Claudin-5 has been shown to 
be highly expressed in the CNS endothelial cells, and a down-regulation of claudin-5 
leads to BBB disruption (Argaw et al., 2009; Morita et al., 1999b; Nitta et al., 2003). 
Our results show a significant decrease of claudin-5 expression in castrated mice 
which is restored by testosterone supplementation, suggesting that testosterone may 
have a regulatory effect on its synthesis. 
Occludin and claudins are linked to a number of cytoplasmic accessory scaffolding 
proteins including ZO-1 to the actin cytoskeleton, this interaction is likely critical to the 
stability and function of the TJ (Abbott et al., 2010; Hawkins and Davis, 2005). The first 
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TJ protein recognized was the 220 kDa ZO-1 phosphoprotein acting as a central 
organizer of the TJ by connecting transmembranous TJ proteins to the actin filaments 
(Erickson et al., 2007; Fanning et al., 1998). Loss or dissociation of ZO-1 from the 
junctional complexes is associated with barrier permeability (Abbruscato et al., 2002; 
Hawkins et al., 2004; Mark and Davis, 2002). In our study, we found a significant 
decrease in the expression of ZO-1 protein in castrated mice which is restored after 
testosterone supplementation.  
Thus, changes in BBB permeability after castration are linked to changes in expression 
of TJ proteins leading to a tight junction disorganization enhancing paracellular 
transport. This suggests that testosterone may regulate the synthesis and/or the 
activity of TJ proteins.  
Levels of circulating androgens change with normal development and aging and these 
changes may contribute to vulnerability of the male to an ischemic event. It has been 
reported that low plasma testosterone in men being associated with increased risk for 
cardiovascular events and stroke and likely worsen outcome in both young and old (for 
review, see Quillinan et al., 2014). However, other studies reported that the relatively 
high levels of testosterone in young adult men may contribute to injury and the increase 
incidence of cerebrovascular disease (Wang et al., 2013). This discrepancy suggests 
that optimum levels of circulating testosterone throughout life would be required to 
prevent neurological complications. 
In our study we found that the BBB disruption induced by chronic depletion of 
testosterone, is associated with an increase of glial (astroglia and microglia) activation 
and an up-regulation of inflammatory molecules (COX-2, iNOS, TNF-α, and IL-1β). 
These results are in agreement with other studies reporting that an increase in 
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cerebrovascular permeability is associated with heightened neuroinflammation. For 
instance, it has been found that female C57BL/6 mice showed a significant increase 
of cerebral IgG extravasation, and this increase in the permeability is associated with 
a remarkable increase of astrocytes markers (GFAP and S100β) (Takechi et al., 2013). 
Other study has demonstrated that pro-inflammatory cytokines including TNF-α, and 
IL-1β regulate the expression of TJ proteins as claudin-5 and ZO-1. In this study using 
healthy C57BL/6j female mice, they have reported a significant extravasation of 
circulating IgG into cerebral parenchyma in the cortex and hippocampal formation of 
aged mice compared to young control mice. This increase in the permeability is 
associated with an up-regulation of GFAP, COX-2, TNF-α, and IL-1β, and a decrease 
in TJ proteins ZO-1 and occludin (Elahy et al., 2015). Our results confirmed these 
studies, that the disruption in the BBB is associated with inflammatory signs in both 
male and female. 
Similar features have been described in a study using castrated young male mice 
described as a model for Parkinson disease, (Khasnavis et al., 2013). Astroglia activity 
has also been reported in castrated adult male rats (Day et al., 1990). Regardless of 
the sequence of events induced by testosterone depletion, BBB impairment and 
neuroinflammation observed in castrated males were accompanied with a significant 
increase of fluorescent marker Fluoro-Jade C density, a known marker for identification 
of neuronal degeneration (Bian et al., 2007; Schmued and Hopkins, 2000), and able 
also to stain activated microglia and astrocytes in a Alzheimer's disease mouse model 
(Damjanac et al., 2007). It has been shown that physiological level of testosterone 
protects against neuronal apoptosis (Hammond et al., 2001; Nguyen et al., 2010). 
Thus, a link can be established between levels of circulating testosterone, failure of 
selective permeability of the BBB and neurodegeneration. Here again, dysfunction of 
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the BBB may be the cause or consequence of degenerative processes (see for review 
Carvey et al., 2009). 
Taken together, these results suggest that circulating gonadal testosterone level 
is a parameter to be taken into account in the cerebrovascular physiology and 
function. Our data provide evidences showing that testicular hormone regulates 
BBB integrity and associated- inflammation in male. However, it is still difficult 
to determine if the inflammatory profile observed after chronic depletion of 
testosterone is a cause or a consequence of the disruption of the BBB. 
 
Further experimental studies examining the role of sex steroid hormone receptors, 
androgenic agonists and antagonists will provide valuable insights into the role of 
androgens in order to understand how the complex hormones/ BBB can be effectively 
targeted for optimization of CNS delivery of therapeutic drugs.  
Testosterone is the major active androgen circulating in blood, testosterone exerts 
many of its effects after conversion to 5α-dihydrotestosterone (DHT) and estrogens. 
The CNS possesses both the 5α-reductase, the enzyme which produces DHT and the 
aromatase which transforms testosterone into estrogens. Testosterone and DHT bind 
to and activate the androgen receptor (AR), while estrogens bind and activate estrogen 
receptors (ERs). These receptors are members of the nuclear receptor family of 
transcription factors, and these nuclear receptors control transcription by recruitment 
of a variety of co-activators and co-repressors (Celotti et al., 1991; Hiipakka and Liao, 
1998).  
Testosterone has been reported for its various effects on numerous body tissues, 
including CNS. One of the lesser known actions of testosterone is its role in 
neuroprotection that takes place via activation of androgen pathways. The function and 
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integrity of the AR, which is considered as an auto-regulated protein, are generally 
thought to depend on adequate circulating level of androgen. Our results show that 
testosterone depletion caused by castration is associated with a significant decrease 
in AR expression and a change in its cellular distribution. In castrated mice, AR labeling 
is not observed as nuclear and intense but appeared cytoplasmic and weaker. In 
castrated mice, the absence of activation of AR by its ligand shall prevent its nuclear 
addressing. By contrast, a significant increase in the expression of nuclear ERα is 
noticed. This latter observation may suggest a compensation system that remains 
unclear. This cellular distribution pattern and expression of steroid receptors are 
concomitant with the BBB failure and decrease in TJ proteins expression (claudin-5 
and ZO-1) induced by castration. The increase in the BBB permeability and the 
modification in the tight junction composition that we observed in the conditional AR 
knock-out mice (ARNesCre), confirm our hypothesis about the role of AR in the formation 
and /or maintenance of the BBB. These ARNesCre mice have a deletion of AR specifically 
in neural cells (astrocytes and neurons). It is now important to determine whether AR 
and ERs are still present in the endothelial cells of brain capillaries in these transgenic 
mice. Experiments in this direction are currently underway. Thus this model may be a 
particularly interesting tool to specifically study in vivo the endothelial AR. 
The use of other conditional transgenic male mice models generated and 
characterized in our team, as mice selectively lacking ERα or ERβ in neural cells, will 
permit to clarify the respective involvement and signaling pathways of these receptors.  
To date, our data suggest the involvement of androgen receptors, and probably 
more widely of sex steroid receptors and their signaling pathways, in the 
integrity of the BBB and the neuroprotection of the CNS in adult male mice.  
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Along with these in vivo studies, we chose to use an ex vivo model for access to the 
molecular mechanisms underlying this plasticity induced by sexual hormones steroids. 
Perifused hypothalamus slices are a useful tool to evaluate short-term action of 
testosterone and the role of each steroid receptor by controlling the composition of the 
incubation medium, while local cellular interactions are preserved. To our knowledge, 
this type of experimental ex vivo model has not been yet reported for studying sex 
steroid receptor signaling pathways. 
In our preliminary studies, our results provide preliminary information on a short-term 
effect of testosterone on the composition of tight junctions and induction of an 
inflammatory reaction in the MPOA of adult mice. To address this purpose, we used 
hypothalamic slices including MPOA region frome castrated mice, incubated with 1 nM 
testosterone for 4 hours. This testosterone concentration reflects a low physiological 
level in plasma testosterone which may vary from 0.7 to 40nM (0.19ng/ml to 
12.18ng/ml) in the adult C57BL/6j male mice (Batty, 1978; Nelson et al., 1975). Both 
estrogens and androgens activate target gene transcription by binding to their 
respective nuclear receptors (genomic action) as well as by binding to receptors 
associated with the cell membrane (non-genomic action) {for review, see (Klinge et al., 
1992)}. In vitro study have reported that a 24 hours-incubation of human vascular 
endothelial cells (HUVEC) with either 10nM estradiol or 10nM DHT have increased 
occludin expression and decreased paracellular permeability. In the present study, 4 
hours of incubation of hypothalamus slices from castrated mice with 1 nM testosterone 
seems to be associated with an increase of endothelial tight junction protein claudin-5 
and ZO-1 expression and a decrease in caveolin-1, parameters which will lead to 
impact paracellular and transcellular BBB permeability. In addition, our results suggest 
that testosterone has an anti-inflammatory effect, and this effect can take place through 
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activation of AR and/or ERs in a few hours. But these observations still need to be 
confirmed, particularly by quantitative analyzes. 
Given the role of circulating testosterone on the neurovascular unity and the integrity 
of the BBB in male, the question arises regarding the role of circulating estrogen in 
female. Indeed, there is growing evidences suggesting that estrogen could exert 
neuroprotective effects on the injured CNS improving cell survival (Miller and Duckles, 
2008). While data in the literature show that ERα regulates the expression of claudin-
5 in the tight junctions (Burek et al., 2010, 2014), mechanism of action of estrogens on 
the BBB integrity and maintenance remains to be elucidated, as neurovascular unit 
elements are important for the structural and functional integrity of the BBB. So, we 
initiated a study investigating the effects of ovariectomy on the BBB permeability, 
compared to estrogen-implanted ovariectomized mice (to avoid the hormonal cycle).  
The present data indicate that BBB permeability for both Evans blue dye and 
exogenous injected-HRP, was increased in ovariectomized female. These 
observations are similar to those obtained in castrated male. Transport of molecules 
across the BBB can occur either transcellularly, mediated by active and energy-
dependent transporters, or through paracellular routes, via a loosening of tight 
junctions between endothelial cells. Both Evan’s blue dye, which binds plasmatic 
serum albumin, and HRP may pass through endothelial tight junctions. In some 
pathological conditions as hypoxia, labeled albumin has been detected in brain 
endothelial cells indicating that albumin is likely to be transported by nonspecific 
vesicular transport (Plateel et al., 1997). Increased transport in the ovariectomized 
females may therefore result from chronic leakiness of the tight junctions of endothelial 
cells, or from increased nonspecific vesicular transfer.  
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Impairment of the blood-brain barrier may also signal a greater potential for leukocyte 
infiltration into the brain and an increase of local inflammation. It is known that 
estrogens reduce endothelial inflammatory activation (Krause et al., 2011; Witt and 
Sandoval, 2014b). Our preliminary results tend to confirm the anti-inflammatory effect 
of estrogens as ovariectomized female showed higher astrocytic activity and iNOS 
expression compared to female ovariectomized and treated with estradiol. 
Recent studies have shown that estrogen receptors α and β are present in 
mitochondria mediating many protective effects (Alvarez et al., 1997; Yager and Chen, 
2007). Functional estrogen receptors are present in the cerebral endothelium (Duckles 
and Krause, 2007). Involvement of estrogen receptors in 17β-estradiol-mediated 
beneficial effects during vascular injury, has been investigated (Connell and Saleh, 
2011; Miller et al., 2005), but, their role in regulating microvascular hyperpermeability 
has not been clearly demonstrated. A preliminary study using conditional knock-out 
ERβ female mice (ERβNesCre) shows a leakage for different tracers, Evans Bleu and 
peroxidase. A modification in the expression of tight junction protein claudin-5 and 
caveolin-1 seems to occur. These observations tend to confirm the involvement of ERβ 
on the integrity of the BBB. 
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Perspectives  
Understanding the BBB physiology is, indeed, critical to get new insights in 
neurological and metabolic diseases involving BBB dysfunction and for the 
development of drugs that can cross the BBB. The results I have obtained during my 
thesis, using different experimental models, give the light about the importance of 
testosterone in BBB physiology and neuroinflammation, and the involvement of 
androgen receptor and/or estrogen receptors.  
Understanding, how testosterone operates to impact these processes is of great 
relevance. Indeed, this could provide new insights into neurological and metabolic 
diseases, which are linked to the hormonal status, and help to improve the outcome of 
hormone replacement in aged and young hypogonadic men.  
Beyond the physiological role of sexual steroid hormones and their receptors in the 
BBB maintenance and the neuroinflammation, my results open new research 
perspectives: what are the consequences of exposure to endocrine disruptors, 
chemical molecules present in the environment and known to interfere with the 
endocrine system? 
Endocrine disruptors (ECDs) are chemicals that may interfere with the body’s 
endocrine system and produce adverse developmental, reproductive, neurological, 
and immune effects in both humans and wildlife. A wide range of substances, both 
natural and man-made, are thought to cause endocrine disruption, including 
pharmaceuticals, dioxin and dioxin-like compounds, polychlorinated biphenyls, DDT 
and other pesticides, and plasticizers such as bisphenol A (BPA). Endocrine disruptors 
may be found in many everyday products– including plastic bottles, metal food cans, 
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detergents, flame retardants, food, toys, cosmetics, and pesticides. The National 
Institute of Environmental Health Sciences (NIEHS) supports studies to determine 
whether exposure to endocrine disruptors may result in human health effects including 
lowered fertility and an increased incidence of endometriosis and some cancers. 
Animal studies have learned much about the mechanisms through which endocrine 
disruptors influence the endocrine system and alter hormonal functions. These 
compounds mimic or partly mimic naturally occurring hormones in the body like 
estrogens, androgens, and thyroid hormones, potentially producing overstimulation, 
can bind to a receptor within a cell and block the endogenous hormone from binding. 
The normal signal then fails to occur and the body fails to respond properly (Sweeney 
et al., 2015)  
One of these ECDs is Di (2-ethylhexyl) phthalate (DEHP). This molecules is a highly 
used in the manufacture of a wide variety of consumer food packaging, some children’s 
products, and some polyvinyl chloride (PVC) medical devices. It is believed to cause 
endocrine disruption in males through its action as an androgen antagonist, and may 
have effects on reproductive function in both childhood and adult exposures. In 2006, 
the National Toxicology Program (NTP) has found that DEHP may pose a risk to 
human development, especially critically ill male infants (Shelby, 2006). Prenatal 
phthalate exposure has been shown to be associated with lower levels of reproductive 
function in adolescent men (Axelsson et al., 2015). 
To my knowledge, there are no study about the effect of DEHP on the BBB permeability 
and consequences on the neurovascular unit. Our project is to treat adult male mice 
with different dose of DEHP and study the effect of this exposure on the permeability 
and function of the neurovascular unit. This project will open the research to highlight 
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the interaction between environmental exposure to ECDs and the risk/or the incidence 
of neurological or metabolic diseases. These data will complement a study in the team 
on the impact of this endocrine disruptor on sexual behavior.
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